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1 Summary 
 
The Thymine DNA Glycosylase (TDG) was initially discovered by its ability to excise the deamination 
products of cytosine and 5-methylcytosine (5-mC), and therefore thought to initiate base excision 
repair (BER) of the resulting G•U  and  G•T  mismatches.  Later, TDG was also found to act in concert 
with transcription factors in the regulation of gene expression. Whereas in some cases the function 
of TDG in gene regulation appeared to be a purely structural one (Chen et al. 2003), its role as a co-
activator of the retinoic acid receptors (RAR/RXR), for instance, was shown to require its catalytic 
activity. In the attempt to connect these two seemingly distinct functions, TDG has been proposed to 
act as a DNA demethylase, removing 5-mC from the promoter regions of genes for transcriptional 
activation (Jost 1993; Jost et al. 1995; Zhu et al. 2000). However, as TDG appeared not to have direct 
5-mC glycosylase activity its role in active DNA demethylation in mammals has remained 
controversial and the mechanism in general elusive.  
With its apparently two-sided nature, TDG has riddled researchers for many years and the stimuli 
and interactions that control TDG function are still under investigation. The aim of my thesis was to 
dissect the role of TDG in DNA repair with a focus on its regulation by post-translational modification, 
and to investigate how TDG-initiated BER contributes to epigenetic stability at CpG islands (CGIs) 
during cell differentiation. 
Both described functions of TDG, in DNA repair and in the regulation of gene expression, require its 
post-translational modification and non-covalent interaction with the small ubiquitin-like modifiers, 
SUMO1 and SUMO2/3 (Hardeland et al. 2002; Steinacher and Schar 2005; Mohan et al. 2007). 
Extensive biochemical studies by our laboratory have shown that SUMOylation of TDG may induce its 
dissociation from the abasic (AP-) site after base excision (Hardeland et al. 2002; Steinacher and 
Schar 2005). However, in vivo evidence corroborating an involvement of SUMOylation in TDG-
dependent BER has been pending and the function of non-covalent SUMO-binding has remained 
elusive. I thus generated a Fluorescence Resonance Energy Transfer (FRET) system to monitor the 
interaction between TDG and SUMO1 or SUMO3 in cells. I was able to confirm a modulation of the 
SUMO1-TDG interaction dynamics in response to DNA damage, whereas the interaction with SUMO3 
remained unaffected. This finding suggests that SUMO3 might regulate TDG function in a context 
other than DNA repair. In the light of recent findings that TDG is indeed involved in processes beyond 
canonical DNA repair, i.e. in maintaining the epigenetic stability of CGIs, our FRET system provides a 
powerful tool to investigate the role of SUMOylation and also specifically SUMO-binding in regulating 
TDG function in these pathways.  
As the interaction partners of TDG range from DNA repair factors to transcription factors and even 
DNA methyltransferases (DNMTs) (Cortazar et al. 2007; Li et al. 2007; Boland and Christman 2008), 
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we set out to investigate the biological function of TDG genetically, by generating a Tdg knockout 
mouse. Much to our surprise, and in contrast to any other known DNA glycosylase, deletion of Tdg 
caused embryonic lethality. Further characterization of MEFs isolated from TDG-proficient 
and -deficient embryos revealed no evidence for a DNA repair defect, but a significant number of 
misregulated genes in differentiated Tdg-/- cells. We found that Tdg knockout caused a loss of active 
histone marks, gain of repressive histone modifications and an accumulation of CpG methylation at 
CGI promoters. Interestingly, this phenotype became apparent only in differentiated but not in 
pluripotent cells. From these data, we proposed a dual function of TDG in maintaining active 
chromatin states at promoters during cell differentiation, first by structurally coordinating histone 
modifying enzymes and second by counteracting errors of the DNA methylation machinery by 
initiating repair of aberrantly methylated cytosines in CGIs. Consistent with a TDG-dependent 
engagement of DNA repair at such sites, we found BER factors to associate with these promoters and 
DNA repair intermediates to accumulate in differentiating cells in a TDG dependent manner. 
These findings established a role of TDG in maintaining epigenome integrity in the context of cell 
differentiation. To investigate how TDG is involved in DNA methylation control, we mapped DNA 
methylation in the genomes of TDG-proficient and -deficient mouse embryonic stem cells (ESCs), 
neuronal progenitor cells (NPs) and MEFs and again found differential methylation to arise only with 
differentiation. Further characterization of the resulting differentially methylated regions (DMRs) 
revealed that those overlapping with a CGI were almost exclusively hypomethylated in TDG-deficient 
compared to -proficient cells, reflecting a failure to establish methylation at these CGIs during 
differentiation. In search of the reason for this failure in a 24 h differentiation timecourse, we found 
global 5-mC levels to rise with differentiation in cells lacking TDG activity, in parallel to the generation 
of the final products of TET-protein catalyzed 5-mC oxidation, 5-formylcytosine (5-fC) and 
5-carboxylcytosine (5-caC), the latter two of which are proposed intermediates of active DNA 
demethylation and substrates for TDG. Differentiation thus appeared to induce methylation but also 
5-mC oxidation to 5-fC and 5-caC for subsequent active demethylation by TDG. We therefore 
analyzed 5-mC and 5-caC levels at the CGI DMRs and found both to rise with differentiation in 
wildtype cells, suggesting that the loss of pluripotency induces a cycle of DNA methylation and 
demethylation at specific CGIs. In Tdg knockout cells, though, this induction appeared to fail whereas 
in cells expressing a catalytically dead mutant TDG (TDGΔcat), the cycle of methylation and 
demethylation was induced but blocked by the inability of TDGΔcat to excise 5-caC. In these cells, 
5-caC will eventually be erased passively by DNA replication but this way of restoring an 
unmethylated C appears not to be sufficient to maintain the cycle and eventually establish 
methylation at these CGIs.  
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Taken together, in collaboration with colleagues from different laboratories I was able to show that 
differentiation triggers a state of high epigenetic plasticity at these CGIs and that catalytically active 
TDG is required to maintain an equilibrium of DNA methylation and demethylation. The imbalance of 
epigenetic marks resulting from knockout of TDG disrupts gene expression programs and the 
accumulation of aberrations eventually leads to loss of viability on the cellular and on the organismic 
level. 
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2 Introduction 
 
 
2.1. DNA Repair and the Concept of Genome Maintenance 
 
DNA is the carrier of genetic information, encoding the building blocks of all organisms. The DNA 
forms a double helical structure, consisting of two complementary single-strands that are made up of 
a deoxyribose-phosphate backbone supporting a sequential assembly of nucleosides with four 
different bases: the purines adenine (A) and guanine (G), and the pyrimidines thymine (T) and 
cytosine (C). The bases of opposite strands form specific hydrogen bonds with one another, 
establishing the complementarity of the two single-strands through the so-called Watson-and-Crick 
base pairing: G pairs with C via three hydrogen bonds, while A and T form two hydrogen bonds. All 
DNA-templated processes like replication, repair and transcription, rely on this basic principle. 
 
 
2.1.1. Sources of DNA Damage and Modification 
 
As an inherently instable molecule, the DNA is constantly at risk of being damaged by reacting with 
oxygen, water or other reactive agents of endogenous or exogenous origin.  
 
Endogenous DNA damage 
 
Endogenous DNA damage can arise, for instance, when the N-glycosidic bond between a DNA base 
and the deoxyribose hydrolyzes spontaneously, producing an apurinic or apyrimidinic (AP) site. Such 
AP-sites lack any instructive coding information and are therefore potentially mutagenic. 
Spontaneous damage can also derive from hydrolysis of the exocyclic amino groups of cytosine, 5-
methylcytosine (5-mC), adenine and guanine, which converts them to uracil, thymine, hypoxanthine 
and xanthine, respectively. Thus, deamination of C and 5-mC  generate  C  →  T  transition  mutations, 
while   the   deamination   product   of   A   pairs   preferentially   with   C,   thus   causing   A  →  G   transitions if 
unrepaired before the next round of DNA replication. As xanthine also pairs with C, deamination of G 
has no mutagenic effect. Another endogenous cause of DNA damage is the replication process itself, 
which can produce mismatches and double-strand breaks despite the high accuracy of the replicative 
DNA polymerases. 
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Oxidative damage can derive from reactions of the DNA with reactive oxygen species (ROS), which 
can arise as by-products of the normal cell metabolism. Oxidative damage to the bases can produce 
for example 8-oxoG   which   causes   G   →   T   mutations,   or   thymine   glycol   which   interferes   with  
replication fork progression. 
Alkylation of bases can also be caused by endogenous agents; S-adenosylmethionine, for example, is 
an enzymatic cofactor which can accidentally generate 7-methylG, 3-methylA or O6-methylG, the 
latter of which is pro-mutagenic as it pairs with T instead of C (Scharer 2003). 
 
Endogenous DNA modification 
 
It is striking that not all alkylation of bases is harmful to the integrity of the genetic code; certain base 
modifications have a function in cellular processes. Such modifications do not alter the base-pairing 
properties but change the   DNA’s overall charge and surface enough to affect DNA-protein 
interactions. The most prominent example is 5-mC, which occurs in mammals almost exclusively in 
the CpG context and serves as an epigenetic mark (see chapter 2.3.3.). The mechanisms that evolved 
to recognize small but harmful modifications to bases appear perfectly suited to read functional base 
modifications as well, a concept that is supported by the notion that members of the DNA 
glycosylase family of proteins, which initiate the Base Excision Repair (BER) pathway by recognizing 
and excising even bases with minor alterations, have been found to be involved in processes beyond 
canonical DNA repair (Jacobs and Schar 2012) (Appendix IV). 
Deamination of bases not only occurs spontaneously but can also be enzymatically induced, which 
plays an important role in innate and adaptive immunity. Members of the apolipoprotein B mRNA 
editing catalytic polypeptide (APOBEC) family of cytodine deaminases confer innate immunity against 
retroviruses by deaminating cytosines in the viral cDNA and thus triggering its degradation by the 
concerted action of UNG2 and APE1 (Harris et al. 2003; Yang et al. 2007). Furthermore, the activation 
induced cytidine deaminase (AID) contributes to antibody maturation in adaptive immunity by 
deaminating cytosines in the course of somatic hypermutation to induce mutations in the light chain 
variable region of immunoglobulin loci (Pavri and Nussenzweig 2011). Also, deamination of cytosine 
followed by uracil processing that produces single-strand breaks required for the initiation of class 
switch recombination (Imai et al. 2003). 
 
Exogenous DNA damage 
 
Exogenous DNA damage can be caused for instance by UV light, which generates pyrimidine dimers 
by inducing the formation of cyclobutane rings between adjacent cytosines and/or thymines, thus 
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disturbing the double helical structure. These dimers are mostly paired with A during replication, 
which is why T-T dimers are less mutagenic than C-T and C-C  dimers.  The  latter  can  cause  C  →  T  or  CC  
→  TT  transition  mutations  if  they  remain  unrepaired (Scharer 2003). 
The integrity of the DNA structure can also be compromised by X-rays,  α-,  β- and  γ-radiation, which 
are summarized as ionizing radiation. These can affect not only the bases but also the deoxyribose 
moieties of the DNA backbone, causing single- and double-strand breaks as well as DNA-DNA or DNA-
protein-crosslinks. These effects arise either directly or through the generation of ROS, like hydrogen 
peroxide, superoxide radical anions or hydroxyl radicals (Scharer 2003). 
Alkylating agents pose a threat to the DNA either by causing intra- or interstrand crosslinks which 
block replication fork progression or by aberrantly methylating DNA bases (Scharer 2003). 
 
 
 
 
2.1.2. Molecular Mechanisms to Repair DNA Damage 
 
To ensure the integrity of the genetic code, cells harbor an arsenal of repair mechanisms that address 
specifically different kinds of DNA damage. Figure 2-01 summarizes the most relevant causes of DNA 
damage, the type of DNA damage they produce and the repair pathway that fixes them. 
 
Direct Repair 
 
The most straightforward way a cell can address DNA damage is by direct chemical reversal of the 
lesion. Bacteria, plants and lower eukaryotes harbor so-called photolyases which can reverse UV light 
induced pyrimidine dimers in a light-dependent   process   called   ‘photoreactivation’   (Essen and Klar 
2006). Higher eukaryotes, on the other hand, depend on Nucleotide Excision Repair (NER) to address 
these photoadducts (see below). 
O6-alkylguanine transferases (AGTs, or in humans O6-methylguanine methyltransferase, MGMT) are 
another example. These proteins convert O6-alkylguanine back to guanine in an irreversible reaction 
that transfers the aberrant methyl-group from the guanine to an acceptor cysteine residue of the 
protein, after which they are inactive and targeted for proteolytic degradation (Pegg 2000). Finally, 
the bacterial iron and 2-ketoglutarate dependent oxygenase AlkB targets methyl-lesions (1-methylA 
and 3-methylC) in DNA and RNA, converting them to their original state through oxidative 
demethylation (Falnes et al. 2007). 
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Figure 2-01: Overview of the most common DNA damaging agents, lesions and corresponding repair 
pathways. Summarized are the most important DNA damage causes (top), the lesions they induce (middle) and 
the pathways employed to repair these lesions (bottom) (Scharer 2003). 
 
 
DNA Double-Strand Break Repair 
 
DNA double-strand breaks (DSBs) can be the product of ionizing radiation or metabolic by-products 
like ROS but also arise during DNA replication or repair. DSBs are among the most harmful DNA 
lesions as they can lead to chromosomal aberrations and deletions, or if unrepaired cause cell death. 
In order to give the cellular repair machinery time to react, DSBs trigger cell cycle checkpoints that 
arrest cell cycle progression. Members of the phosphatidylinositol 3-kinase-like kinase (PIKK) family, 
namely ATM (ataxia-telangiectasia mutated) and ATR (ATM and Rad 3-related), are thought to 
activate the central checkpoint regulators p53, Chk1 and Chk2, which in turn activate Cdk2/CyclinE 
and Cdk2/CyclinB1 to mediate G1 and G2 arrest, respectively (Langerak and Russell 2011). 
Depending on the cell cycle stage, DSBs are repaired preferentially either by homologous 
recombination (HR) or non-homologous end joining (NHEJ). HR is mostly employed in S and G2 phase 
when a sister chromatid is available as an identical copy of the damaged double-strand that can 
serve as a template for synthesis the original sequence across the DSB. This requires strand-invasion 
and the formation of so-called Holliday-junctions, the ultimate resolution of which may result in a 
reciprocal exchange of the engaged DNA double-strands, known as sister chromatid exchange. In G1 
and early S phase, when a sister chromatid is not available, cells utilize the more error-prone NHEJ to 
repair DSBs and avoid cell death. In this pathway, free ends at the break are captured, tethered and 
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re-attached through minimal base-pairing, which often results in deletions and point mutations 
(Friedberg 2003). 
 
 
Nucleotide Excision Repair 
 
Bulky DNA lesions that perturb the overall structure of the DNA double helix and interfere with DNA 
replication and transcription are corrected by the Nucleotide Excision Repair (NER) machinery. NER 
can be subdivided by the mode of damage recognition into global genome repair (GGR) and 
transcription-coupled repair (TCR). As the name implies, TCR involves the transcription machinery 
sensing a lesion that blocks the progression of the RNA polymerase, whereas in the transcription-
independent GGR pathway, a helix-distorting damage is recognized by a complex of XPC and HR23B. 
In both cases, the DNA is locally unwound and the damage-containing  strand  is  cleaved  3’  and  5’  of  
the damage, generating a single-stranded DNA stretch of 24-32 nucleotides. The double-strand is 
restored  through  repair  synthesis  by  polymerase  δ  and/or  ε  and  ligation  by  DNA  ligase   I (Friedberg 
2003). 
Defects in NER are connected to a predisposition to cancer and premature ageing. Two syndromes 
are caused by loss-of-function of NER factors, namely Xeroderma pigmentosum caused by defects in 
GGR, and Cockayne syndrome resulting from defective TCR. The fact that certain types of Xeroderma 
pigmentosum are connected to neurological abnormalities and that patients with Cockayne 
syndrome display developmental and neurological defects, reflects the involvement of NER factors in 
processes beyond DNA repair (Kamileri et al. 2012).  
 
 
Mismatch Repair 
 
Although strictly taken no physical DNA damage, base mismatches and small insertions/deletions 
that derive from base misincorporation by and slippage of DNA polymerases during the DNA 
replication process have to be corrected to avoid mutations. Such replication errors are corrected by 
the Mismatch Repair (MMR) system that can distinguish between the template and the newly 
synthesized DNA strand. In eukaryotes, mismatched bases and small insertion/deletion loops are 
recognized   by   MutSα   (heterodimer   of   hMSH2-hMSH6),   larger   loops   by   MutSβ   (heterodimer   of  
hMSH2-hMSH3), which in subsequent steps recruit the MLH1/PMS2 heterodimer. This heterodimer, 
termed   MutLα,   recognizes   the   newly   synthesized   strand   by   replication-associated strand 
discontinuities, e.g. between unprocessed Okazaki fragments. Furthermore, the PMS2 subunit of 
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MutLα   was   found   to   possess   endonuclease   activity   in   concert   with  MutSα,   PCNA   and   replication  
factor C (RFC) that could induce strand discontinuities (Kadyrov et al. 2006). Such a nick in close 
proximity to the mismatch serves as an entry point for excision of the newly synthesized strand by 
exonucleases (e.g. EXO1) through and beyond the mismatch, followed by DNA repair synthesis by a 
replicative DNA polymerase and sealing of the nick by DNA ligase I (Friedberg 2003). 
 
 
2.1.3. Base Excision Repair and Single-strand Break Repair 
 
Single-base damage caused by deamination, oxidation or alkylation is mainly addressed by Base 
Excision Repair (BER). As this pathway is central to my thesis, I summarize it here in more detail. 
This pathway is initiated by DNA glycosylases, a family of enzymes that evolved to specifically 
recognize irregular DNA base modifications. DNA glycosylases recognize a substrate base by flipping 
it out of the double-helical context into an active site pocket. Subsequently, they cleave the N-
glycosidic bond between the base and the deoxyribose, which produces an AP-site. In Appendix IV, I 
am presenting a detailed review on this ancient family of enzymes, their mode of action and their 
involvement in processes beyond canonical DNA repair, for instance in adaptive immunity and active 
DNA demethylation. 
Two sub-pathways are distinguished in BER, depending on whether just a single nucleotide is 
replaced (short-patch) or a stretch of 2-13 nucleotides (long-patch, Fig. 2-02). Short-patch BER 
involves a mono- or bifunctional glycosylase, distinguished by their mode of base excision. 
Monofunctional glycosylases only catalyze base excision by utilizing an activated water molecule for 
nucleophilic attack on the N-glycosidic bond. Bifunctional glycosylases use the amino group of a 
conserved lysine for this purpose, resulting in a covalent Schiff’s  base  intermediate. Their  inherent  3’  
AP lyase activity enables bifunctional glycosylases to cleave the AP-site by   β-elimination. The 
resulting 3’  α,β-unsaturated aldehyde is processed by an AP endonuclease (e.g. APE1 in human and 
mouse) to  produce  the  3’OH required for repair synthesis. 
Since monofunctional glycosylases have no AP lyase activity, nicking of the AP-site is performed by 
APE1  which  generates  a  3’OH  and  a  5’deoxyribose-phosphate  (5’dRP)  end.  DNA  polymerase  β  (Polβ)  
harbors  a  5’dRP   lyase  activity,   thus  hydrolyzing   the  5’dRP  prior   to   filling   the   single-nucleotide gap. 
The remaining nick is sealed either by DNA ligase I or by a complex of DNA ligase III with XRCC1 
(Almeida and Sobol 2007) (Fig. 2-02). 
The  5’  end  produced  by  APE1  upon  incising  an  oxidized  or  reduced  AP-site cannot be processed by 
the 5’dRP  lyase  activity  of  Polβ.  In  this  case,  a stretch of DNA 3' to the excised bases is displaced and 
resynthesized through long-patch BER. The current mechanistic model proposes that strand-
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displacement   is   accomplished   through   DNA   synthesis   by   polymerase   δ,   ε   or   β,   aided   by   the  
Proliferating Cell Nuclear Antigen (PCNA), the replication factor C (RFC) and the poly (ADP-ribose) 
polymerase 1 (PARP1). The resulting DNA flap structure of 2-13 nucleotides is degraded by the flap 
endonuclease 1 (FEN1) and the ends are sealed by DNA ligase I (Fig. 2-02) (Almeida and Sobol 2007; 
Fortini and Dogliotti 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-02: Overview of short- and long-patch BER and SSBR in human cells. Short-patch (SP-) BER is initiated by 
a mono- or bifunctional glycosylase excising a substrate base. APE1 or the inherent AP lyase activity of a 
bifunctional glycosylase cleaves the AP-site, followed by processing of the free DNA ends to allow repair 
synthesis  by  Polβ.  Finally,  the  remaining  nick  is  ligated  by  LigaseIII   (LIGIIIα)  in complex with XRCC1. Long-patch 
BER is employed when strand incision by APE1 produces ends that are refractory  to  end  processing  by  Polβ.  In  
this case, the  damaged  strand  is  displaced  through  DNA  synthesis  by  Polβ,  δ  or  ε  aided  by  PCNA,  the  resulting  
DNA flap is cleaved by FEN1 and the ends are sealed by Ligase I (LIGI). An APE1-independent pathway is 
initiated by NEIL1 or 2, followed by end-processing by PNK (PNKP). SSBR is initiated by PARP which recognize a 
single-strand   break   and   recruits   XRCC1/LIGIIIα,   which   in   turn   provide   a   scaffold   for   the   assembly   of  
downstream   factors.   The  damaged   5’   and  3’   termini   (red circles) are further processed by APE1 or PNKP to 
yield 3’OH  and  5’  phosphate  moieties.  Subsequent  steps  are  similar  if  not  identical  to  SP- or LP-BER. Adapted 
from (Kim and Wilson 2012) with information from (Caldecott 2003). 
 
 
Downstream of base excision and AP-site incision, BER converges with the single-strand break repair 
pathway (SSBR). Hence, BER and SSBR share many proteins and features except for the initiation 
step, which, in the latter case, appears to be coordinated by the poly (ADP-ribose) polymerase 1 
Single-Strand Break 
LIGIIIα/XRCC1 
PNKP 
APE1 
PARP 
SSBR 
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(PARP1) instead of a DNA glycosylase. PARP1 recognizes the single-strand break and recruits XRCC1 
which serves as a scaffold for the assembly of the SSBR complex (Masson et al. 1998). The DNA ends 
are   processed   to   generate   a   3’OH  and   a  5’   phosphate  moiety,  which   can   involve   several   enzymes  
depending  on  the  type  of  residue  at  the  3’  and  5’  end,  e.g.  APE1  or  the  polynucleotide  kinase  (PNK)  
(Fig. 2-02). The subsequent repair steps are similar, if not identical to those of BER with regard to the 
factors involved and the short- or long-patch repair sub-pathways (Fortini and Dogliotti 2007). 
Oxidized bases like dihydrothymine or α-anomeric 2'-deoxynucleosides like  α-2'-deoxyadenosine can 
also be repaired by nucleotide incision repair (NIR) a pathway equivalent to BER except for the 
initiation step. NIR is independent of DNA glycosylases but relies on APE1 which cleaves the DNA 
backbone  5’  of  these  bases.  NIR  of  deaminated  purine  bases  is  initiated  by  EndoV  which  incises  one  
nucleotide  3’  of  the  lesion  (Dalhus et al. 2009).  
Moreover, oxidized bases have been shown to be repaired independently of APE1, following the 
action of the bifunctional glycosylases NEIL1 and 2 that catalyze a simultaneous beta-delta 
elimination.  The  resulting  3’  phosphate  end   is  processed  by  PNK  to  generate   the  3’OH  required  by  
Polβ  for  repair  synthesis  (Fig.  2-02) (Wiederhold et al. 2004; Das et al. 2006; Kim and Wilson 2012). 
 
 
2.2. The Thymine DNA Glycosylase (TDG) 
 
2.2.1. Classification and Characterization of TDG 
 
DNA glycosylases can be categorized into three superfamilies: the Helix-hairpin-Helix (HhH) 
glycosylases, the Endonuclease VIII-Like (NEIL) glycosylases and the Uracil DNA glycosylases (UDG). 
The latter has been named after the Escherichia coli Uracil-N-Glycosylase (Ung), the first glycosylase 
found to excise uracil from DNA. Uracil in DNA can arise through deamination of cytosine or U 
misincorporation during DNA replication, producing  G•U  mismatches   or  non-mutagenic   A·∙U   pairs, 
respectively. While the recognition and repair of uracil as a foreign base in DNA appears relatively 
straightforward, the deamination of methylated cytosine (5-mC) gives rise to thymine, which as a 
normal DNA base cannot be easily recognized as damage. Thus, a subfamily of the UDGs evolved to 
recognize and excise thymine when it is mispaired with guanine. These monofunctional Mismatch-
specific Uracil DNA Glycosylases (MUGs) form specific contacts with the opposing base to distinguish 
a T derived from deamination of 5-mC from a canonical   A·∙T   pair. The first member of this family 
isolated was the human TDG, identified by its ability to recognize and excise thymine opposite 
guanine (Wiebauer and Jiricny 1989; Neddermann and Jiricny 1993). 
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Members of the MUG protein family harbor  an  α/β  fold  structural  domain  that  is  characteristic  of  the  
UDG superfamily. All MUGs have a common and rather simple architecture, consisting of a conserved 
core domain containing the active site flanked by variable N- and C-terminal domains. Within the 
core domain, the MUG orthologs share 37-52% sequence identity on the amino acid level (Cortazar 
et al. 2007). Members of this protein family have been identified in organisms throughout the tree of 
life, from E. coli and Schizosaccharomyces pombe over Drosophila melanogaster to Xenopus laevis 
and mammals (Wiebauer and Jiricny 1989; Neddermann and Jiricny 1993; Gallinari and Jiricny 1996; 
Hardeland et al. 2003). One characteristic of the MUG proteins is their large catalytic cavity that can 
accommodate a broad spectrum of damaged bases for excision (Barrett et al. 1999). 
Human TDG is made up of 410 amino acids. The mouse ortholog exists as two splice variants, TdgA 
and TdgB, the latter lacking the first 24 amino acids of the N-terminus (Neddermann and Jiricny 1993; 
Gallinari and Jiricny 1996). Whether these two isoforms serve distinct biological functions remains 
unclear. The N-terminal domain of TDG has been shown to be essential for efficient processing of 
G•T   mismatches (see chapter 2.2.2.) and both terminal domains are involved in protein-protein 
interactions (see chapter 2.2.3).  
 
 
2.2.2. Mechanism of Substrate Recognition and Processing 
 
Structural studies on E. coli Mug have provided insight into the catalytic mechanism of damage 
recognition and base excision by the MUG proteins. While the damaged base is flipped into the 
catalytic pocket, conserved amino acid residues within that cavity form a wedge that takes the place 
of the damaged base in the double-stranded DNA, forming specific contacts and thus mimicking 
Watson-Crick base pairing with the widowed G. Due to this combined nucleotide 
flipping/intercalation mechanism, MUG proteins only process modified bases in double-stranded 
DNA and exhibit a strong preference for substrates opposite guanine (Barrett et al. 1998). 
Extensive biochemical studies have shed light on the mechanism employed by TDG to search for, 
recognize and excise a damaged base. The flexible N-terminal domain mediates non-specific DNA 
binding, switching from an open to a clamp-like conformation upon binding to DNA. This DNA binding 
capacity of the N-terminal domain has also been found to be essential for effective processing of 
G•T,  probably  stabilizing  the  glycosylase-substrate complex (Hardeland et al. 2002; Hardeland et al. 
2003; Steinacher and Schar 2005). 
The clamp-like configuration presumably allows TDG to slide along the DNA in search of a substrate 
base. When encountering a lesion, TDG employs the same combined nucleotide 
flipping/intercalation mechanism as Mug. A highly conserved asparagine residue within the catalytic 
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pocket (in human N140, in mouse TdgA N151) positions an activated water molecule for hydrolytic 
attack on the N-glycosidic bond between the base and the deoxyribose (Barrett et al. 1998; Barrett et 
al. 1999; Hardeland et al. 2000). In contrast to Mug, TDG remains firmly bound to the AP-site after 
release of the damaged base. This product inhibition is mediated by the specific contacts formed 
with the widowed guanine and the non-specific DNA binding of the N-terminus (Hardeland et al. 
2002; Steinacher and Schar 2005). As AP-sites represent a lesion that is even more hazardous than 
the original base damage as they can easily turn into single- and double-strand breaks, their hand-
over to downstream acting repair factors has to be tightly controlled. The high affinity of TDG to its 
product AP-site probably serves the purpose of stabilizing this dangerous repair intermediate. It was 
shown that post-translational modification with Small Ubiquitin-like Modifiers (SUMOs) regulates this 
hand-over as well as the dissociation of TDG (see chapter 2.2.4.) (Hardeland et al. 2002; Steinacher 
and Schar 2005).  
 
 
2.2.3. Biological Functions of TDG 
 
Classical DNA repair 
 
TDG recognizes and excises U or T mispaired with G, arising from spontaneous or enzymatic 
deamination of cytosine or 5-mC, respectively. Methylated cytosine (5-mC) is even more sensitive to 
spontaneous hydrolytic reactions at its exocyclic amino-group than cytosine (Ehrlich et al. 1990). 5-
mC occurs predominantly in CpG dinucleotides which have been found to be a hotspot for mutation, 
possibly not only because of 5-mC deamination but also because alkylation damage to the 
neighboring G is repaired less efficiently by MGMT (Bentivegna and Bresnick 1994). Both, 
deamination of 5-mC and unrepaired O6-methylguanine  would  result  in  C  →  T  transition mutations. C 
→  T  transitions  are  among  the  most  frequent  mutations  associated  with  human  cancer   (Sjoblom et 
al. 2006; Wood et al. 2007; Rubin and Green 2009), making up about 25% of all somatic mutations in 
the p53 tumor suppressor gene in human cancers, in certain tumors even ~50% (Petitjean et al. 
2007).  
Furthermore, the spontaneous deamination of 5-mC (but possibly also inefficient repair of O6-
methylguanine in a methylated CpG) has been proposed to have caused the underrepresentation of 
CpG dinucleotides observed in organism with DNA methylation. CpG islands (CGIs) are 
characteristically hypomethylated, which has been suggested to have preserved their high CpG 
content (Antequera 2003; Jones 2012). What mechanisms maintain CGIs in a hypomethylated state, 
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however, remains unclear although recent studies suggest an involvement of TDG-dependent BER in 
protecting CGIs from aberrant methylation ((Illingworth and Bird 2009) and Appendices II and III). 
Four glycosylases have evolved capacities to counteract the deamination of cytosine, i.e. 
mutagenesis   by   G•U   mismatches: the Uracil N-Glycosylase UNG, the Single-strand specific 
Monofunctional Uracil Glycosylase SMUG1, Methyl-binding domain glycosylase MBD4 and TDG. Of 
these, MBD4 and TDG also process  G•T  mismatches  that arise from 5-mC deamination. In agreement 
with a function in mutation avoidance, knockout of Mbd4 and knockdown of Smug1 result in a mild 
increase  in  C  →  T  transition  mutations  (Millar et al. 2002; Wong et al. 2002; An et al. 2005). Inhibition 
of UNG in human cells also leads to a mild increase in mutations. In agreement with a role of UNG in 
innate and adaptive immunity downstream of enzymatic cytosine deamination, knockout of Ung in 
mice results in the development of B-cell lymphomas, deficiencies in antibody diversification and 
defective innate immunity against retroviral infection (Radany et al. 2000; Rada et al. 2002; Nilsen et 
al. 2003). SMUG1 is thought to serve as a back-up for UNG in counteracting the accumulation of 
uracil in genomic DNA, which has recently been corroborated by the knockout of Smug1 in mice (An 
et al. 2005; Kemmerich et al. 2012). 
With its large catalytic cavity, TDG accommodates a broad spectrum of substrates comprising not 
only   G•U   and   G•T   mismatches   but   also   uracil-derivates modified at the C5 position, e.g. 
5-fluorouracil or 5-bromouracil, etheno-adducts like 3,N4-ethenocytosine and oxidized pyrimidines 
like thymine glycol (see Table 2-01) (Hardeland et al. 2003). Furthermore, TDG was reported to have 
5-mC glycosylase activity, yet these findings could not be corroborated so far (Jost 1993; Zhu et al. 
2000). Recently, TDG has been shown to process 5-formylcytosine (5-fC) and 5-carboxylcytosine 
(5-caC), the oxidation products of 5-hydroxymethylcytosine catalyzed by the Ten Eleven Translocator 
(TET) family of 5-mC hydroxylases (see chapter 2.4.) (He et al. 2011; Maiti and Drohat 2011).  
In contrast to UNG, MBD4 and SMUG1, the knockout of Tdg does not increase mutation frequencies 
in standard mutation assays, suggesting that its function in classical DNA repair is neglectable, at 
most redundant. Interestingly though, in contrast to all other DNA glycosylases, we and others have 
found deletion of Tdg in mice to cause embryonic lethality, hinting at a non-redundant function of 
TDG in embryonic development (Cortazar et al. 2011; Cortellino et al. 2011).   
Still, the DNA repair function of TDG is not entirely obsolete, as was demonstrated in the context of 
5-FU processing. 5-FU is a base analog that is often used in chemotherapy as it is incorporated into 
RNA and DNA, disturbing RNA synthesis and DNA replication. TDG has been found to be one of the 
major contributors to 5-FU  induced  cytotoxicity.  It  excises  this  base  analog  from  A•5-FU base pairs, 
lingering on the resulting AP-site and thus interfering with downstream repair processes, which leads 
to an accumulation of DNA strand breaks. Accordingly, depleting MEFs and Hela cells of TDG 
rendered them resistant to 5-FU (Kunz et al. 2009). 
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Table 2-01: Substrate spectrum of TDG orthologs* 
Substrate** hsTDG   hsTDG ΔN hs/mmTDGΔcat ecMug  spThp1p  dmThd1p 
G•U   +++ +++ nd +++ +++ +++ 
A•U   + + nd + +++ ++ 
ss U  - - nd - +++ - 
G•FU   +++ nd ++ nd +++ +++ 
A•FU   ++ nd - nd +++ ++ 
ss FU  ++ nd nd nd ++ ++ 
G•BrU   +++ nd nd nd ++ +++ 
A•BrU   + nd nd nd + - 
ss BrU  - nd nd nd + - 
G•hmU  +++ nd nd + - ++ 
G•hU  +++ nd nd ++ +++ nd 
G•T   +++ - -/+ - - ++ 
G•Tg   ++ nd nd nd nd nd 
G•εC   +++ nd nd +++ +++ +++ 
A•εC   ++ nd nd nd +++ ++ 
ss εC   - nd nd + +++ - 
G•Hx   + + nd nd +++ + 
T•Hx   - - nd - +++ - 
ss Hx  - nd nd nd +++ - 
G•εA   - nd nd + ++ - 
T•εA   - nd nd - ++ - 
ss εA   - nd nd nd + - 
G•mC   -/+ nd - nd - - 
G•hmC - nd - nd nd nd 
G•fC +++ nd nd nd nd nd 
G•caC +++ nd -/+ nd nd nd 
ss caC ++ nd nd nd nd nd 
G•heC   - nd nd ++ +++ nd 
G•hpC   - nd nd - +++ nd 
G•G   - nd nd nd + - 
* Relative processing efficiencies of recombinant human full size TDG (hsTDG), N-terminally truncated TDG 
(hsTDG  ΔN)  and human or murine catalytic amino acid residue mutated TDG (TDGΔcat, N140A in human, N151A 
in mouse TdgA) and the orthologs of E. coli (ecMug), S. pombe (spThp1p) and D. melanogaster (dmThd1p). Base 
release  efficiencies  are  indicated  as:  +++,  high;  ++,  intermediate;  +,  low;  −,  insignificant;  nd,  not  determined. 
** The putative substrate base is in bold letters. ss, single strand; F, fluoro-; Br, bromo-; h, hydroxy-; hm, 
hydroxymethyl-; Tg, thymine glycol; ε, etheno-; Hx, hypoxanthine; f, formyl-; ca, carboxyl-; he, hydroxyethano-; 
hp, hydroxypropano-. Adapted from (Cortazar et al. 2007) with information from (Hardeland et al. 2001; He et 
al. 2011; Maiti and Drohat 2011) and Alain Weber, personal communication and Appendix III. 
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Transcriptional regulation  
 
TDG has been shown to interact with several transcription factors, transcriptional co-activators and 
the DNA methyltransferases Dnmt3a and b. The first indication for an involvement of TDG in 
transcriptional regulation was provided by Chevray and colleagues in 1992, who reported a direct 
interaction between the glycosylase and c-Jun, a basic leucine zipper transcription factor that is part 
of the activator protein 1 (AP-1) complex (Chevray and Nathans 1992). The function of TDG as a co-
activator of transcription was corroborated when it was found to interact with two nuclear receptors, 
the retinoic acid receptor (RAR) and the retinoid X receptor (RXR), to potentiate their binding to 
retinoic acid response elements (RAREs) and to enhance the transactivation of a reporter gene by 
RAR/RXR (Um et al. 1998). A structurally intact but catalytically inactive mutant TDG (N151A) failed 
to significantly stimulate RAR/RXR-mediated transcription, suggesting that its glycosylase activity is 
essential for its co-activator function in this context (Hardeland, U. and Schär, P., unpublished data). 
Furthermore,  TDG  was   found  to   interact  with  estrogen  receptor  alpha  (ERα)   in  a   ligand-dependent 
manner.  ERα  and  ERβ  are  the  nuclear  receptors  mediating  the  major  responses  to  estradiol.  TDG  acts  
as a co-activator   of   ERα   but,   unlike   with RAR/RXR, its glycosylase activity is dispensable for this 
function. Therefore, it was suggested that TDG serves as a structural scaffold in this case (Chen et al. 
2003). 
Similarly, the catalytic activity of TDG was found to be dispensable for a physical and functional 
interaction with the CREB binding protein (CBP) and its paralog p300. CBP/p300 are transcriptional 
co-activators with intrinsic histone acetyltransferase activity. They stimulate transcriptional 
activation in collaboration with a number of sequence-specific transcription factors, e.g. CREB and 
p53, through chromatin modeling and interactions with the basal transcription machinery (Goodman 
and Smolik 2000). TDG interacts with CBP/p300 through its N- and C-terminal domains, potentiates 
CBP-activated transcription and was found to be a substrate for acetylation by CBP/p300. 
Interestingly, TDG acetylation abolishes its interaction with CBP as well as with the downstream-
acting BER factor APE1 (Tini et al. 2002). 
Two reports describe a repressive effect of TDG on gene transcription. Rat TDG was found to interact 
with the thyroid transcription factor TTF1 and to repress TTF1-activated transcription in transient co-
transfection experiments (Missero et al. 2001). Additionally, the interaction of TDG with Myocardin, 
a co-activator of the serum response factor (SRF) in the regulation of smooth muscle-specific gene 
expression, was found to interfere with the Myocardin-SRF interaction and binding of Myocardin to 
its target promoters (Zhou et al. 2008). 
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The function of TDG in the regulation of gene expression has been associated with the establishment 
and maintenance of epigenetic marks during cell differentiation. The role of TDG in this context is 
described in chapters 2.4.2. as well as in Results 4.2. (Appendix II) and 4.3. (Appendix III). 
 
 
2.2.4. Regulation of TDG Function by Post-Translational Modification 
 
Modification by Small Ubiquitin Like Modifiers (SUMOs) 
 
The high affinity of TDG for its product AP-site benefits the cell by protecting these dangerously 
fragile sites and thereby preventing the spontaneous generation of DNA single- and double-strand 
breaks. On the other hand, this tight AP-site binding interferes with downstream steps of BER, which, 
for instance in the case of the base analog 5-FU that is frequently used in cancer therapy, results in 
the accumulation of unrepaired AP-sites that eventually trigger cell death (Kunz et al. 2009). Correct 
timing of the hand-over of this repair-intermediate to the downstream BER factors is therefore of 
utmost importance and requires a tight regulation. TDG was shown to be post-translationally 
modified by Small Ubiquitin-like Modifiers (SUMOs), which was implicated in regulating TDG’s  
dissociation from the AP-site (Hardeland et al. 2002; Steinacher and Schar 2005).  
SUMOs are structurally similar to ubiquitin but share less than 20% sequence homology. 
SUMOylation can modulate structural and functional features of its target protein, including the 
stability, subcellular localization, protein-protein interactions and activity. Four distinct SUMO genes 
have been identified in the human genome, encoding SUMO1-4. SUMO2 and 3 share 97% sequence 
homology and are therefore often referred to as SUMO2/3. While SUMO1 and 2/3 are ubiquitously 
expressed, SUMO4 is only found in kidney, lymph nodes and spleen (Geiss-Friedlander and Melchior 
2007).  
TDG has been shown to be modified by SUMO1 and 2/3 (Hardeland et al. 2002). The SUMO-
conjugation process requires several enzymatic steps, starting with a SUMO-activating enzyme E1 
(SAE1/SAE2), which catalyzes the formation of a thioester bond between SUMO and SAE2. 
Subsequently, SUMO is transferred to a cysteine in the SUMO-conjugating enzyme E2 (UBC9) and 
further to a lysine residue in a target protein. The SUMO acceptor lysine in TDG (K341 in mouse 
TdgA) lies within a C-terminal SUMOylation consensus motif (VKEE) (Hardeland et al. 2002). This last 
step of the conjugation process is often – but not always – catalyzed by a SUMO E3 ligase which is 
thought to mediate target specificity (Geiss-Friedlander and Melchior 2007). In the case of TDG-
SUMOylation, such an E3 ligase has yet to be identified.  
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Extensive biochemical analyses have shed light onto the regulation of TDG function by SUMOylation 
(Fig. 2-03). The flexible N-terminus of TDG undergoes a conformational change upon binding to 
homoduplex DNA, mediating non-specific DNA interaction that has been found to be essential for 
effective  G•T  processing  (Fig.  2-03 B) (Hardeland et al. 2002). This binding capacity keeps TDG firmly 
attached to the AP-site after base excision (Fig. 2-03 D). SUMOylation reverses the conformational 
switch in the N-terminus, abolishing the tight AP-site binding (Fig.2-03 E). Finally, deSUMOylation by 
a Sentrin-specific protease (SENP) restores the DNA binding ability of TDG (Steinacher and Schar 
2005).  
 
 
 
 
Fig.2-03: A model for SUMO modulated dynamic DNA interactions of TDG during BER. (A) DNA-free TDG is 
present in the cell nucleus in an open conformation. (B) Upon binding to DNA, the N-terminus forms a closed 
structure with the catalytic core domain. This clamp-like conformation may allow TDG to slide along the DNA in 
search of  a  potential  substrate.  (C  and  D)  G•U- or  G•AP-site-bound TDG reflects a third conformational state 
where the catalytic site forms specific contacts with the guanine opposite (dashed lines). The non-specific and 
the specific DNA contacts now cooperate to keep TDG firmly bound to the substrate. (E) SUMOylation of TDG 
then induces a fourth conformational state, neutralizing the non-specific DNA interactions of the N-terminus 
and facilitating the dissociation of the enzyme from the AP-site. (F) APE1 gains access to the AP-site and carries 
on the BER process. DeSUMOylation by SENP proteins allows recycling of TDG and SUMO. (Steinacher and 
Schar 2005) 
(A) 
(B) 
(C) 
(D) (E) 
(F) 
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A role of SUMOylation in regulating the release of TDG from the AP-site has been corroborated by 
structural analyses showing that SUMO-conjugation   induces   the   formation   of   a   protruded   α-helix 
within the catalytic domain that was proposed to facilitate TDG dissociation (Baba et al. 2005, 2006). 
Furthermore, in agreement with a role of SUMOylation in timing the dissociation of TDG from the AP-
site until downstream BER factors are in place to take over the repair intermediate, presence of APE1 
stimulates the release of TDG (Fig. 2-03 F) (Waters et al. 1999).  
In addition to being SUMOylated, TDG contains two SUMO Interaction/Binding Motif (SIM or SBM), 
one in the N- and one in the C-terminal domain (Mohan et al. 2007). SBMs mediate non-covalent 
SUMO-interactions and consist of a hydrophobic core with N- or C-terminally flanking acidic and/or 
serine residues (Minty et al. 2000; Song et al. 2004; Hecker et al. 2006).  
The function of non-covalent SUMO binding of TDG is less clear than that of SUMOylation. While 
SUMOylation is thought to induce conformational changes in its target proteins that affect their 
affinity to other proteins, SUMO-binding is regarded as a kind of proteinaceous glue, stabilizing 
complexes through interactions of SBM-containing proteins with SUMO-conjugated factors. An 
example for this function is the formation of promyelocytic leukemia protein (PML) nuclear bodies 
(NBs). SUMOylation of PML has been suggested to induce the assembly of PML networks through 
non-covalent interactions with the SBM of other PML molecules (Shen et al. 2006). A similar scenario 
might also apply for TDG as it was shown to localize to PML-NBs in a SUMO-dependent manner. 
However, the role of SUMO-binding and SUMOylation in regulating the interaction between TDG and 
PML is not yet clearly defined. There have been contradictory reports, one claiming that SUMO-
binding and SUMOylation of TDG are necessary for the TDG-localization to PML-NBs, the other 
proposing that SUMO-binding mediates and SUMOylation of TDG abolishes the interaction with PML 
(Takahashi et al. 2005; Mohan et al. 2007). 
Furthermore, SUMO1-binding of TDG has been shown to be essential for the stimulating effect on 
CBP-dependent transcription. SUMOylation of TDG on the other hand proved to abolish the 
interaction with and acetylation by CBP (Mohan et al. 2010). As the interaction with CBP involves the 
N-terminal domain of TDG, the conformational change induced by SUMOylation might disrupt this 
interaction (Tini et al. 2002). Also, intramolecular interactions of conjugated SUMO with the two 
SBMs might interfere with interactions with other SUMOylated factors (Mohan et al. 2007). 
However, this point is not entirely clear as another study based on NMR spectroscopy revealed no 
competition between intermolecular and intramolecular SUMO-binding of the C-terminal SBM 
(Smet-Nocca et al. 2011). The same study also reported that SUMO1-binding but not SUMOylation 
induces a conformational change in TDG, thus contradicting previous work. 
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Taken together, SUMO-binding and SUMOylation play essential roles in regulating TDG function by 
mediating protein-protein interactions or abolishing protein-protein and protein-DNA interactions, 
respectively. However, the details of this regulation are not yet fully understood. 
 
 
 
Modification of TDG by Ubiquitylation 
 
The fact that four mammalian glycosylases with apparently redundant UDG activity have co-evolved 
suggests that they serve distinct functions. One way cells could diverse these enzymatically 
redundant functions is by cell cycle regulation. TDG was found to be degraded in S-phase through the 
ubiquitin-proteasome system, strikingly at the same time when expression of UNG is induced. While 
TDG levels are high in G2-M and G1 phase but is rapidly degraded at the onset of S-phase, the 
pattern of UNG2 levels is exactly inverse with a peak in early S-phase and ubiquitin-proteasome 
mediated degradation towards the end of the replication process (Fischer et al. 2004; Hardeland et 
al. 2007).  While  UNG2’s  main   function   appears   to  be   the   excision  of  misincorporated  uracil   (A•U)  
during DNA replication (Otterlei et al. 1999), TDG appears better suited for excision of uracil and 
thymine arising through deamination events in non-replicating  DNA  (G•U  or  G•T).  The  activity  of  TDG  
on   A•U   is   rather   low   and   its   high   affinity   for   AP-sites might interfere with the progression of 
replication forks. UNG2 on the other hand excises U opposite A with high efficiency and turnover. 
Exclusion of TDG from S-phase thus prevents its activity from interfering with the replication process 
(Hardeland et al. 2007). 
Ubiquitylation, like SUMOylation, involves an ubiquitin-activating E1, a ubiquitin-conjugating E2 
enzyme and an E3 ubiquitin ligase. The E3 responsible for TDG-ubiquitylation has yet to be identified.  
The ubiquitylation and SUMOylation systems have been reported to interact in antagonistic or non-
antagonistic ways on certain target proteins, sometimes competing for the same acceptor site (Ulrich 
2005). However, such a crosstalk in the case of TDG has not been described. 
 
 
Phosphorylation and Acetylation 
 
The N-terminal domain of TDG was found to be acetylated by CBP and phosphorylated by the protein 
Kinase   C   α   (PKCα)   in   a   mutually   exclusive   manner   (Tini et al. 2002; Mohan et al. 2010). Both 
modifications occur on adjacent lysine (acetylation) and serine (phosphorylation) residues in a 
conserved sequence motif SKKSGKS. While phosphorylation can occur on free and DNA-bound TDG 
alike, DNA-binding reduces TDG susceptibility to acetylation, suggesting that this modification 
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requires release from the DNA. Additionally, acetylation was shown to decrease the homoduplex 
binding  and  G•T  processing  capacity  of  TDG  but  apparently  does  not  affect  AP-site binding (Mohan et 
al. 2010). 
The role of phosphorylation in regulating the function of TDG is still unclear although it was proposed 
to preserve its   G•T   processing   activity   by   preventing   acetylation.   Phosphorylation   has   been  
suggested to modulate the SUMO-modification of certain target proteins, e.g. in the case of IƘBα,  the  
inhibitor of the transcription factor NF-ƘB. Phosphorylation of IƘBα   prevents its SUMOylation and 
primes it for degradation by the ubiquitin-proteasome system (Desterro et al. 1998). Whether 
phosphorylation of TDG has an effect on its modification by SUMO remains to be tested. However, 
phosphorylation may be involved in cell cycle regulation of TDG, i.e. by enhancing interactions with 
an E3 ubiquitin ligase (Gao and Karin 2005; Hardeland et al. 2007). 
 
 
2.3. Epigenetic Regulation of Gene Expression 
 
2.3.1. Chromatin Structure and Dynamics 
 
In the nucleus of eukaryotic cells, genomic DNA is packaged into a protein-DNA complex termed 
chromatin. The basic building blocks of chromatin are the nucleosome core particles which consist of 
147 base pairs (bp) of DNA wrapped in 1.7 superhelical turns around a histone octamer. These 
octamers consist of two H3-H4 and two H2A-H2B histone dimers. Nucleosome core particles are 
separated by linker DNA of 10-80 bp length associated with the linker histone H1, altogether forming 
a 10 nm   fiber,   resembling   “beads   on   a   string”,  which   is   further   compacted   into   a   fibre of ~30 nm 
diameter (Felsenfeld and Groudine 2003; Hubner et al. 2012). Further compaction into higher-order 
structures involves long-range intra- and interchromosomal interactions mediated by chromatin 
associated structural organizer complexes such as the CCCTC-binding factor (CTCF), cohesins (Lee and 
Iyer 2012), and others. Chromosome Conformation Capture (3C) experiments have revealed that 
chromatin is packaged into fractal globules. All fractal globules of one chromosome appear to occupy 
a distinct area of the nucleus, a so-called chromosomal territory (Hubner et al. 2012). 
The chromatin structure represents a second layer  of  genetic  information  “on  top  of” the DNA base 
sequence.   This   “epigenetic”   information   is   shaped  by  developmental and environmental cues that 
instruct heritable patterns of chromatin structure to regulate gene expression in a cell type specific 
manner and thus determine cell fate. The   sum   of   this   “epigenetic”   information   is   termed  
“epigenome”.   Chromatin   exists either in a condensed (heterochromatin) or in a more open, 
accessible form (euchromatin). The latter contains mostly transcriptionally active genes (but may 
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contain silent genes or heterochromatinized regions), whereas heterochromatin in its most 
condensed form is inaccessible for the large protein complexes involved in gene transcription. It thus 
contains mostly transcriptionally inactive genes and repetitive sequences (Hubner et al. 2012). 
DNA replication, recombination, repair and activation or silencing of transcription, all involve 
alterations of the chromatin structure. This modulation can occur in three ways: First, by ATP-
dependent chromatin remodeling complexes, second, through exchange of the core histones with 
other histone variants, third, through alterations of epigenetic modifications, namely histone 
modifications and DNA methylation (Felsenfeld and Groudine 2003).  
For gene regulatory factors to be able to bind to their target sequences in the genome, their binding 
sites - which may lie deeply buried within a nucleosome - have to be made accessible without 
unraveling the overall chromatin architecture. This is accomplished by chromatin remodeling 
complexes that metabolize ATP to alter the DNA-histone interactions so that a nucleosome is 
relocated to a neighboring stretch of free DNA, transiently exposing the previously occupied 
sequence (Becker and Horz 2002).  
The canonical histones can be replaced by histone variants to regulate transcriptional activation or 
silencing, chromatin structure, DNA repair and ES cell differentiation (Talbert and Henikoff 2010). For 
instance, a variant of H2A, H2AX, which is ubiquitously present throughout the genome, is 
phosphorylated in the course of DNA strand break repair, e.g. in the context of DNA damage or V(D)J 
recombination during antibody diversification (Fernandez-Capetillo et al. 2004). Furthermore, the 
histone variant H3.3 was found to be associated with active chromatin, whereas H3.2 correlates with 
a repressive chromatin state (Hake and Allis 2006). 
 
 
2.3.2. Histone Modifications 
 
The core histones consist of a globular domain and an amino-terminal tail, both of which were found 
to be subject to an ever-growing number of post-translational modifications, including 
phosphorylation, acetylation, methylation, mono- and poly-ADP-ribosylation,   deimination,   β-N-
acetylglucoamine-modification, proline isomerization, SUMOylation and ubiquitylation. These 
modifications not only change the interactions between nucleosomes and between histones and 
DNA,   but   are   also   thought   to   form   a   “histone   code”   that   is   “read”   by   various   protein   complexes  
involved for instance in chromatin remodeling or transcription (Bernstein et al. 2007). Here, I will 
focus on histone acetylation and methylation, introduce the enzymes catalyzing these modifications 
(writers) and the factors that recognize them (readers and effectors). For an in-depth review on 
other histone modifications, refer to (Bannister and Kouzarides 2011). 
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Histone Acetylation 
 
While the function of many of these modifications is still not fully understood, some basic principles 
have emerged. Acetylation of lysine residues almost always increases transcriptional activity and 
chromatin accessibility, presumably by neutralizing the charge interaction between the DNA 
backbone and the positively charged lysine residues of the histone tails (Bernstein et al. 2007; 
Bannister and Kouzarides 2011). Acetylation is highly dynamic and controlled by two families of 
enzymes with antagonistic functions: the histone acetyl-transferases (HATs) and the histone 
deacetylases (HDACs). HATs act as part of large multi-protein complexes (see also next sub-chapter) 
and can be subdivided into different groups with specific functions, type-A and type-B HATs. The 
latter is responsible for acetylating newly synthesized histones in the cytoplasm. Type-A HATs can 
modify histones that are already integrated into nucleosomes, and many members of this family are 
involved in transcriptional co-activation, e.g. CBP/p300. In contrast, HDACs are mostly transcriptional 
repressors as they restore the positive charge of a lysine through deacetylation, tightening the 
interaction between the histone tail and the DNA.  
Like HATs, HDACs are present in several large protein complexes, often with other members of the 
HDAC family. HDAC1 and HDAC2, for instance, are subunits of the NuRD, Sin3a and Co-REST 
repressor complexes (Bannister and Kouzarides 2011). 
 
Histone Methylation 
 
Histone methylation does not alter the charge of the histone tail but rather functions as a recognition 
site for histone-code  “readers”,  proteins with a chromo-, bromo-, MBT, Tudor or PHD finger domain. 
Thus, methylation can have different effects, depending on which residues are modified and with 
how many methyl-groups. Methylation occurs mostly on lysine or arginine residues, in which lysine 
can be mono-, di- or tri-methylated and arginine mono- or di-methylated (symmetrically or 
asymmetrically). For instance, H3K4me3 marks promoters and transcriptional start sites of active and 
“poised”   (to   be   activated)   promoters, whereas H3K4me1 is associated with introns and distal 
regulatory elements termed enhancers (Black et al. 2012). H3K9 and H3K27 trimethylation on the 
other hand is generally associated with repression of transcription. The methyl-donor for both, lysine 
and arginine methylation is S-adenosylmethionine (SAM) (Bannister and Kouzarides 2011). 
At the center of establishing and maintaining active or repressive chromatin states are trithorax 
(TrxG) and polycomb group (PcG) proteins, respectively. Both form large multi-protein complexes 
that contain both writers and readers of histone modifications, and that exhibits not only histone 
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methylating but also HAT or HDAC and other activities, reflecting the functional interlink between 
different histone-modifications. 
TrxG proteins can be subdivided into three classes, one consisting of SET-domain containing factors 
that methylate histone tails (writers), a second including ATP-dependent chromatin remodeling 
factors that read the histone methylation established by the SET-domain proteins (readers and 
effectors), and a third class that binds directly to specific DNA sequences and serve multiple 
functions. Five PcG protein complexes have been identified to date. Polycomb repressive complex 1 
(PRC1) and 2 (PRC2), for instance, establish repressive chromatin states, e.g. through their H3K9 
methyltransferase, H3K4 and H3K36 demethylase and H3K27 methyltransferase activities (Lanzuolo 
and Orlando 2012). 
All histone lysine methyltransferases (HKMTs) that modify histone tails have a common SET domain 
that harbors the enzymatic activity and catalyzes the transfer of a methyl-group from S-
adenosylmethionine  (SAM)  to  the  ε-amino group of a target lysine. One of the first SET-domain TrxG 
proteins identified in mammals was MLL1, which catalyzes H3K4 trimethylation (following mono- and 
di-methylation) primarily at HOX genes. MLL1 was originally identified as a gene inducing human 
leukemia through aberrant fusion, e.g. with AF9 or TET1, caused by chromosomal rearrangements. 
(Schuettengruber et al. 2011). A prominent example for a SET-domain containing PcG protein is EZH2 
(enhancer of zeste), the catalytic subunit of PRC2, which catalyzes di- and tri-methylation of H3K27. 
Interestingly, EZH2 also recognizes H3K27me3, which makes it not only a writer but also a reader of 
this chromatin mark (Lanzuolo and Orlando 2012). 
Lysine methylation is reversible through the action of a lysine-specific demethylase (LSD1), which can 
demethylate mono- and dimethylated lysine. Target specificity and biological role is conferred by the 
different protein complexes LSD1 is associated with. For instance, as a subunit of the Co-REST 
complex, LSD1 demethylates mono- or dimethylated H3K4, acting as a co-repressor, but in complex 
with the androgen receptor, it demethylates H3K9, functioning as a co-activator. Trimethylation of a 
histone lysine can be reversed by jumonji domain proteins, of which JMJD2 was the first trimethyl 
lysine demethylase identified. The histone demethylase JARID2 for example is a subunit of PRC2 
(Marmorstein and Trievel 2009; Bannister and Kouzarides 2011). 
 
Inheritance of Histone Modifications 
 
How epigenetic information encoded by histone modifications is maintained during/after DNA 
replication remains poorly understood. Several models have been proposed over the years how 
histone modifications are inherited during mitotic divisions. The simplest, a semi-conservative 
inheritance mechanism, would rely on equal distribution of the two copies of each core histones to 
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the daughter strands upon DNA replication, and a symmetrical copying of the modification onto the 
newly deposited histones. However, it is unknown if histone modifications occur in a symmetric 
manner on both copies of each histone within a single nucleosome and whether nucleosomes are 
distributed semi-conservatively during DNA replication. Indeed, recent work questions such a mode 
of distribution of H3-H4, which carry the modifications most likely to be relevant for epigenetic 
phenomena (Zhu and Reinberg 2011). 
The observation that many histone modifiers localize to the replication forks in S-phase has raised 
the hypothesis that factors within or associated with the DNA replication machinery recruit 
chromatin-modifying enzymes to restore the histone modifications on newly synthesized chromatin.  
Yet,  this  model  cannot  apply  for  certain  histone  modifications  that  appear  to  “mature”  throughout  
the cell cycle (Zhu and Reinberg 2011). 
It is clear that the inheritance of histone modifications requires some instructive pre-existing 
modifications to serve as templates for restoration of the chromatin states during or after DNA 
synthesis. Assuming a random distribution of nucleosomes to the nascent DNA strands, newly 
deposited histones might be modified analogous to a neighboring nucleosome, similar to a 
phenomenon   termed  “chromatin-modification  spreading”.  Such  spreading  of  histone  modifications  
has been found to occur with H4K16 acetylation, H3K9 and H3K27 methylation (Cockell et al. 1998; 
Grewal and Moazed 2003; Margueron et al. 2009). 
Histone modifications are functionally interlinked with DNA cytosine methylation in the 
establishment of the epigenetic code, although the hierarchical order in which these modifications 
are written and read is not clear. While the mechanism of propagation of histone modifications is still 
under debate, the biochemistry of the DNA methylation system offers a logical and plausible concept 
for inheritance (see 2.3.3.).  
 
 
2.3.3. DNA methylation 
 
CpG Methylation System 
 
CpG dinucleotides in mammalian cells are subject to methylation at the C5 position of cytosine. The 
occurrence of 5-mC is negatively correlated with the density of CpG dinucleotides, the CpG-richest 
sequences, also termed CpG islands (CGIs), showing the lowest methylation levels (Bird et al. 1985; 
Kafri et al. 1992; Illingworth and Bird 2009). Non-CpG methylation is common in plants but was found 
to be a characteristic exclusively of the pluripotent stem cell state in mammals and is lost with 
differentiation (Ramsahoye et al. 2000; Lister et al. 2009). In the human genome, over half of the 
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total amount of 5-mC is associated with repetitive sequences and contributes to genome stability by 
repressing recombination and the transcription of retrotransposons (Hu and Rosenfeld 2012). 
Cytosine methylation is accomplished by three DNA methyltransferases, the maintenance DNA 
methyltransferase Dnmt1 and the de novo DNA methyltransferases Dnmt3a and b. Like histone 
methyltransferases, Dnmts use SAM as a methyl-group donor. Deletion of Dnmt1 or Dnmt3b in mice 
is embryonic lethal and Dnmt3a knockout mice die about one month after birth (Li et al. 1992; Okano 
et al. 1999). Cultured triple knockout (Dnmt1-/-Dnmt3a-/-Dnmt3b-/-) ES cells lose the ability to 
differentiate (Tsumura et al. 2006). 
The de novo DNA methyltransferases Dnmt3a and Dnmt3b – in concert with the catalytically inactive 
cofactor Dnmt3L – establish methylation patterns in early development and contribute to the 
maintenance of these patterns through cell divisions (Jones and Liang 2009). How Dnmt3a and b are 
recruited to their target sites is not entirely clear although several reports suggest that they may be 
directed by histone modifications or associated factors (Fuks et al. 2003; Vire et al. 2006; Ooi et al. 
2007; Dong et al. 2008). Faithful transmission of methylation patterns through mitotic divisions is 
conferred by Dnmt1 which is targeted to hemimethylated CpGs by Np95, e.g. following DNA 
replication, to restore the fully methylated state (Sharif et al. 2007). As DNA methylation and histone 
modifications are functionally interlinked, the Dnmt1-mediated inheritance of DNA methylation 
patterns might also support the faithful transmission of histone marks by providing cues for their 
restoration. 
 
DNA Methylation in Transcriptional Regulation 
 
DNA methylation plays a crucial role in the control of gene expression, e.g. in the allele-specific 
expression of imprinted genes and in establishing cell type-specific expression patterns during cell 
fate determination. Depending on its localization, DNA methylation can have different effects on 
transcriptional activity. Enrichment of 5-mC in close proximity to a transcription start site (TSS) 
inhibits transcription initiation but DNA methylation in the gene body has been found to even 
stimulate transcriptional elongation and may control splicing (Laurent et al. 2010; Jones 2012). The 
effect of DNA methylation at enhancer regions on gene expression is only beginning to become clear. 
Enhancers are mostly CpG poor regulatory sites located at variable distances from gene promoters 
and marked by transcription factor binding. Genome-wide studies of DNA methylation in mouse ES 
cells and neuronal precursors have associated transcription factor binding with the CpG methylation 
level of enhancers (Stadler et al. 2011). As a single CpG in a single cell can only be either methylated 
or unmethylated, the intermediate methylation levels observed at these regions possibly reflect a 
highly dynamic methylation state, shaped by competing DNA methylation and demethylation which 
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averages to intermediate levels in a cell-population. Indeed, these low methylated regions (LMRs) 
have been found to be associated with 5-hmC, a potential intermediate of DNA demethylation, and 
generation of 5-hmC appears to facilitate enhancer activation (Stadler et al. 2011; Serandour et al. 
2012). 
 
CpG Islands 
 
CpG islands (CGIs) represent stretches of relatively high CpG density (observed/expected ratio >0.65) 
in the otherwise CpG-depleted genomes of all organisms with DNA methylation. CGIs overlap with 
the promoters of all ubiquitously expressed genes and also about 40% of those expressed in a tissue-
specific pattern (Illingworth and Bird 2009). CGIs are maintained in a hypomethylated state which is 
thought to have protected these genomic regions from deamination-induced 5-mCpG→TpG  
mutation. However, the mechanisms conferring this immunity of CGIs to de novo methylation remain 
largely unknown. DNA sequence itself has been proposed to make CGIs refractory to the activity or 
binding of Dnmt3a and b (Fig. 2-04 A). Such a scenario is unlikely considering the high density of 
CpGs, which are the preferred substrate of Dnmts (Ramsahoye et al. 2000). Alternatively, the 
association of transcription factors might sterically block the access of Dnmts to CGIs (Fig. 2-04 C). 
Several lines of evidence support this hypothesis, e.g. the fact that the promoters of all constitutively 
expressed genes and 93% of those expressed during mouse embryogenesis contain CGIs (Ponger et 
al. 2001; Illingworth and Bird 2009). Moreover, the presence of the active histone mark H3K4me3 has 
been shown to inhibit binding of Dnmt3L (Fig. 2-04 C) (Ooi et al. 2007). H3K4 methyltransferase 
complexes are targeted to CGIs by the CXXC domain, conferring binding to unmethylated CpGs, of 
factors like Cfp1 or MLL1 (Clouaire et al. 2012). 
Finally, transcription itself and the formation of R-loops (RNA-DNA hybrid structures) have been 
proposed to maintain hypomethylation at CGIs immediately downstream of a TSS (Ginno et al. 2012). 
A third possibility how CGIs might be protected from methylation is a targeted proof-reading 
complex that removes aberrant 5-mC (Fig.2-04 B).  First evidence for such a proof-reading activity 
came with the finding that in vitro methylated CGIs become demethylated when introduced into ES 
cells (Frank et al. 1991). The discovery of the TET proteins as 5-mC hydroxylases has shed new light 
on possible mechanisms involved in CGI methylation proof-reading (Tahiliani et al. 2009), especially 
since TET1 localizes to CGIs (Williams et al. 2012). However, such a proof-reading complex might not 
be the first and foremost mechanism to keep CpG islands unmethylated but might rather function as 
a caretaker to correct aberrant methylation caused by the failure of the two other – or as yet 
unknown – mechanisms (see next chapter).   
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Fig. 2-04: Possible mechanisms maintaining hypomethylation at CGIs. (A) Intrinsic sequence properties might 
keep CpGs in CGIs unmethylated (white lollipops) by inhibiting activity or binding of DNA methyltransferases 
(DNMT). (B) CGIs might be subject to methylation but a targeted DNA demethylase (DM) complex might 
remove 5-mC (black lollipops) from these genomic loci. (C) Occupation by transcription factors (TF) and RNA 
polymerase II (RNA polII) might sterically block the access of Dnmts to CGIs. Also, the active histone mark 
H3K4me3 was shown to inhibit binding of the DNMT cofactor DNMT3L. (Illingworth and Bird 2009) 
 
 
CpG Methylation Instability  
 
Carcinogenesis and ageing are accompanied by a disruption of DNA methylation patterns. In general, 
cancer cells exhibit hypomethylation of the bulk genome punctuated by hypermethylation at CGIs. 
Hypomethylation occurs mostly in CpG poor regions and contributes to tumorigenesis through 
aberrant gene activation, loss of transposon and recombination repression and destabilization of the 
chromatin structure e.g. at telomeres (Schar and Fritsch 2011; Gokul and Khosla 2012). CGI 
hypermethylation at the promoters of tumor suppressor genes resulting in transcriptional 
downregulation is one of the hallmarks of carcinogenesis. (Hanahan and Weinberg 2000; Gronbaek 
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et al. 2007). Causes for aberrant DNA methylation can be mutations in or misregulation of the Dnmt 
genes, false targeting of the Dnmts or an imbalance of the methyl-group donor SAM (Schar and 
Fritsch 2011). Still, whether DNA methylation errors are the cause or the consequence of 
carcinogenesis remains unclear.  
Yet, the fact that the DNA methylation machinery can erroneously methylate regions that should 
remain unmethylated makes it clear that proof-reading mechanisms must have evolved for this 
epigenetic mark (Schar and Fritsch 2011). Also, the erasure of DNA methylation, e.g. in order to reset 
the epigenome to a totipotent state (see chapter 2.3.4.), illustrates the need for reversibility of DNA 
methylation. In plants, 5-mC demethylation is accomplished by 5-mC glycosylases but mammals 
appear to employ more complex mechanisms (see chapter 2.4.) (Zhu 2009).  
 
 
2.3.4. Epigenome dynamics in mammalian development 
 
Multicellular organisms develop out of a single cell, the zygote. After fertilization, the epigenetic 
marks of the paternal and maternal genomes, present as distinct structures in the zygote, have to be 
erased to restore totipotency, the ability to generate any cell type. Newly established epigenetic 
programs   determine   cell   identity   and   provide   a   heritable   “cellular   memory”.   Although   histone  
modifications play a crucial role in establishing the gene expression profiles that confer cell identity, 
this chapter focuses mostly on DNA methylation dynamics. 
Upon entering the oocyte, the densely packed and transcriptionally silent paternal chromatin 
undergoes extensive remodeling to become transcriptionally inducible. This includes replacement of 
protamines, sperm-specific histone-analogs, with canonical histones provided by the oocyte, as well 
as DNA decondensation, which results in the formation of the paternal pronucleus (Jenkins and 
Carrell 2012). The paternal pronucleus undergoes rapid, global DNA demethylation, with the 
exception of imprinted loci, IAP retrotransposons and centromeres. As this global erasure of 5-mC 
precedes and coincides with the first round of DNA replication, it is thought to be an active process 
(see chapter 2.4.2.). The maternal pronucleus escapes this global DNA demethylation event through 
mechanisms that are as of yet not entirely clear, although an involvement of repressive histone 
modifications and the maternal factor Stella has been suggested (Nakamura et al. 2007; Wossidlo et 
al. 2011; Szabo and Pfeifer 2012). Demethylation of the maternal DNA is gradually achieved through 
several  cell  divisions  upon  reactivation  of  the  oocyte’s  cell  cycle,  consistent  with  a  passive  process  by  
inhibition of maintenance methylation (Jenkins and Carrell 2012). The erasure of the majority of this 
epigenetic mark allows for the establishment of new, cell type-specific DNA methylation profiles. 
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A first divergence in the epigenetic profiles of the zygote-derived cells becomes evident at the 
morula stage, where cells in the periphery are primed to become extra-embryonic tissue, whereas 
cells at the center eventually give rise to the embryo proper (Johnson and Ziomek 1981). In the 
blastocyst, the peripheral trophectoderm cells reach the lowest levels of 5-mC, while in the inner cell 
mass DNA methylation has already begun to be restored by de novo methyltransferases (DNMT3). 
One of the first genes silenced through DNA methylation in the epiblast, which determines lineage 
trajectory, is Elf5, a trophectoderm-specific transcription factor (Seisenberger et al. 2013). During and 
following implantation of the mouse embryo, about 480 gene promoters become methylated and 
thus transcriptionally silenced, including a set of CGI promoters. Among them are many pluripotency 
factors, i.e. Rex1, but also germline-specific genes and tissue-specific factors that are re-expressed in 
later stages of development, e.g. hematopoietic genes (discussed below) (Borgel et al. 2010). 
Primordial Germ Cells (PGCs), the precursors of the gametes, inherit a significant amount of DNA 
methylation from the epiblast they are derived from, including imprinted loci inherited from the 
parental generation. To reset these somatic methylation profiles to that of germ cells that are 
capable of forming a totipotent zygote, PGCs undergo global DNA demethylation that spares only the 
retrotransposons with the highest mutagenic potential. Male or female gamete-specific methylation 
profiles are established gradually until the prospermatogonia stage or in the growing oocyte, 
respectively. New imprints are established   according   to   the   embryo’s   gender   (Seisenberger et al. 
2013). 
A subset of tissue-specific genes was found to be silenced in early development but reactivated in 
later stages.  Among these are brain-, eye- or hematopoiesis-specific genes, i.e. Mbp, Cryaa, Cplx4, 
Obf1, Tlr6 and Cytip. The promoters of these genes display intermediate CpG-density and were found 
to acquire DNA methylation in early embryogenesis. Yet, the promoters of the eye-specific genes 
Cryaa and Cplx4 become demethylated during eye-development, as are those of Tlr6 and Cytip in the 
hematopoietic lineage and that of Obf1 during adult B-cell differentiation (Borgel et al. 2010). This 
targeted erasure of 5-mC is likely to employ different mechanisms than the global DNA 
demethylation observed in zygotes and PGCs (discussed in chapter 2.4.). 
 
 
2.4. DNA demethylation 
 
2.4.1. Concepts of DNA demethylation 
 
The fact that plants have evolved enzymes with 5-mC glycosylase activity and appear to achieve DNA 
demethylation through BER has fueled the search for analogous enzymes in mammals. Passive 
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removal of 5-mC has long been established to occur through inhibition of DNA methylation 
maintenance by Dnmt1, e.g. to gradually achieve global demethylation of the maternal pronucleus. 
However, the rapid loss of 5-mC in the paternal pronucleus and in PGCs suggests the involvement of 
an enzymatic component. 
Indeed, the discovery of the TET proteins as 5-mC hydroxylases has shed light on the mechanism of 
global DNA demethylation (Tahiliani et al. 2009; Ito et al. 2010). Recent studies have revealed that 
TET3 mediated conversion of 5-mC to 5-hmC and subsequent dilution by DNA replication causes a 
global loss of 5-mC in the paternal pronucleus (Gu et al. 2011; Inoue and Zhang 2011; Wossidlo et al. 
2011). Furthermore, global demethylation of primordial germ cells has been demonstrated to be 
driven by TET-catalyzed conversion of 5-mC to 5-hmC, followed by a decline of 5-hmC levels 
consistent with replication-mediated dilution (Hackett et al. 2013). 
Such a semi-active process of DNA demethylation, converting 5-mC to 5-hmC which is no longer 
maintained by Dnmt1 (Valinluck and Sowers 2007), appears perfectly suitable for global erasure of 
5-mC. Alternative pathways that were proposed for global demethylation entail a DNA repair step 
(see chapter 2.4.2.), which would generate potentially hazardous AP-sites and DNA strand-breaks at 
an alarming number. Still, the BER factor APE1 and BER facilitator PARP1 were shown to be essential 
for global DNA demethylation in PGCs (Hajkova et al. 2010). How BER contributes to these global 
events remains to be elucidated. However, replication-independent pathways for enzymatic DNA 
demethylation may well be employed in controlling DNA methylation at specific sites. 
Direct removal of the methyl-group has been proposed as a most straightforward way to actively 
convert 5-mC back to C. The 5-mC binding domain protein MBD2 has been reported to exhibit such 
activity but this finding could not be reproduced by other groups so far (Bhattacharya et al. 1999). 
Also, Mbd2 knockout mice exhibit normal 5-mC levels and paternal pronucleus demethylation, 
shedding doubt over a biologically relevant MBD2-mediated DNA demethylation process (Hendrich 
et al. 2001; Santos et al. 2002). 
An alternative to the removal of the methyl-group is excision of 5-mC through DNA repair. Two major 
pathways have been considered in such a scenario: nucleotide excision repair (NER), which would 
remove a stretch of DNA that contains the methylated CpG, and BER, which would remove 5-mC 
directly. The unmethylated CpG would be restored by repair synthesis in both cases. 
The NER machinery has been implicated in transcriptional regulation in absence of DNA damage. NER 
factors are recruited to active gene promoters and contribute to chromatin remodeling for efficient 
transcription initiation (Schmitz et al. 2009; Le May et al. 2010). The NER endonucleases XPG and XPF 
were shown to be essential for controlling DNA demethylation at promoter and transcriptional 
termination sites although the mechanistic connection between strand incision by XPG or XPF and 
DNA demethylation remains unclear (Le May et al. 2012). As NER mostly recognizes and corrects 
36 
 
helix-distorting lesions, the cue triggering NER action in the context of DNA demethylation has yet to 
be identified. One possibility is the occurrence of AP-sites which have been shown to be repaired by 
NER under certain circumstances (Lin and Sancar 1989; Huang et al. 1994; Kim and Jinks-Robertson 
2010). 
The search for a mammalian 5-mC DNA glycosylase initiating DNA demethylation by BER has revealed 
an enzyme capable of excising 5-mC from hemimethylated DNA in chicken embryo extracts. This 
enzyme later turned out to be the chicken homolog of TDG, in complex with RNA and an RNA 
helicase (Jost 1993; Jost et al. 1995; Fremont et al. 1997; Jost et al. 1997; Jost et al. 1999; Zhu et al. 
2000). Yet, the glycosylase activity of TDG on 5-mC could not be corroborated so far with 
recombinant enzymes. A more plausible pathway, which is supported by recent reports, is the 
conversion of 5-mC to a more suitable substrate for DNA glycosylases (discussed in chapter 2.4.2). 
 
 
2.4.2. Current models for BER-mediated active DNA demethylation 
 
As 5-mC is more susceptible to deamination than C and as several DNA glycosylases evolved to 
counteract such spontaneous deamination events, enzymatic deamination has long been considered 
as a potential first step of DNA demethylation, followed by BER. Candidate 5-mC deaminases in such 
a pathway include the activation induced deaminase (AID) and the apolipoprotein B mRNA-editing 
enzyme complex (APOBEC) family of proteins as well as Dnmt3a and b. 
AID was shown to contribute to demethylation of the Oct4 and Nanog gene promoters during 
somatic cell reprogramming (Bhutani et al. 2010). AID has also been implicated in global DNA 
demethylation in PGCs, as AID-deficient mouse PGCs exhibit threefold higher methylation levels at 
embryonic day 13.5 as their wildtype counterparts (Popp et al. 2010). Furthermore, a deamination-
coupled DNA demethylation pathway was also observed in zebrafish embryos, involving deamination 
of 5-mC by AID and subsequent excision by MBD4 (Rai et al. 2008). 
Dnmt3a and b have also been shown to deaminate 5-mC in vitro under conditions of SAM depletion. 
Whether such an environment is generated in vivo is unclear, but transient recruitment of the 
Dnmt3s and TDG has been shown to be associated with cyclical methylation and demethylation at 
estrogen-responsive promoters. Interestingly, reminiscent of the reports by J.P. Jost and colleagues, 
this putative DNA demethylation complex also includes the RNA helicase p68, suggesting the 
complex to be targeted and/or stabilized by an RNA component (Kangaspeska et al. 2008; Metivier et 
al. 2008). 
The discovery of the TET proteins as 5-mC hydroxylases shed new light on a possible BER-coupled 
DNA demethylation pathway (Tahiliani et al. 2009; Ito et al. 2010). Interestingly, a 5-hmC glycosylase 
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activity had been identified in calf thymus long ago (Cannon et al. 1988), alas the responsible enzyme 
has never been identified and none of the mammalian DNA glycosylases characterized appears to be 
capable of excising 5-hmC on its own (He et al. 2011; Maiti and Drohat 2011). More recently, it was 
suggested that the concerted action of TET proteins and AID or APOBEC proteins facilitate 5-mC 
demethylation through subsequent generation of 5-hmC and deamination to 5-hydroxymethyluracil 
(5-hmU), followed by excision of 5-hmU by either TDG or SMUG1 (Boorstein et al. 2001; Hardeland et 
al. 2003). One study implicated TET1 and Apobec1-catalyzed deamination of 5-hmC in neuronal 
activity-induced site-specific active DNA demethylation in the adult mouse brain (Guo et al. 2011). 
Also, AID was reported to interact directly with TDG in a coupled deamination-BER pathway of DNA 
demethylation (Cortellino et al. 2011). However, a recent study of the enzymatic properties of AID 
and APOBEC proteins revealed that 5-hmC is no suitable substrate for deamination by these 
enzymes, whereas a residual activity on 5-mC was confirmed (Nabel et al. 2012).  
Further insight into a potential mechanism of active DNA demethylation came with the finding that 
TET proteins can oxidize 5-hmC further to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), 
both of which are readily excised by TDG but – unlike the deamination products of 5-mC and 5-hmC – 
apparently by no other DNA glycosylase (He et al. 2011; Ito et al. 2011; Maiti and Drohat 2011). Given 
the fact that TDG is also the only DNA glycosylase known so far with a developmental phenotype 
(Cortazar et al. 2011; Cortellino et al. 2011; Jacobs and Schar 2012), its non-redundant 5-fC/5-caC 
glycosylase activity might hint at an essential role of TDG in DNA demethylation during development. 
However, the significance of such a TET-TDG mediated pathway during development has remained 
elusive. 
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3 Aims of the Thesis 
 
TDG has been implicated in two seemingly disconnected biological processes, DNA repair and 
transcriptional regulation. Both functions have been shown to require SUMOylation or SUMO-
binding (Hardeland et al. 2002; Steinacher and Schar 2005; Mohan et al. 2007). The regulation of TDG 
function by SUMOylation has been studied extensively in biochemical assays and we previously 
proposed that SUMOylation induces dissociation of TDG from its product AP-site (Steinacher and 
Schar 2005). However, an involvement of SUMOylation in TDG-dependent BER had not been 
corroborated by in vivo data.  
The first goal of my PhD thesis was to generate a tool to monitor the SUMO-TDG interaction in 
living cells, unchallenged and in presence of DNA damaging agents. To this end, I established a 
Fluorescence Resonance Energy Transfer (FRET) system, which we used to characterize the covalent 
and non-covalent SUMO1- and SUMO3-binding of TDG. 
 
In the attempt to reconcile its functions in DNA repair and in the regulation of gene expression, TDG 
was proposed to actively demethylate DNA by directly excising 5-mC (Zhu et al. 2000). As this model 
was not corroborated by independent experimental evidence, the involvement of TDG in active DNA 
demethylation has remained elusive. Still, we found deletion of Tdg in mouse to cause embryonic 
lethality and epigenetic aberrations at CGIs in Tdg knockout cells. These aberrations suggested a dual 
role of TDG in safeguarding CGIs, one in coordinating the maintenance of active histone marks and 
one in counteracting aberrant DNA methylation. The underlying mechanisms, however, have 
remained obscure. 
The second goal of my PhD thesis was to investigate the mechanism by which TDG contributes to 
the epigenetic stability of CGIs. To this end, I – in collaboration with others – dissected the causes for 
aberrant methylation levels in Tdg knockout cells in the course of cell differentiation to address the 
involvement of BER, deamination and/or oxidation in controlling CGI methylation. 
 
The study of factors involved in maintaining stable chromatin states raises the need for tools to 
investigate the rates of epigenetic change (epimutagenesis). However, unlike for genetic change 
(mutagenesis), no such tools have been designed nor developed thus far.  
The third goal was thus to establish a system that allows quantitative monitoring of the epigenetic 
stability of promoters. To this end, I established an ES cell-based system that allows a timed release 
of an exchangeable promoter of interest from selective pressure and several read-out options to 
monitor promoter activity, applicable in high-throughput screening approaches as well as in studying 
stochastic effects on a clonal basis. 
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4 Results 
 
The following section summarizes the results presented in the manuscripts provided in the appendix 
as well as supplementary results not included in the manuscripts. 
 
4.1. Measuring the SUMO-Interaction Dynamics of the Thymine DNA Glycosylase by 
Fluorescence Resonance Energy Transfer (Appendix I) 
 
Post-translational modification with Small Ubiquitin-like Modifiers (SUMOs) can affect the subcellular 
localization, enzymatic activity, three-dimensional structure or protein-interactions of a target 
protein and is thus involved in regulating and coordinating various cellular processes, e.g. in DNA 
replication and repair but also in pathways connected to development (Gill 2004; Lomeli and Vazquez 
2011). SUMO is also bound non-covalently by proteins with a SUMO Interaction/Binding Motif 
(SIM/SBM). We have previously reported that SUMOylation of TDG facilitates the dissociation of the 
glycosylase from the AP-site by abolishing the non-specific DNA-interaction of the N-terminal domain 
(Hardeland et al. 2002; Steinacher and Schar 2005). TDG also interacts non-covalently with SUMO 
(Hardeland et al. 2002), via two SIM/SBM motifs located in the N-terminal and the C-terminal 
domains (Mohan et al. 2007) 
In this part of my PhD thesis, I present the development of a Fluorescence Resonance Energy 
Transfer (FRET) system to monitor the SUMO1- and SUMO3-interactions of TDG in living cells. FRET is 
a physical process involving the transfer of an energy quantum between a donor and an acceptor 
fluorophore, in our case Cerulean and Citrine, respectively. This energy transfer requires an overlap 
of the emission spectrum of the donor with the absorption spectrum of the acceptor, so that an 
energy quantum emitted by the donor in an excited state can be absorbed by the acceptor 
fluorophore, which subsequently emits a photon in a wavelength beyond that of the donor. The 
transfer can only occur if the donor and acceptor are in a suitable orientation and in close proximity 
(10 to 80 Å) of one another. Thus, the interaction between two proteins of interest can be monitored 
by fusing one to the donor fluorophore and one to the acceptor (Siegel et al. 2000). 
We generated and validated a series of constructs encoding wildtype TDG as well as a SUMOylation 
deficient  mutant  (K341R,  TDG  ∆S)  and  a  catalytically  dead  mutant  (TDG  ∆cat)  fused  N- or C-terminally 
to the FRET acceptor Citrine. The donor Cerulean was N-terminally fused to SUMO1 and SUMO3. We 
could confirm full-length expression and catalytic activity of the TDG fusion proteins, although the N-
terminal tag appears to interfere with efficient expression and the non-specific DNA interactions of 
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the N-terminal domain (Appendix I, Fig.2b, 2c and 3d). Additionally, we proved that the fluorophore 
tags on both, TDG and SUMO, do not interfere with the SUMO conjugation pathway or with their 
respective subcellular localization (Appendix I, Fig. 2d and Fig. 4). 
We provide proof that the SUMO1- and SUMO3-interactions of TDG can be monitored in living cells 
and that these interactions occur at a surprisingly high steady state in the absence of induced DNA 
damage (Appendix I, Fig. 4 and 5). Including the SUMOylation-deficient mutant TDG ∆S  in  our  system  
enabled us to distinguish between covalent and non-covalent SUMO-interactions. We found a 
significantly higher FRET signal for the SUMO3-interaction   of   wildtype   TDG   than   for   TDG   ΔS,  
suggesting that a significant part of the cellular TDG pool is covalently attached to SUMO3 in the 
presence of endogenous levels of DNA damage (Appendix I, Fig.5b). On the other hand, it appears 
that SUMO1 is mostly associated with TDG through its SBMs rather than through a covalent bond as 
we do not find a significant difference between the FRET signal produced by the SUMO1-interaction 
of  wildtype  TDG  and  TDG  ΔS  (Appendix  I,  Fig.  5a).   
To validate our system, we tested whether excess DNA damage alters the TDG-SUMO-interaction 
dynamics. By treating cos7 cells transiently expressing the FRET constructs with the base analog 5-FU 
which is incorporated into the DNA and represents a substrate for TDG-mediated repair, we were 
able to shift the balance between SUMO-binding and SUMO-modification of TDG. Interestingly, the 
treatment  only  affected  the  interaction  with  SUMO1  and  not  with  SUMO3  (Fig.  5).  TDG  ΔS  appears  to  
lose the interaction with SUMO1 upon treatment with 5-FU, which is in agreement with previous 
reports of SUMO- and DNA-binding of recombinant TDG being mutually exclusive (Smet-Nocca et al. 
2011). We observe a small increase of the SUMO1 interaction of wildtype TDG upon induction of 
DNA damage. As the FRET signal derived from the SUMO1-interactions of wildtype TDG is a mix of 
covalent and non-covalent SUMO-binding, and as the non-covalent interaction is reduced upon 5-FU 
treatment, we conclude that modification of TDG by SUMO1 is in fact stimulated by DNA damage 
(Appendix I, Fig. 5a). This observation supports a role of SUMOylation in regulating TDG function 
during DNA repair. 
SUMO3, on the other hand, appears to be covalently attached to part of the cellular TDG pool even 
in absence of DNA damage. Upon 5-FU treatment, the association of SUMO3 with TDG through its 
SBMs appears to be stimulated, evident in a mildly increased FRET signal derived from the SUMO3-
interactions  of  TDG  ΔS  (Appendix  I,  Fig.5b).  As  the  overall  interaction  of  wildtype  TDG  with  SUMO3  is  
reduced, covalent SUMO3 binding appears to be dissolved upon induction of DNA damage. 
Taken together, it appears that the interaction with SUMO1 and SUMO3 regulate TDG function in 
different contexts. As TDG is involved not only in canonical DNA repair but also in the regulation of 
gene expression, these two different processes might employ different SUMO family members. 
SUMOylation of TDG in response to exogenous DNA damage appears to involve mostly SUMO1, 
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whereas SUMO3 might control TDG function in the context of transcriptional regulation by mediating 
protein-protein interactions with transcription factors or histone modifying enzymes. SUMO1 was 
shown to mostly interact with the C-terminal SBM of TDG (Smet-Nocca et al. 2011), raising the 
question whether the N-terminal SBM serves a distinct function and mediates interactions within a 
different set of complexes, possibly involving SUMO3. Our FRET system provides a powerful tool for 
elucidating the different roles of SUMO1- and SUMO3 interaction of TDG and the conditions affecting 
these interaction dynamics. 
We further designed and generated a FRET system to monitor the conformational switch of TDG 
between an open and a closed form by fusing the FRET donor Cerulean to the C-terminus and the 
acceptor Citrine to the N-terminus of TDG. We found that attaching fluorophore tags to both termini 
drastically increased the relative catalytic activity of  TDG  on  a  G•T   substrate   (Appendix  1   Fig.   3d).  
Therefore, double-tagged TDG might not be able to efficiently switch to or remain in a closed 
conformation. Still, pilot experiments revealed a robust FRET signal. As some biochemical and 
structural evidence suggests the formation of TDG homodimers ((Maiti et al. 2008; Morgan et al. 
2011) and Roland Steinacher, personal communication), we included dimerization controls: single-
tagged TDG fused N- or C-terminally to either Cerulean or Citrine. We found FRET to occur between 
single-tagged TDG molecules, although it remains unclear in which conformation, parallel or anti-
parallel, this interaction occurs. N-terminally Citrine- and C-terminally Cerulean-tagged TDG 
produced a robust FRET signal which was significantly enhanced when both tags were fused to the C-
terminus (Appendix 1, Fig.6). The FRET efficiency was potentiated further with double-tagged TDG, 
which is probably mostly due to doubling the number of fluorophores between which the energy 
transfer can occur, although we cannot exclude that part of the FRET signal derives from an 
intramolecular energy transfer. Furthermore, we found a significantly higher FRET signal produced by 
double-tagged TDG   ΔS   compared   to   wildtype   TDG,   suggesting   that   SUMO-modification interferes 
with dimerization. It remains to be tested whether this interaction involves only two TDG molecules 
or is in fact a polymerization, and whether it is mediated by DNA and/or SUMO-binding. 
Dimerization of TDG on the DNA in the course of DNA repair might serve the purpose of inhibiting 
BER or NER of any damage occurring in close proximity of the produced AP-site on the opposite 
strand. The generation of two opposing AP-sites or the degradation of a whole stretch of DNA 
opposite an AP-site might result in double-strand breaks. It is likely that mechanisms evolved to avoid 
such a clash of two DNA repair processes. Such a function of TDG dimerization becomes especially 
appealing with regard to DNA demethylation in which TDG has been implicated. 5-mC occurs mostly 
symmetrically in a palindromic CpG dinucleotide and a BER-coupled DNA demethylation process 
would have to be restricted to one strand at a time to avoid double-strand breaks (see also Appendix 
III). 
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In conclusion, we have generated a FRET system that provides a powerful tool to elucidate the role of 
the SUMO-TDG-interaction in DNA repair and other contexts. Furthermore, we provide the first 
evidence of TDG dimerization in living cells, which may have a function in ensuring strand specificity 
during DNA demethylation processes.   
 
Contribution: 
I designed, generated, validated and characterized all FRET constructs used in this study. I cultured 
and transfected cos7 cells, performed protein extraction from cos7 cells, conducted Western blot 
analysis, base release assay, microscopy and image analysis, and wrote the manuscript in Appendix I. 
 
 
 
4.2. Embryonic lethal phenotype reveals a function of TDG in maintaining 
epigenetic stability (Appendix II) 
 
The interaction partners of TDG are various, ranging from DNA repair factors to transcription factors 
and chromatin modifiers. Thus, TDG has been implicated not only in DNA repair but also in the 
regulation of gene expression. To elucidate the biological function of TDG, we generated Tdg-/- mice 
and found TDG to be essential for embryonic development, unlike any other mammalian DNA 
glycosylase. TDG knockout embryos display internal haemorhage by E10.5 and die around E11.5 
(Appendix II, Fig. 1a). To investigate whether loss of the DNA repair function of TDG causes 
embryonic lethality, we tested the sensitivity of wildtype and Tdg-/- immortalized MEFs to ionizing 
radiation and H2O2 but found that TDG deficiency had no effect on cell survival. Furthermore, a 
standard mutator assay revealed no increase in the frequency of spontaneous mutations (Appendix 
II, Supplementary Fig. 2). The function of TDG in canonical DNA repair, if any, is likely redundant and 
compensated for by other DNA glycosylases with an overlapping substrate spectrum. 
We further investigated whether deletion of Tdg affects the regulation of gene expression in MEFs. 
Expression analysis revealed 461 misregulated genes in the Tdg knockout of which many encode 
transcription factors, thus suggesting direct as well as indirect gene expression effects of the TDG 
loss. The gene networks most affected were connected to embryogenesis and development 
(Appendix II, Supplementary Fig. 3a). 
As TDG has been implicated in active DNA demethylation, we analyzed DNA methylation at the CGI 
containing promoters of genes downregulated in Tdg knockout MEFs. CGI are normally maintained in 
a hypomethylated state, but sequencing of Na-bisulphite converted DNA isolated from wildtype and 
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Tdg knockout MEFs revealed an accumulation of aberrant de novo DNA methylation in absence of 
TDG (Appendix II, Fig. 1c). We found that TDG is associated with these promoters by chromatin 
immunoprecipitation (ChIP) but found no enrichment of TDG on an intergenic control region or the 
transcriptionally silent promoters of Oct4 and Tuba3 (Appendix II, Fig. 1d). It thus appears that TDG is 
targeted to active gene promoters, possibly to protect them from acquiring aberrant de novo DNA 
methylation and transcriptional silencing. 
Further analysis of the chromatin status of these gene promoters revealed a loss of di-methylation of 
lysine 4 on histone 3 (H3K4me2) which is associated with an active chromatin state. In parallel, we 
found these loci to gain repressive histone marks: active promoters which showed only H3K4me2 in a 
wildtype background (e.g. those of Sfrp2 and Twist2) acquired H3K27 tri-methylation (H3K27me3), 
whereas promoters with a bivalent chromatin state (coinciding H3K4me2 and H3K27me3 e.g. at the 
promoters of Hoxa10 and Hoxd13) acquired H3K9me3 (Appendix II, Fig. 1e). Stable complementation 
of Tdg-/- MEFs with a vector encoding TDG rescued the chromatin state at the promoters and the 
expression of Sfrp2 and Twist2 (Appendix II, Fig. 2). However, we found that those promoters that 
lost H3K4me2 completely and gained H3K9me3 (e.g. those of Hoxd13 and Hoxa10) could not be 
reversed to a bivalent chromatin state by re-introducing Tdg into knockout MEFs, suggesting that 
heterochromatinization of these promoters progressed beyond a point of reversibility in our 
experimental system. 
To investigate the origin of the epigenetic instability we observe in absence of TDG, we profiled gene 
expression in Tdg positive and negative ES cells and after in vitro differentiation to neuronal 
progenitor cells (NPs). Interestingly, we found almost no differentially regulated genes in ES cells but 
a significant increase of transcriptional misregulation (297 genes) after differentiation to NPs (Fig. 
3a). Analysis of gene networks most affected revealed a connection to developmental functions and 
many of the misregulated genes to have promoter CGIs and to be targets of the polycomb repressive 
system (Appendix II, Supplementary Fig. 7a).  We could confirm enrichment of TDG at the promoter 
of misregulated genes in ES cells and NPs. Moreover, we found TDG associated with the promoters of 
Oct4 and Nanog in ES cells but not in NPs (Appendix II, Fig. 3b) suggesting that TDG loses affinity to 
these promoters upon heterochromatinization, which may explain why TDG complementation failed 
to rescue the chromatin state of the heterochromatinized Hoxd13 and Hoxa10 promoters in MEFs. 
Na-bisulphite sequencing revealed increased levels of DNA methylation at several promoters of 
genes downregulated in Tdg-/- NPs but not in ES cells (Appendix II, Fig. 3c). Similarly, aberrant histone 
modifications only arose upon in vitro differentiation, evident in a gain of H3K27me3 at the 
promoters of Hoxa10 and Hoxd13 (Appendix II, Supplementary Fig. 8). Taken together, epigenetic 
aberrations in absence of TDG appear to arise only in differentiated cells, suggesting a function of 
TDG in establishing and maintaining epigenetic marks during cell differentiation. 
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To elucidate whether this function of TDG entails downstream BER, we tested for an association of 
key BER factors with these TDG-bound gene promoters. We found a TDG-dependent enrichment of 
XRCC1 and APE1 in MEFs at these genomic regions, whereas XRCC1 appears to bind independent of 
TDG in ES cells (Fig. 4a). Furthermore, we found an induction of chromatin associated XRCC1 foci in 
TDG positive but not in TDG-deficient ES cells that were differentiated for 8 h with retinoic acid (RA) 
(Appendix II, Supplementary Fig. 9). Additionally, Tdg-/- cells exhibited reduced sensitivity to 
inhibition of poly(ADP-ribose) polymerase (PARP) upon differentiation (Appendix II, Supplementary 
Fig. 10), suggesting that differentiation in the presence of TDG induces the formation of single-strand 
DNA breaks the further processing of which requires XRCC1 and PARP. 
Investigating the origin of the imbalance of histone modifications at these promoters, we found that 
the histone acetyltransferase CBP and the H3K4 specific methyltransferase MLL1 are enriched at the 
promoters of genes downregulated in TDG knockout MEFs, and that this association depends on the 
presence of TDG in MEFs but not in ES cells (Appendix II, Fig. 4b). Interestingly, CBP/p300 has been 
shown to interact with TDG and to protect promoters from H3K27 tri-methylation (Tini et al. 2002; 
Pasini et al. 2010). 
In conclusion, our results suggest a dual role of TDG in maintaining an active chromatin state at CGI 
promoters during differentiation: first by structurally coordinating the association of chromatin 
modifiers responsible for establishing and maintaining active histone marks (e.g. MLL1 and 
CBP/p300), second by enzymatically contributing to protection of these CGIs against aberrant 
methylation (Appendix II, Fig. 4c). The induction of DNA single-strand breaks in response to RA 
differentiation in addition to the association of XRCC1 and APE1 with CGI promoters in a TDG-
dependent manner suggests that this latter function entails BER, hinting at a repair mediated DNA 
demethylation process contributing to epigenome stability during cell differentiation. 
 
Contribution: I established immunocytochemical staining of XRCC1 and PCNA (Supplementary 
Fig. 9a), performed imaging of ES cells at 0 and 8 h of RA differentiation and visual assessment of 
XRCC1 foci number in S-phase and non-S-phase cells in 5 independent, blinded experiments 
(Supplementary Fig. 9b). I further assessed XRCC1-foci number in H2O2 treated and mock treated ES 
cells (Supplementary Fig. 9c) and confirmed equal cell cycle profiles of TDG positive and negative ES 
cells after 8 h of RA differentiation (data not shown). Moreover, I established immunostaining of 
H3K4me2, H3K27me3 and H3K9me3, which I performed on ES cells differentiated for 0, 48 and 96 h 
with RA in replicates. The global patterns of these chromatin modifications did not differ between 
TDG-proficient and -deficient cells within this timeframe of differentiation (data not shown). 
For all experiments involving ES cells, I prepared Feeder cells, conditioned the ES cells for an 
undifferentiated state for 3 passages on Feeders and prepared frozen stocks. During the 
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establishment of Na-bisulphite sequencing, I prepared genomic DNA from ES cells at 0, 48 and 96 h of 
RA differentiation and conducted bisulphite conversion. PCR-amplified DNA fragments were cloned 
into bacterial vectors and transformed into E.coli. I prepared plasmid DNA from 117 bacterial clones 
for commercial sequencing. I further prepared total RNA from ES cells differentiated for 48 h with RA 
for gene expression analyses by qRT-PCR (Supplementary Fig. 6c). Finally, in the attempt to 
investigate the mechanism underlying TDG catalyzed DNA demethylation at CGIs, I generated DNA 
substrates for base release assays to test a potential 5-hmC glycosylase activity. We found no activity 
of TDG on 5-hmC (data not shown) which has by now been confirmed by other studies. The 
conversion of 5-hmC to 5-fC and 5-caC  and  TDG’s  glycosylase  activity  on  these bases was reported 
later (He et al. 2011; Ito et al. 2011; Maiti and Drohat 2011). 
 
 
 
4.3. TDG maintains a transitory equilibrium of CpG island methylation and oxidative 
demethylation during cell differentiation (Appendix III) 
 
Our previous efforts to elucidate the biological function of TDG in embryo development has 
implicated TDG in safeguarding CGIs during cell differentiation by coordinating histone modifiers 
responsible for an active chromatin state as well as by counteracting aberrant DNA methylation. 
Recently, TDG has been implicated in a putative DNA demethylation pathway involving the Ten 
Eleven Translocator (TET) family of proteins. TET1-3 convert 5-mC to 5-hydroxymethylcytosine 
(Tahiliani et al. 2009) and further to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), the latter 
two representing excellent subtrates for TDG (He et al. 2011; Maiti and Drohat 2011). 
To investigate a function of TDG in DNA methylation control, we performed MeDIP in combination 
with next generation sequencing on DNA from TDG positive and negative ES cells, in vitro 
differentiated neuronal progenitors (NPs) and MEFs derived from litter-matched wildtype and TDG 
knockout embryos around E10.5. While we found no differentially methylated regions (DMRs) in ES 
cells, in vitro differentiation gave rise to more than 900 DMRs in NPs, a number that increased about 
40 fold in MEFs, a more advanced stage of differentiation (Appendix III, Fig. 1b). Further 
characterization of the NP DMRs revealed that DMRs with a high CpG density were mostly 
hypomethylated in knockout NPs, whereas CpG poor DMRs were almost exclusively hypermethylated 
(Appendix III, Fig. 1c). Moreover, we wondered whether differential methylation affected regions 
involved in the regulation of gene expression. We found that hypomethylated DMRs were on 
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average localized closer to a TSS and more often associated with promoters (ENSEMBL TSS -1.5 kb 
and +0.5 kb) than hypermethylated DMRs (Appendix III, Fig. 1d and e).  
As we previously proposed a function of TDG in safeguarding CGIs against aberrant DNA methylation, 
we tested whether the NP DMRs overlapped with CGIs. DMRs were indeed significantly enriched for 
CGIs and almost all these CGI DMRs were hypomethylated in the Tdg knockout background 
(Appendix III, Fig. 2a). This finding was counterintuitive given that CGIs are generally considered 
devoid of CpG methylation, demanding explanation. As, in principle, hypomethylation in TDG-
deficient NPs can derive either from a loss of methylation already present at the ES cell stage or from 
a failure to de novo methylate sequences in absence of TDG during differentiation, we intersected 
the hypomethylated CGI DMRs with CGIs that are hypermethylated in wildtype NPs compared to 
wildtype ES cells. Almost all CGI DMRs overlapped with CGIs that are poised for methylation during 
differentiation (Appendix III, Fig. 2b). Thus, hypomethylation of CGIs in Tdg knockout NPs arises 
through a failure to de novo methylate these regions. 
As only a minority of CGIs are differentially methylated across cell types and those that are do not 
necessarily overlap with gene promoters (Illingworth and Bird 2009; Jones 2012), we intersected the 
CGI DMRs with published datasets of histone modifications and DNA binding factors to characterize 
which type of CGI is affected by the absence of TDG. We found that the CGI DMRs were depleted for 
promoters (ENSEMBL TSS -1.5 kb and +0.5 kb), RNA polymerase II, p300 and H3K27ac. On the other 
hand, we found the CGI DMRs to be significantly enriched for TET1 binding sites, H3K4me1, 
H3K27me3 as well as distal regulatory regions that were recently characterized as low methylated 
regions (LMRs) (Stadler et al. 2011). Especially with NP-specific LMRs, i.e. binding sites of 
transcription factors only expressed or active in NPs, we found a striking overlap of 52%. The 
association of hypomethylation in the TDG-deficient NPs with LMRs expanded also to CpG poor 
DMRs, 20% of which were LMRs. Taken together, this characterization revealed that CGI DMRs 
overlap with polycomb targets (H3K27me3) (Kuzmichev et al. 2002) and enhancer regions (LMRs) 
(Stadler et al. 2011) which appear to be in a silent or poised state, enriched for H3K4me1 but not 
p300 or H3K27ac (Creyghton et al. 2010). 
Reduced levels of 5-mC at the CGI DMRs can be explained either by a failure to recruit Dnmt3a and b, 
which were both shown to interact with TDG (Li et al. 2007; Boland and Christman 2008), or by a 
chemical conversion of 5-mC to a derivative that is no longer recognized by the 5-mC antibody used 
for MeDIP. Such a conversion could entail deamination, which would result in a pre-mutagenic  G•T  
mismatch, or TET catalyzed oxidation to 5-hmC and further to 5-fC and 5-caC. Alternatively, 5-hmC 
could   be   deaminated   to   give   rise   to   a   G•5-hmU mismatch. Both deamination-coupled scenarios 
would  result  in  C  → T transition mutations. 
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To test these different hypotheses, we performed hairpin bisulphite sequencing (BS-seq), which 
allows simultaneous assessment of strand-specific methylation and mutation frequency at selected 
targets with  a  sequencing  read  depth  of  ~10’000.  To  be  able  to  distinguish  between  a  structural  and  
a catalytic function of TDG, we performed in vitro differentiation in a complemented cell system 
(Tdg-/- ES cells complemented with wildtype Tdg, catalytically inactive TdgΔcat or the empty 
complementation vector). Analysis of a set of representative CGI DMRs confirmed hypomethylation 
of 5 out of 7 targets in knockout NPs and cells expressing TdgΔcat  (Appendix III, Fig. 3). As the catalytic 
inactive but structurally intact TDG should still be capable of recruiting other factors like Dnmt3a and 
b, it is unlikely that hypomethylation is caused by a failure to direct the de novo methyltransferases 
to these regions during differentiation. Importantly, we did not find any increase in   the   C   → T 
mutation frequency in knockout and TDGΔcat. We thus conclude that 5-mC is not lost due to 
deamination and ultimately mutation of CpGs at these CGIs. 
As the product of TET mediated oxidation, namely 5-hmC, 5-fC and 5-caC are not maintained through 
DNA replication by Dnmt1 (Valinluck and Sowers 2007; Inoue et al. 2011), we performed a short 
(24 h) RA differentiation timecourse to avoid dilution of these 5-mC derivates. Further, to reduce 
epigenetic heterogeneity, we preconditioned the ES cells in 2i medium for 4 passages prior to RA 
differentiation, which, nota bene, reduced the global 5-mC levels by approximately 50% (Appendix III, 
Fig. S2b). By monitoring RNA and protein levels of key factors like TET1 and TET2, but also of 
pluripotency genes and transcription factors silenced or induced by differentiation, we were able to 
confirm equal loss of pluripotency in all three complemented ES cell lines (Appendix III, Fig. S1). It is 
noteworthy that AID RNA levels remained extremely low throughout differentiation and protein 
levels were below the detection limit in Western blot analysis (Appendix III, Fig. S1c). 
 We investigated the global levels of 5-mC, 5-hmC, 5-fC, 5-caC and 5-hmU throughout the 24 hours 
timecourse of RA differentiation and found the levels of 5-mC, 5-fC and 5-caC to rise significantly 
with time in knockout and TDGΔcat but not in wildtype cells (Appendix III, Fig. 4 and S2a). Differential 
5-mC and 5-fC levels between TDG-proficient and -deficient cells thus arose with differentiation. 
5-caC levels were already in the pluripotent state about 9 fold higher in cells lacking TDG activity, 
which is in agreement with previous observations in Tdg knockdown experiments (He et al. 2011). 
We also verified that TDGΔcat retains no activity on 5-caC but found that it binds this substrate with 
higher affinity than C, 5-mC or 5-hmC (Appendix III, Fig. 5b and c). Taken together, our findings 
suggest that differentiation-induced methylation is accompanied by the generation of higher 
oxidized 5-mC derivatives which accumulate in TDG deficient cells. 
To investigate whether the changes observed on the global scale reflect the situation at the CGI 
DMRs, we performed targeted analysis of 5-mC and 5-caC levels. We found the levels of 5-mC and 5-
caC to increase in both, wildtype and TDGΔcat cells but not in absence of TDG. TDGΔcat cells displayed a 
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striking accumulation of 5-caC at the CGI DMRs (Appendix III, Fig. 5a). It thus appears that 
differentiation-induced methylation of the CGI DMRs is accompanied by stepwise oxidation of 5-mC. 
As the overall trajectory of the CGI DMRs points towards methylation in NPs (Appendix III, Fig. 3), the 
generation of not only 5-mC but also 5-caC suggests that 5-caC eventually has to be removed and 
replaced with C, the substrate for Dnmt3a and b. In knockout cells, on the other hand, RA 
differentiation induced neither methylation nor the generation of 5-caC at the CGI DMRs, suggesting 
a structural function of TDG in inducing or maintaining the cycle of cytosine methylation and 
demethylation. 
To further investigate the structural and catalytic contribution of TDG to the cycle of CGI methylation 
and demethylation, we performed chromatin immunoprecipitation (ChIP) to monitor the association 
of TET1, the most highly expressed member of the TET family in ES cells (Appendix III, Fig. S1a and b), 
to the CGI DMRs during differentiation. We found that after incubation with RA, TET1 binds to the 
CGI DMRs with increasing affinity in wildtype cells but loses this affinity with differentiation in 
knockout and, surprisingly, also in TDGΔcat  cells (Appendix III, Fig. 6a and S4). 
As TDGΔcat   is incapable of processing 5-caC but binds this substrate with high affinity, we reasoned 
that TDGΔcat   might bind the accumulating 5-caC at the CGI DMRs and thus destabilize TET1 
association. We therefore performed ChIP to compare the affinity of wildtype and TDGΔcat  to the CGI 
DMRs. Indeed, we found that wildtype TDG is associated with the DMRs only transiently, whereas 
TDGΔcat  accumulated at the CGI DMRs (Appendix III, Fig. 6c and S5). The inability of TDGΔcat   to turn 
over might result in unusual DNA demethylation intermediates after the next round of DNA 
replication, i.e. hemi-caC sites which are no longer a substrate for TET1. 
Taken together, we found that TDG controls the transition of CGI methylation states during cell 
lineage restriction by safeguarding the balance of 5-mC and its oxidized derivatives during a state of 
high epigenetic plasticity. We found that cell differentiation induces a cycle of DNA methylation and 
oxidative demethylation at CGIs associated with polycomb targets and poised enhancers and 
propose that TDG not only contributes catalytically to this cycle by excising the products of TET 
mediated 5-mC oxidation but also structurally coordinates initiation and/or maintenance of the cycle. 
 
Contribution:  I cultured the complemented ES cell lines before and during the 24h RA timecourse, 
checked the cell cycle profile of undifferentiated and differentiated cells by FACS (data not shown), 
prepared genomic DNA, RNA and protein extracts of a 2i control (-16h) and timepoints 0, 4, 8 and 
24 h, and organized and coordinated the LCMSMS analysis of genomic levels of 5-mC derivatives in 
collaboration with researchers from the Hans Krokan laboratory in Trondheim, Norway. Moreover, I 
conducted qRT-PCR and Western Blot analyses for the 24 h timecourse, as well as statistical analysis 
of the LCMSMS, MeDIP, GLIB, caCDIP and ChIP results. Together with A. Wirz, I prepared chromatin 
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and performed TET1- and TDG-ChIP of timepoints 0, 8 and 24 h. I also performed and coordinated 
bioinformatic analyses to characterize NP DMRs with regard to the correlation between methylation 
change and CpG density, proximity to the nearest TSS and overlap with various (epi)genomic 
features. Finally, I wrote the manuscript in Appendix III. 
 
 
 
 
4.4. Supplementary Results 
 
4.4.1. A cell-based assay to measure the epigenetic stability of gene promoters 
 
The finding that mechanisms exist to ensure the epigenetic stability of promoters during cell 
differentiation has raised the need for tools to assess the rate of stochastic epigenetic aberrations. 
To this end I set out to develop a cell-based assay to measure the epigenetic stability of promoters, 
which can be applied in high-throughput screens as well as to analyze stochastic events on a clonal 
basis. 
In a pilot experiment, I explored a fluorescence microscopy-based approach (Meilinger et al. 2009) to 
compare the silencing kinetics of the cytomegalovirus (pCMV) promoter driving mCherry expression 
to the epigenetically more stable chicken actin promoter (pCAG) driving the expression of GFP. Both 
constructs were transiently co-transfected into TDG-proficient and -deficient MEFs and cells were 
imaged for 2, 4, 6 and 8 days after transfection (Fig. 4-01). Both constructs are non-replicating as 
they lack a mammalian origin of replication and, thus, we expect dilution by cell-replication to 
contribute to loss of fluorescence signal.  
Although pCAG is regarded as an epigenetically more stable promoter, we found a rapid loss of GFP 
signal within the first 2-4 days. Furthermore, we observed a faster loss of signal of both constructs in 
TDG knockout compared to wildtype MEFs (Fig. 4-01b), which can be interpreted either as faster 
dilution of the constructs in knockout MEFs or as differential silencing of the constructs in absence of 
TDG.  
The proliferation-rate and also the rate of random integration of the constructs into the genome 
might produce cell-line specific biases, raising the need for a more controlled approach to monitor 
promoter silencing, excluding such artifacts. Moreover, as this simple promoter silencing assay is 
limited in its applications, I designed and generated a construct for stable integration into ES cells 
that allows keeping the promoter of interest under selective pressure and timing its release to 
monitor gradual silencing. The construct, termed plProX, contains two modified Cre recombinase 
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target (lox) sites, lox511 and lox2272, facilitating site-directed, unidirectional exchange of the whole 
cassette. Upstream of lox511, we inserted 8 repeats of the lac operator (lacO) sequence to allow 
targeting of a factor of interest fused to the lac repressor (lacI). Such targeting of TDG has been 
shown to induce DNA demethylation of the targeted sequences (Gregory et al. 2012). Downstream of 
lox2272, we integrated a firefly luciferase reporter gene to allow for simplified expression monitoring 
(Fig. 4-02). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-01: Silencing of transiently transfected fluorescence reporter constructs. a) pCMV mCherry and pCAG 
GFP were co-transfected into TDG wildtype and knockout MEFs. Images were acquired every second day with 
equal settings. b) Medians of 130 - 400 cells per time point and sample. Fluorescence intensities were 
normalized to the respective median at day 4; error bars, s.e.m. of normalized intensities, *, p < 0.01, ***, p < 
0.0001, Mann-Whitney test. 
 
day                     2                             4                               6                                8 
     pCAG                     GFP        pCMV                mCherry 
a) 
b) 
*** 
*** 
* 
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The Cre-lox exchangeable cassette consists of the promoter of interest, driving expression of the 
puromycin N-acetyltransferase (PuroR) that confers resistance to puromycin. PuroR allows not only 
selecting for stable integration of the construct in the ES cell genome but also for keeping the 
promoter of interest under selective pressure and thus active. PuroR is flanked by flippase (FLP) 
recognition target (FRT) sites which allow removal of PuroR by FLP-FRT recombination. Removing the 
selective pressure mediated by PuroR allows gradual silencing of the promoter of interest which can 
be monitored as transcription of a reporter gene encoding a fusion of GFP with the HSV-1 thymidine 
kinase (TK) downstream of the second FRT site. Expression of GFP allows live cell sorting to attain a 
pure population of cells having gone through FLP-FRT recombination to start the silencing time 
course. Silencing can be monitored as gradual loss of GFP fluorescence by microscopy, as a reduction 
in GFP-positive cells by FACS, by measuring GFP-TK mRNA levels and by selection for silencing with 
ganciclovir for clonal analyses (St Clair et al. 1987).  
 
 
Figure 4-02: Scheme of the plProX construct. FLP-FRT recombination allows removal of PuroR and thus release 
of the selective pressure on promoter 1. Additionally, transcription of a GFP-TK reporter gene is switched on, 
which allows cell sorting for a pure population of GFP-TK expressing cells and subsequent monitoring of 
silencing by fluorescence microscopy, FACS, qRT-PCR and ganciclovir selection. The whole cassette can be 
exchanged by Cre-lox recombination to analyze other promoters of interest. A sequence encoding firefly 
luciferase downstream of lox2272 allows a simplified analysis of gene expression. The line above PuroR or GFP-
TK indicates transcription, ! marks the position of transcription terminator sequences. 
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I generated a first construct with the CMV promoter, which provides sufficient expression levels of 
PuroR for initial selection, and selected for stable integration of the construct into the genome of Tdg 
knockout ES cells in the presence of puromycin. An initial screen of the stable plProX clones was 
performed by PCR on genomic DNA, testing for the presence of lox511 and lox2272 (Fig. 4-03a).  
 
 
Fig. 4-03: Characterization of ES cell clones with stable integration of plProX. a) Initially, presence of the lox 
sites was verified by PCR on genomic DNA with 2 primer pairs each (circled numbers). b) Clones with verified 
lox sites were transiently co-transfected with vectors encoding mCherry and an optimized flippase (FLPo), the 
latter catalyzing the removal of FRT-site flanked PuroR, resulting in the expression of GFP-TK. c) Genomic DNA 
from clones with FLP-activatable GFP-expression was subjected to Southern blot (SB) analysis to test for single-
copy integration of plProX. The hybridization site of the probe is indicated in a. E, EcoRI-, B, BglII-digested DNA. 
 
a) 
b) 
c) 
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Additionally, clones that were verified to contain the construct were co-transfected with a vector 
encoding an optimized FLP recombinase (FLPo) and one encoding mCherry as a transfection control. 
Images were acquired two days after transfection (Fig. 4-03b). Clones that expressed GFP after 
transfection with FLPo were further characterized with regard to copy number of the construct 
integrated into the genome. Genomic DNA was digested either with EcoRI or with BglII, both of 
which cut once within the plProX construct. The DNA fragments containing the construct were 
subsequently detected by Southern blot with a radioactive probe hybridizing to the sequence of 
PuroR (Fig. 4-03a and c). In collaboration with S. Diggelmann, I identified the clones 1d-4 
(characterization not shown), 5d-13, 5d-16 and 5d-31 as containing a single copy, the latter two of 
which yield a robust GFP signal in FACS analysis (data not shown).  
 
 
        
Fig. 4-04: LacO-lacI mediated targeting of mCherry-tagged factors. a) Scheme of targeting to 256 lacO repeats 
in NIH3T3 cells and IPTG-induced dissociation of lacI-tagged TDG. b) lacI-TDG-mCherry transiently expressed in 
NIH3T3. The arrow indicates the position of the lacO array within the cell nucleus, evident as a focus of 
mCherry fluorescence (left panel). After addition of 5 mM Isopropyl-β-D-thiogalactopyranosid (IPTG) to the 
medium, lacI-TDG-mCherry dissociates from the lacO array (right panel). c) Targeting of lacI-AID-mCherry and 
lacI-MLL1 SET-mCherry in NIH3T3. The arrows indicate the focal accumulation of the lacI-fusion protein on the 
lacO array.   
 
 
Further characterization of these clones will entail ganciclovir selection, test for efficient Cre-lox 
recombination and a preliminary characterization of silencing rates. Finally, two independent clones 
will be complemented with a vector containing a Tdg minigene controlled by the authentic Tdg 
promoter and allowing alternative splicing to produce isoforms A and B. For separation of function 
a) 
c) 
TDG b) 
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studies, we also generated a variant of this minigene expressing a catalytic inactive but structurally 
intact isoform of TDG. 
As our system includes the option to target factors of interest to the promoter through lacO lacI 
interaction, we generated constructs encoding AID, the MLL1 SET domain and TDG fused to mCherry 
and lacI. In parallel to establishing the plProX system, we validated targeting and IPTG-induced 
dissociation of the fusion proteins in an availble lacO cell system (Soutoglou et al. 2007) (Fig. 4-04). 
The lacI-fusion constructs can thus be used to address mechanistic questions with the plProX system 
by measuring the effect of the targeted activities on silencing rates or even reactivation of the 
promoter.  
Taken together, the plProX system provides a novel and versatile method to monitor the epigenetic 
stability of gene regulatory sequences and to facilitate high throughput screens as well as the 
isolation and analysis of stochastic silencing events in a cell population, equivalent to the fluctuation 
test available for the assessment of genetic mutation rates.  
 
Methods:  
 
Construction of plProX. Essentially as described in Appendix I. All components were PCR amplified 
with primers containing additional restriction sites, FRT or lox sites where required and inserted into 
EGFP-1 (Clontech). The gene encoding firefly luciferase replaced EGFP and introduced lox2272. The 
CMV  promoter   introduced   lox511,  PuroR   the  5’  FRT  site.  The  GFP-TK   fusion  with  a  5’  FRT  site  was  
assembled in EGFP-N1 and subsequently inserted between PuroR and lox2272. All PCR-amplified 
fragments were verified by sequencing (Microsynth, Switzerland). 
 
Cell culture. All cell lines were incubated at 37°C, 5% CO2 and 100% moisture. ES cells were cultured 
essentially as described in Appendix III. Tdg-/- cells were cultured in ECM with LIF and transfected 
with   1,   2   or   5   μg   of   endotoxin   free   plProX   plasmid   (Qiagen,   Switzerland)   using   jetPEI™   (Polyplus  
Transfections, France). Clones were selected with 1.5 μg/mL  puromycin   for  5-7 days. Single clones 
were constantly cultured with 1 μg/mL   puromycin.   Transfection   of   mCherry-N1 and FlpO was 
performed with jetPEI. 
NIH3T3 cells with lacO repeates (NIH2/4) were cultured in Dulbecco’s   Modified   Eagle’s   Medium  
(DMEM) supplemented with 10% FCS and 2 mM L-glutamine and transfected with lacI-fusion 
constructs   using   jetPEI™.      To reverse targeting of lacI-fusion proteins, culture medium was 
supplemented with 5 mM IPTG. 
 
Extraction of genomic DNA. As described in Appendix III. 
55 
 
Validation of lox sites by PCR. Fragments surrounding the lox sites were amplified with Paq5000 
polymerase   in   standard   polymerase   chain   reaction   according   to   the   manufacturer’s  
recommendations. Primer pairs used are listed in Table 4-01. 
 
Southern Blot. 15 μg  genomic  DNA  was  digested  with  5U  EcoRI or BglII per  μg  DNA   for  5  hours   at  
37°C,  then  with  additional  5U  per  μg  DNA  overnight.  DNA  was  purified  by  ethanol  precipitation  and  
resuspended for ~5 h at 55°C shaking at 14000 rpm, followed by separation on a 0.7% agarose gel in 
TBE with 50 V for 8 h.  DNA  was  stained  with  0.3  μg/mL  ethidium  bromide  and  visualized  under  UV.  
DNA was depurinated by incubating the gel in 0.1% HCl for 10 min. The gel was rinsed in ddH2O, 
equilibrated for 10min in 4N NaOH and the DNA transferred overnight to a nylon membrane (Zeta-
probe, BioRad, Switzerland) in 4N NaOH. The membrane was briefly rinsed 3 times in 2x SSC, DNA 
was crosslinked to the membrane by incubation for 2 h at 80°C. The probe detecting the sequence of 
PuroR was PCR   amplified  and   100ng  of   the   purified   PCR  product  was   radiolabelled  with   50μCi   [α-
32P]-dCTPs (Perkin Elmer, Switzerland) using the Fermentas Hexalabel DNA labeling kit (Fermentas, 
Switzerland). Excess nucleotides were removed with the QIAquick Nucleotide Removal Kit (Qiagen, 
Switzerland). The membrane was pre-hybridized in hybridization buffer (0.25M Na2HPO4, pH 7.2, 7% 
SDS) for 15 min - 2 h at 65°C before addition of the probe and incubation overnight at 65°C. 
Subsequently, the membrane was washed at 65°C, three times in Wash Solution I (40 mM Na2HPO4, 
pH 7.2, 5% SDS), twice in Wash Solution II (40 mM Na2HPO4, pH 7.2, 1% SDS), followed by incubation 
for 48 h on a phospho-imager screen in a light-tight cassette and scan with a Typhoon fluorescence 
scanner (GE Healthcare, Switzerland). 
 
Table 4-01: Primers used in clone characterization. 
 Name 5‘-3‘  sequence 
Primer 
pair 1 
pEGFP F CCGTATTACCGCCATGCATTAG 
CMV 5' R GTTATGTAACGCGGAACTCC 
Primer 
pair 2 
TK seq 3 CTG CTG CAA CTT ACC TCC GG 
TK BglII NotI rev CGA GCG GCC GCA GAT CTG GGT CGT CCA CCA GAC CCC 
ACG 
Primer 
pair 3 
Across lox511 fw GGC CTT TTG CTG GCC TTT TGC TC 
Across lox511 rev GTC AAT GGG CGG GGG TCG TTG 
Primer 
pair 4 
Across lox2272 fw CAG GGC TCG CAG CCA ACG TC 
Across lox2272 re CGC GCC CAA CAC CGG CAT AA 
Southern 
Blot probe 
PuroR probe fw ACA TCG AGC GGG TCA CCG AG 
PuroR probe rev CCA TAG AGC CCA CCG CAT CCC 
All primers were obtained from Microsynth, Switzerland. 
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Contribution: I designed and generated the plProX construct and the TDG complementation vectors. 
Furthermore, I selected ES cell clones stably transfected with plProX and performed initial 
characterization by PCR and fluorescence microscopy. Moreover, I supervised the Master project of 
S. Diggelmann who continues characterization of the clones, e.g. by Southern blot. 
 
 
 
 
4.4.2. Generation of 5-caC through inducing oxidative damage in live cells 
 
The TET proteins were found to oxidize 5-mC to 5-hmC and further to 5-fC and 5-caC (Tahiliani et al. 
2009; He et al. 2011; Ito et al. 2011). LCMSMS analysis of global 5-fC and 5-caC levels in Tdg knockout 
and TdgΔcat cells revealed 2-9 fold enrichments compared to wildtype cells, which is in agreement 
with TDG being the primary DNA glycosylase responsible for the excision of 5-fC and 5-caC. However, 
as these higher oxidized 5-mC derivatives are not maintained by Dnmt1 (Valinluck and Sowers 2007; 
Inoue et al. 2011) and, thus, diluted by DNA replication, it is striking that such a high level of 5-fC and 
5-caC accumulate in TDG-deficient cells. We therefore asked whether 5-fC and 5-caC might arise 
spontaneously through non-enzymatic oxidation of 5-hmC and, thus, if oxidative stress might have an 
impact on epigenetic stability. 
We treated Tdg-/- ES cells complemented with wildtype Tdg or TdgΔcat with H2O2 to induce oxidative 
stress and subsequently performed immunofluorescence staining with a specific anti 5-caC antibody. 
Surprisingly, we found 5-caC to localize in distinct foci throughout the nucleus in absence of oxidative 
damage and independent of cell cycle stage, irrespective of the TDG status. These foci did not co-
localizing with focal PCNA during S-phase (Fig. 4-04a), indicating that they do not associate with 
progressing replication forks. As 5-caC localization in ES cells has not been described so far, neither 
by immunofluorescence staining nor by genome wide mapping, it remains to be verified that 5-caC 
indeed clusters in foci. However, 15min of incubation in H2O2 appeared to increase the number of 
foci in a dose dependent manner in wildtype cells but not in TDGΔcat (Fig. 4-04b), suggesting that the 
latter is either refractory to H2O2-induced generation of 5-caC or that the already elevated levels of 
5-caC in TDGΔcat represent a ground state that allows no further induction of 5-caC without erratic 
effects. The wider range of foci numbers observed in TDGΔcat might indicate the latter. 
We next measured the global levels of 5-mC, 5-hmC, 5-fC, 5-caC and - as a control - 8-oxoG by 
LCMSMS. 15min of H2O2 exposure plus 15min of recovery increased the global 8-oxoG levels 
approximately 7 fold in wildtype genomic DNA compared to mock treated cells (Fig. 4-04c). 
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Interestingly, 5-mC levels were decreased and 5-hmC, 5-fC and 5-caC levels were increased by H2O2 in 
wildtype cells, suggesting that the application of oxidative stress indeed oxidized 5-mC to 5-hmC and 
further. However, the H2O2 treatment appeared ineffective in TdgΔcat and knockout cells, as evident 
from the unchanged levels of 8-oxoG. The variable efficacy of the treatment might be caused by the 
instability of H2O2. Surprisingly though, the effect observed in wildtype cells appeared to be reversed 
in TdgΔcat and knockout cells suggesting that the treatment converted 5-hmC, 5-fC and 5-caC in a way 
not detectable in our approach.  
 
 
 
 
Fig. 4-04: Non-enzymatic generation of 5-fC and 5-caC. a) Immunofluorescence staining of 5-caC and PCNA in 
wildtype ES cells mock treated in PBS for 15min. DAPI was used to stain DNA. b) Number of 5-caC foci per cell 
(n=7-12), visually assessed in z-stacks acquired on a confocal microscope (Leica SP5). Floating bars indicate 
median plus range. Statistical analysis by two-way Anova with Bonferroni post-test. ** p<0.001. c) LCMSMS 
quantification of the indicated modified bases in the genome of wildtype (wt), TDGΔcat (Δcat) and knockout (ko) 
cells. Bars indicate number per 106 unmodified bases (A, C, T and G). 
 
a) 
b) c) 
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These results were obtained in a single experiment the reproduction of which failed due to the 
erratic effects of H2O2 on the induction of oxidative damage. Still, my preliminary results indicate that 
higher oxidized 5-mC derivatives could indeed arise non-enzymatically, suggesting that oxidative 
stress, besides inducing genetic mutations, might also destabilize cell programming. The question 
how oxidative damage affects 5-mC and its derivatives thus remains an important one and will have 
to be readdressed in a more robust set-up. Other reagents which are more stable, i.e. menadione, 
might prove more suitable to study the generation of 5-fC and 5-caC under oxidative stress. 
 
Methods: 
 
ES cell culture. Essentially as described in Appendix III. Cells were cultured in 2i medium prior to 
treatment with 100 μM  (if  not  indicated  otherwise)  H2O2 in PBS or just PBS (mock control) for 15 min. 
Cells were left for 15 min in culture medium to recover followed by further processing. 
 
Immunocytochemistry. Essentially as described in Appendix II. Cells were fixed in -20°C cold methanol 
for 5 min on ice and then rehydrated for 2x 15 min in PBS. After permeabilization with 0.2% TritonX-
100/PBS for 5 min on ice, cells were rinsed with PBS and DNA was depurinated with 2 N HCl for 
20 min. Cells were washed with PBS and neutralized by two 10 min washes in 100mM Tris-HCl pH 8. 
After blocking with blocking solution (BS; 2% BSA, 0.05% Tween20, PBS) for 1 h at room temperature, 
cells were incubated with the primary antibodies (anti 5-caC 1:500, Active Motif, Belgium; anti-PCNA 
FITC 1:400, Leinco Technologies, Missouri USA) in BS over night at 4°C. Three 10 min washes with BS 
were followed by incubation with secondary antibody (goat anti rabbit Alexa 594 1:500, Invitrogen – 
Life Technologies Switzerland) in BS for 1 h. After two 10 min washes in BS and one in PBS, DNA was 
stained   with   5   μg/mL   DAPI.   Excess   DAPI   was   removed   by   two   5 min washes in PBS followed by 
mounting in Vectashield (Vector Labs, UK). Z-stacks were acquired on a Leica SP5 with 405 nm, 
488nm and 594 nm laser lines (Leica, Switzerland).  
 
LCMSMS. As described in Appendix III. Conditions for 8-oxo(dG) were as for C-modifications. Mass 
spectrometry detection of 8-oxo(dG) was performed using an MDS Sciex API5000 triple quadrupole 
(Applied Biosystems – Life Technologies, Norway) operating in positive electrospray ionization mode 
for the mass transition 284.1/168.2. 
 
Contribution: I cultured the ES cells and performed the treatment with H2O2. Moreover, I established 
the 5-caC immunofluorescence staining, conducted microscopy-based analysis and visual assessment 
59 
 
of 5-caC foci number. I further prepared genomic DNA from treated and mock treated cells for 
LCMSMS analysis. 
 
 
 
 
 
 
4.4.3. Familial loss-of-function TET2 mutation does not correlate with the disease phenotype 
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Members of the TET family of proteins have been implicated in myeloid malignancies. Only recently, 
TET proteins have raised considerable attention in the epigenetics field, owing to the discovery of 
their biochemical activity as iron- and alpha-ketoglutarate- dependent dioxygenases, converting 5-
methylcytosine to 5-hydroxymethylcytosine, and ultimately to 5-formylcytosine and 5-
carboxylcytosine (chapter 2.4.2. and (Tan and Shi 2012)). Whereas TET1 was originally identified as a 
fusion partner of MLL, generated by aberrant chromosomal rearrangements in acute myeloid 
leukemia (AML) (Lorsbach et al. 2003), TET2 mutations have been identified in patients with 
hematological diseases like myeloproliferative neoplasms (MPN), myelodysplastic syndromes and 
AML (Tefferi et al. 2009). Among these mutations are frameshifts, nonsense and missense mutations 
that abolish its catalytic activity. Hence, patients with TET2 mutations display lower overall 5-hmC 
levels and hypermethylation at promoter regions (Ko 2010, Figueroa 2011, Liu X 2013). The impact of 
TET2 inactivation on myeloid malignancies is not yet fully understood although it was proposed to 
promote expansion of mutant progenitor or stem cells in the course of hematopoiesis (Delhommeau 
et al. 2009; Figueroa et al. 2010; Schaub et al. 2010; Swierczek et al. 2011). However, it is unclear 
whether TET2 inactivation is sufficient to cause disease. 
The frameshift mutation TET2-D1858fs was identified as a heterozygous germline mutation in a 
familial case of MPN (Schaub et al. 2010). The frameshift is caused by a deletion of 4 nt that results in 
a stretch of 27 amino acids unrelated to the original sequence before a premature stop-codon. The 
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mutation thus abolishes two out of three amino acid moieties required for binding of Fe(II) ions and 
2-oxoglutarate, namely H1881 and R1896 (Tailiani 2009, Ito 2010). Despite the fact that knockdown 
of TET2 resulted in expansion of progenitor and stem cells in a mouse model (Figueroa et al. 2010), 
two individuals carrying the heterozygous mutation were found to be asymptomatic regarding blood 
counts or reported hematological diseases but displayed decreased levels of 5-hmC in DNA isolated 
from peripheral blood mononuclear cells (Veligodskiy et al, manuscript in preparation). Therefore, 
we tested the catalytic activity of TET2-D1858fs. In addition to the analysis of global 5-hmC levels in 
genomic DNA of HEK293T cells expressing wildtype or mutant TET2 by dot blot (Veligodskiy et al, 
manuscript in preparation), we tested the ability of TET2-D1858fs to induce the generation of 5-hmC 
in HEK293T cells by immunofluorescence staining and confocal microscopy. We found that wildtype 
TET2 readily generated 5-hmC, whereas the naturally low levels of 5-hmC in HEK293T cells remained 
unchanged in cells expressing TET2-D1858fs or a previously described truncated and inactive TET2-
S1848x (Langemeijer et al. 2009) (Fig. 4-05). We conclude that the frameshift mutation D1858fs 
abolished TET2 activity and that the absence of a phenotype in these patients may be explained with 
compensation by the functional copy of TET2. 
In conclusion, we report two cases of a heterozygous germline loss-of-function mutation in TET2 in 
individuals without any symptoms of hematological disease. Whereas the functional copy of TET2 
might be sufficient to suppress a phenotype, 5-hmC levels are decreased in peripheral blood 
mononuclear cells from these individuals (Veligodskiy et al., manuscript in preparation). Also, the 
development of symptoms in members of the same family with haploinsufficiency of TET2 suggests 
an involvement of other, as yet unknown factors. Notably, knockdown of TET2 by 40-80% in murine 
hematopoietic stem cells (which might be comparable with haploinsufficiency) was shown to impair 
differentiation (Figueroa et al. 2010) and mice with targeted deletion of TET2 develop myeloid 
malignancies (Li et al. 2011). 
Taken together, the decrease in 5-hmC levels alone appears to not be sufficient to explain the 
development of symptoms, raising the question whether TET2 is structurally rather than 
enzymatically required for controlling haematopoiesis. A recent study revealed that TET2 targets the 
O-linked  β-N-acetylglucosamine transferase (OGT) to chromatin to modify a serine in H2B (Chen et al. 
2013; Deplus et al. 2013; Vella et al. 2013). As this TET2-OGT complex is potentially involved in the 
regulation of gene expression, it remains to be elucidated whether truncated TET2, i.e. TET2-
D1858fs, is still capable of interacting with and targeting OGT. 
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Fig. 4-05: 5-hmC levels in HEK293T cells expressing wildtype and mutant myc-tagged TET2. a) Representative 
confocal images (z-stack projection) acquired 44-48 h after transfection. TET2-S1848x and TET2-D1858fs do not 
generate 5-hmC. b) Scatter plot of log2-transformed average intensities of myc and 5-hmC signals (0 to 255) 
per cell nucleus with linear regression. s, average slope resulting from 3 replicate experiments ± s.e.m.; p-
values of t-test versus wildtype. 
 
 
Methods: 
 
Immunocytochemistry. HEK293T cells were seeded onto sterile coverslips in 12-well plates at 3 x 104 
cells/well one day prior to transfection with expression constructs encoding myc-tagged wildtype 
TET2, D1858fs, S1848x and empty vector (myc only) using JetPEITM (Polyplus Transfections, France) 
a) 
b) 
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according  to  the  manufacturer’s  instructions.  44-48 h post transfection, cells were fixed for 10 min in 
3.7% paraformaldehyde/PBS, washed briefly in PBS and incubated for 5min in pre-chilled methanol 
at -20°C. After 30 min of rehydration in PBS, cells were permeabilized for 30 min in 0.2% TritonX100/ 
PBS, incubated for 15 min in 2 N HCl and neutralized for 10 min in 100mM Tris-HCl pH 8.4. Cells were 
blocked for 1 h at room temperature in 3%BSA, 0.1% Tween 20 in PBS (BS), incubated over night at 
4°C with primary antibodies (mouse anti-myc 9E11, Santa Cruz, rabbit anti-hydroxymethylcytosine, 
Active Motif, Belgium) 1:200 in BS, followed by detection with secondary antibodies (goat anti-rabbit 
Alexa594, goat anti-mouse Alexa488, Invitrogen - Life Technologies, Switzerland) 1:200 in BS for 30-
60 min at room temperature. Nuclei were stained with 5 μg/mL of   4’,6-diamidino-2-phenylindole 
(DAPI) and cover slips were mounted in VectaShield (Vector Labs, UK). Images were collected as z-
stacks on a Leica SP5 confocal microscope (Leica, Switzerland), using the 20x objective for 
quantification and 63x objective for visualization of cellular TET2 and HMC distribution. Four z-stacks 
per sample were acquired with the 405nm, 488nm and 594nm laser lines, and subsequently 
converted to 2D tiff images by maximum intensity projection in ImageJ (http://imagej.nih.gov/ij/) for 
further image analysis. 
 
Image analysis. Image quantification was performed with the CellProfilerTM software 
(www.cellprofiler.org). Cell nuclei were identified in the DAPI images with the 
“IdentifyPrimaryObjects”  module  (between  20  and  80  pixel  units in diameter), with a lower boundary 
of  the  “Otsu  PerObject”  derived  threshold  of  0.05.  Misinterpreted  objects  were  manually   removed  
with   the   “EditObjectsManually”   module.      HMC   and   mycTET2   intensities   were   quantified   in   the  
remaining regions using the “MeasureObjectIntensities”  module.  Average  intensities  per  cell  (ranging  
from 0 to 255) were log2 transformed with a pseudocount of 1 (y=log2(x+1)). The corresponding 
figures were generated in R (www.r-project.org). 
 
 
Contribution: I transfected HEK293T cells with wildtype and mutant myc-tagged TET2. Subsequently, 
I established immunocytochemical co-staining of 5-hmC and myc-tagged TET2, conducted image 
acquisition, automated image analysis with the CellProfiler software (www.cellprofiler.org) and 
statistical analysis with R. 
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4.5. DNA Glycosylases: In DNA Repair and Beyond (Appendix IV) 
 
The integrity of the genome is safeguarded by a number of cellular DNA repair mechanisms that have 
evolved to specifically address different kinds of damage. Single-base lesions caused by oxidation, 
deamination or alkylation are repaired by the Base Excision Repair (BER) pathway which is initiated 
by DNA Glycosylases. These enzymes are capable of detecting base damage that does not distort the 
overall structure of the DNA double helix but is pro-mutagenic  or   cytotoxic  by  disturbing  a  base’s  
Watson-Crick base-pairing properties or interferes with DNA replication. Detection of such small 
irregularities is possible through a mode of action common to all DNA glycosylases: they flip a 
damaged base out of the double helix and into a catalytic site cavity, in which specific interactions 
between the base and key amino acid residues ensure recognition of the damage and alignment of 
the base for hydrolysis of the N-glycosidic bond. 
While all DNA glycosylases share this base-flipping mechanism, they differ in how they scan the DNA 
for base lesions, how such lesions are initially recognized and how excision of a damaged base is 
catalyzed. I performed a comprehensive study of the literature and explored the principles of design 
relating to the function of DNA glycosylases in the recognition of DNA base modifications in the 
context of canonical DNA repair and other processes, e.g. adaptive immunity and DNA demethylation 
(Appendix IV).    
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5 Concluding Discussion and Outlook 
 
Following its discovery as mismatch directed Thymine DNA Glycosylase, studies on TDG function have 
revolved mainly around classical aspects of DNA repair and genome stability. However, recent 
discoveries pointed into a quite different direction, implicating TDG dependent repair processes in 
the maintenance of epigenetic rather than genetic stability. These important discoveries have shaped 
the progress of my PhD thesis, the aims of which was to investigate TDG function both 
mechanistically and biologically.  
TDG has been isolated as interaction partner of many different kinds of proteins. Most often these 
were transcription factors, implicating a contributing of TDG to the regulation of gene expression. 
Besides transcription factors, Dnmt3a and Dnmt3b were also found to interact with TDG, connecting 
the glycosylase with DNA methylation control (Cortazar et al. 2007; Li et al. 2007; Boland and 
Christman 2008). The search for interaction partners with TDG as a bait, however, was much less 
yielding, and produced only a few hits. The strongest interaction partners identified in this way were 
Small Ubiquitin like Modifiers (SUMOs), and it turned out that TDG is indeed covalently modified but 
also non-covalently interacts with SUMOs. Biochemical studies have implicated SUMOylation in 
controlling the dissociation of TDG from its product AP-site (Hardeland et al. 2002; Steinacher and 
Schar 2005; Mohan et al. 2007). To investigate the function of TDG SUMOylation in vivo, I have 
established a Fluorescence Resonance Energy Transfer (FRET) system and was able to show first 
evidence for an involvement of SUMOylation in TDG dependent DNA repair in live cells. Preliminary 
studies of the SUMO-TDG interaction indicated that SUMO1 and SUMO3 might control TDG function 
in distinct contexts, as I was able to shift the balance of covalent and non-covalent SUMO1-binding 
by inducing DNA damage, whereas the SUMO3-interaction remained mostly unaffected. Moreover, I 
found a surprisingly high level of SUMO-TDG interaction already in absence of exogenous DNA 
damaging agents. These studies were based on the classical paradigm that TDG is a bona fide DNA 
repair protein counteracting DNA damage. However, this view has changed with the finding that TDG 
contributes to epigenetic stability. 
In the light of recent findings that TDG is involved in chromatin maintenance and more specifically in 
maintaining a cycle of DNA methylation and demethylation (Appendix II and III), the steady state of 
SUMO-TDG interaction we observed might reflect the contribution of SUMO to regulating TDG-
dependent processes beyond canonical DNA repair. Be it in counteracting DNA damage or in 
safeguarding chromatin states, TDG operates in an intricate framework of enzymatic cascades that 
need to be tightly controlled to ensure efficient substrate processing, handover and dissociation in a 
complex of structural and catatlytic factors. SUMOylation and SUMO-binding are very likely involved 
in regulating these processes and transactions, creating a need for tools to monitor the SUMO-
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interactions of the key players of genome and epigenome maintenance in living cells. Our FRET 
system allows analyzing the SUMO-TDG interaction dynamics not only in response to DNA damage 
but also for instance in the course of ES cell differentiation. By including a SUMOylation deficient 
mutant TDG, we can distinguish between the contribution of SUMO-binding and SUMOylation to 
controlling TDG function in these processes. 
Remarkably, our attempt to generate a FRET system to monitor the conformational changes of TDG 
revealed that part of the cellular TDG pool exists as homodimers. In the context of active DNA 
demethylation, it is tempting to speculate that homodimerization of TDG might inhibit simultaneous 
repair processes on opposing DNA strands. As 5-mC mostly occurs symmetrically on a palindromic 
CpG dinucleotide, mechanisms must have evolved to avoid the simultaneous conversion of both 5-
mCs to a BER-substrate and subsequent generation of two adjacent AP-sites. On the other hand, the 
high affinity of TDG for its product AP-site might already block the access of TET proteins to the 
opposite 5-mC. These hypotheses may be tested in the future by making use of biochemical assays, 
for instance by testing whether pre-incubation of TDGΔcat with a substrate containing 5-caCpG/ 
5-hmCpG inhibits oxidation of 5-hmC to 5-fC/5-caC by TET. Combination with the FRET system using 
purified FRET fusion proteins (single- or double-tagged TDG) would allow testing a) whether 
dimerization depends on DNA and b) whether a potential exclusion of TET from the opposite 5-hmC 
involves TDG dimerization.  
 
Establishing the function of TDG in safeguarding epigenetic transitions, we found that knockout of 
Tdg in mice is embryonic lethal and that CGI promoters acquire aberrant methylation during in vitro 
differentiation in TDG-deficient ES cells. Furthermore, we observed that RA-induced in vitro 
differentiation increases the number of XRCC1 foci and the sensitivity to PARP inhibition in wildtype 
but not in Tdg knockout cells (Appendix II), indicating that single-strand breaks are induced upon 
differentiation in a TDG dependent manner. We found further support for the hypothesis that cell 
differentiation is accompanied by TDG-dependent DNA repair processes when we observed that the 
loss of pluripotency triggers a state of high epigenetic plasticity that is characterized by the 
generation of 5-mC and its higher oxidized derivates 5-fC and 5-caC at CGIs. TDG appears to 
contribute to this cycle of DNA methylation and oxidative demethylation not only enzymatically by 
initiating BER of 5-fC and 5-caC to restore an unmethylated C, but also structurally as we found 
initiation and/or maintenance of the cycle to fail in Tdg knockout cells. Interestingly, TdgΔcat appears 
to structurally support initiation but due to its inability to excise 5-caC fails to maintain the cycle and 
- by binding with high affinity to the accumulating 5-caC at these genomic regions - destabilizes the 
association of TET1. 
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In the absence of TDG, differentiation stimuli might trigger undirected and uncoordinated 
methylation. A failure to assemble the protein complex required to maintain the balance between 
methylation and demethylation might cause the stochastic patterns of hypermethylation we 
observed at CGI promoters in Tdg knockout NPs by pyrosequencing of bisluphite converted genomic 
DNA. In apparent contrast to this finding, genome-wide methylation analysis by MeDIP-seq revealed 
that most differentially methylated CGIs in TDG knockout NPs are hypomethylated. However, 
keeping in mind that MeDIP relies on an antibody for the specific enrichment of 5-mC containing 
DNA fragments and bisulphite sequencing does not distinguish between 5-mC and 5-hmC, it may 
very well be that the aberrant methylation we observed by bisulphite sequencing was in fact an 
accumulation of 5-hmC. Moreover, the fact that this hypermethylation appeared rather mild might 
reflect that 5-fC and 5-caC, which are indistinguishable from C in bisulphite sequencing, accumulate 
rather than 5-hmC at these CGI promoters. As methods for mapping 5-fC and 5-caC are being 
developed (Raiber et al. 2012), it will be possible to analyze the balance between the different C-
modifications on a genome-wide scale. The combination of, for instance, 5-caCDIP with next 
generation sequencing holds the promise of shedding light onto which sites are affected by this 
differentiation induced cycle of DNA methylation and demethylation. Intersecting such data with 
published data sets might reveal 1) what signals are necessary to target the key factors involved to 
these specific sites and 2) what determines the overall trajectory of this cycle towards a methylated 
or an unmethylated state.  
Another question to be addressed is what role TET2 and TET3 play in this cycle. As TET1 is gradually 
downregulated upon differentiation, it is likely that the other members of the TET family take over at 
later stages of differentiation and in terminally differentiated cells, providing altered target 
specificities that might be required in these cells. 
 
To facilitate mechanistic studies into the maintenance of epigenetic stability, I developed a model 
system that allows assessment of the rates of spontaneous epigenetic aberrations by monitoring the 
silencing of gene promoters or other sequences of interest. While the core reporter system is 
established and functional and first experiments in stable TDG proficient and deficient backgrounds 
are pending, pilot experiments with a transient transfection setup studies already indicated that 
differential silencing dynamics between TDG-proficient and -deficient cells can be measured. Besides 
measuring silencing rates, the goal was also to make the tool applicable for analyzing stochastic 
epigenetic aberrations at a clonal level, and for high-throughput screening for factors or even 
chemical compounds affecting the epigenetic stability of gene promoters. Moreover, by faciliating 
the targeting of factors like MLL1, AID, TET1 or TDG to the promoter of interest by lacO-lacI 
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interaction, we hope to provide a tool for mechanistic investigations into the signals required for 
assembling the complex mediating epigenetic changes. 
 
Epigenetic instability and thus the failure of pathways proof-reading the epigenome is also a hallmark 
of many human cancers. The mechanisms behind this epigenetic instability, especially with regard to 
DNA methylation, are only beginning to be uncovered. For instance, fusions of TET1 with MLL have 
been identified in several patients with acute myeloid leukemia (Lorsbach et al. 2003) and TET2 
mutations have been associated with myeloid malignancies (Tefferi et al. 2009). Future studies will 
have to address if mutation, misregulation or mistargeting of the TET proteins - and TDG for that 
matter - might be involved in carcinogenesis and cancer progression. In a collaboration, we 
addressed the correlation of a heterozygous loss-of-function TET2 mutation found in a familial case 
of MPN with disease phenotype. Strikingly, this mutation was found in family members both with 
and without myeloid disease symptoms, illustrating the complexity of the interlink between disease 
and  the  system  that  maintains  a  “healthy”  epigenome. 
 
In conclusion, our studies have revealed an essential function of TDG in development and more 
particularly as part of the cellular machinery that safeguards and possibly directs epigenetic 
transitions during cell differentiation. In the course of my thesis, I produced data that may guide 
future studies and generated tools that can be exploited in the analyses of the intricate framework of 
factors maintaining epigenome stability, to investigate the dynamic protein-protein interactions 
involved and their effect on promoter stability.  
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Abstract 
 
The Thymine DNA Glycosylase (TDG) initiates Base Excision Repair (BER) of single-base damage, 
preferentially the deamination products of cytosine and 5-mythylcytosine, uracil and thymine, 
respectively. By hydrolyzing the N-glycosidic bond between the damaged base and the deoxyribose, 
TDG produces an abasic (AP) site to which TDG remains firmly attached. We have previously shown 
that modification of TDG with Small Ubiquitin-like Modifiers (SUMOs) facilitates the dissociation of 
TDG from its product AP-site by inducing a conformational change from a closed to an open 
conformation. Since this hypothesis was based solely on biochemical studies, the significance of the 
SUMO-TDG interaction for BER in vivo remains unclear. Here, we present a Fluorescence Resonance 
Energy Transfer (FRET) system that allows monitoring the SUMO-interactions of TDG in living cells, 
and we provide evidence that the interaction dynamics measured by FRET can be altered by inducing 
DNA damage. Furthermore, we established a FRET system for the dimerization of TDG and report 
that part of the cellular TDG pool exists as homodimers. 
 
 
Introduction 
 
The DNA encoding all genetic information is under constant risk of damage by deamination, 
oxidation or alkylation. Most frequently, such chemical modifications concern the DNA bases, which 
are then corrected through the Base Excision repair (BER) system. BER is initiated by DNA 
glycosylases which recognize the damage base in the DNA and flip it out of the DNA double helix into 
a catalytic pocket for hydrolysis of the N-glycosidic bond (Lindahl and Wood 1999). The resulting 
abasic (AP) site is then further processed by an AP endonuclease (APE1) producing a single-strand 
break which is subsequently repaired through short-patch or long-patch BER (Fortini and Dogliotti 
2010).  
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The Thymine DNA Glycosylase (TDG) was first discovered by its ability to excise the deamination 
products of cytosine (C) and 5-methylcytosine (5-mC), uracil and thymine mispaired with guanine, 
respectively, but its substrate spectrum encompasses a broad range of pyrimidine derivates, e.g. 5-
fluorouracil (5-FU) or 5-hydroxymethyluracil (5-hmU) (Cortazar et al. 2007; Jacobs and Schar 2012). 
Recently, 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), the oxidation products of the Ten 
Eleven Translocator (TET) family of 5-mC hydroxylases, have been shown to be efficiently excised 
from DNA by TDG, suggesting an involvement of TDG in the epigenetic regulation of gene expression 
through a putative DNA demethylation pathway (He et al. 2011; Maiti and Drohat 2011). In this 
context, it is noteworthy that among the interaction partners of TDG are not only DNA repair factors 
but  also  transcription  factors   like  the  retinoic  acid  receptor  (RAR)  or  the  estrogen  receptor  α  (ERα)  
and the de novo DNA methyltransferases Dnmt3a and b (Cortazar et al. 2007).  
The search for interaction partners of TDG has revealed an involvement of post-translational 
modification with Small Ubiquitin-like Modifiers (SUMOs) in TDG-initiated BER (Hardeland et al. 
2002). SUMOylation represents a fast and (in most cases) reversible way to regulate protein stability, 
subcellular localization, enzymatic activity or interaction dynamics. The SUMO protein family includes 
three genes in mammals, SUMO1, 2 and 3; the latter two share 97% sequence identity and are often 
referred to as SUMO2/3. While most of the cellular SUMO1 pool appears to be constitutively 
attached to target proteins, SUMO2/3 appear to become conjugated to target proteins primarily as a 
reaction to environmental stress (Saitoh and Hinchey 2000). A fourth gene, encoding SUMO4, is 
present only in the human genome and is expressed mostly in lymph nodes, kidney and spleen 
(Geiss-Friedlander and Melchior 2007). 
SUMO is synthesized as an inactive precursor and processed by a SUMO-specific isopeptidase 
(SENtrin-specific Protease, SENP) to yield a glycine-glycine motif at the C-terminus, which can form 
an isopeptide bond with an acceptor lysine of a target protein. The SUMO proteins are covalently 
attached to their respective target protein in a multi-step process, initiated by a SUMO activating 
enzyme E1 (heterodimer of SAE1/SAE2) which adenylates SUMO, facilitating the formation of a 
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thioester bond with SAE2. SUMO is then transferred to the SUMO-conjugating enzyme (E2) UBC9, 
and further to a lysine residue in the target protein, this last step often but not always being 
mediated by SUMO E3 ligases. The E3 ligase responsible for SUMOylating TDG has so far remained 
elusive. The modification is reversible through the action of SENPs (Geiss-Friedlander and Melchior 
2007). 
A majority of the SUMO-targets appear to be nuclear proteins, many of which are involved in DNA 
replication and transcription or in the regulation of chromosome structure and dynamics, suggesting 
SUMO to be a key player in genome maintenance and stability (Gill 2004). Moreover, knockout of any 
of the non-redundant components of the SUMO conjugation pathway has been reported to be 
embryonic lethal, suggesting a crucial role of SUMOylation in development (Lomeli and Vazquez 
2011). 
Apart from forming covalent bonds, SUMO has been shown to interact non-covalently with proteins 
containing a so-called SUMO Interaction/Binding Motif (SIM or SBM), which consist of a hydrophobic 
core, flanked N- or C-terminally by acidic and/or serine residues (Minty et al. 2000; Song et al. 2004).  
TDG interacts covalently as well as non-covalently with SUMO1 and SUMO2/3 (Hardeland et al. 
2002). The SUMO acceptor lysine K341 (in murine splice-variant TdgA) lies within a C-terminal 
SUMOylation consensus motif (VKEE). Additionally, two SBMs have been identified in TDG, one in the 
N- and one in the C-terminal domain (Mohan et al. 2007).  
Extensive biochemical studies have revealed that SUMOylation induces a conformational change in 
TDG that regulates the dynamics of the initiation of BER (Steinacher and Schar 2005). Upon binding 
to homoduplex DNA, the N-terminal domain of TDG forms a clamp-like structure that allows the 
glycosylase to slide along the DNA in search of a substrate base. When encountering a damaged base 
and flipping it into the catalytic pocket, specific interactions with the opposite guanine in addition to 
the homoduplex DNA-binding activity of the N-terminal domain cooperate to bind TDG firmly to the 
substrate for excision, after which TDG stays firmly bound to the AP-site (Waters et al. 1999; 
Hardeland et al. 2000). SUMOylation of the C-terminus facilitates the dissociation of TDG by opening 
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the clamp-like conformation, thus neutralizing the homoduplex binding activity of the N-terminus 
(Hardeland et al. 2002; Steinacher and Schar 2005). Downstream-acting repair factors like the AP-
endonuclease1 (APE1) and XRCC1 stimulate SUMOylation of TDG, suggesting that AP-site binding 
may serve the purpose of stabilization of these hazardously fragile sites until the BER complex is in 
place for hand-over of the repair intermediate ((Steinacher and Schar 2005) and unpublished data). 
To confirm this function of TDG SUMOylation as well as the conformational switch of TDG between 
an open and a closed form in vivo, we developed a tool for monitoring the SUMO-interactions and 
the conformational changes of murine TDG in live cells. We established a Fluorescence Resonance 
Energy Transfer (FRET) system, which allows measuring the interaction between two proteins by 
fusing one to a donor fluorophore and one to an acceptor fluorophore with a suitable absorption 
spectrum. If the two proteins of interest bring the fluorophores in close proximity (10 to 80 Å) and a 
favorable orientation, an energy quantum is transferred from the donor in its excited state to the 
acceptor fluorophore. The thus excited acceptor emits light in a wavelength beyond the emission 
spectrum of the donor. Here, we report that the inter- and intramolecular interaction dynamics of 
TDG can be measured in vivo by FRET and that the SUMO-interaction dynamics can be altered by 
inducing DNA damage.  
 
 
Materials and Methods 
 
Vector construction 
The FRET constructs were assembled by standard cloning techniques in IRES constructs holding either 
the chicken actin promoter and a Puromycin resistance cassette downstream of the IRES (pCAIp used 
for TDG constructs, the positive control Citrine-Cerulean and Citrine) or the CMV promoter and a 
Hygromycin resistance (pCMIh, analogous to pIREShyg, Clontech, used for SUMO constructs and 
Cerulean). Murine TDG, SUMO and the fluorophores were PCR amplified with adaptor primers 
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holding the required restriction sites. All oligonucleotides used for cloning can be found in 
Supplementary Table 2. A schematic overview of the cloning strategy is shown in Supplementary 
Fig. 1. 
The sequence encoding for the wildtype Tdg (murine splice variant A, mTdgA) or the SUMOylation-
deficient mutant mTdgA K341R (TDG ΔS) was inserted into the EcoRI and BamHI sites of pCAIp, 
introducing additional restriction sites for NheI, BsrGI, XhoI and ClaI. For N-terminal fusion with EGFP 
or Citrine, the respective coding sequence was inserted into the EcoRI and BsrGI sites upstream of 
TDG. C-terminal fusion was accomplished by introducing the fluorophore sequence into the 
downstream XhoI and BamHI sites. The DNA fragment encoding for Cerulean was digested with XbaI 
and NheI and inserted into the NheI site  at  the  5’  end  of  TdgA. For the C-terminal fusion, the coding 
sequence was inserted into the XhoI and ClaI sites 3’  of  TdgA. 
The sequences encoding human SUMO1 and 3 (identical with murine proteins at the amino acid 
level) with a glycine-glycine motif at the C-terminus were PCR-amplified from pCDNA3-HA-SUMO1GG 
or pCDNA3-HA-SUMO3GG (kindly provided by Ron Hay), respectively, and inserted into the EcoRV 
and NotI sites of pCMIh, additionally introducing XhoI, NheI and BsrGI sites. The Cerulean encoding 
sequence was introduced into the XhoI and NheI sites upstream of the SUMO1/3 encoding sequence. 
The FRET positive control vector pCAIp Citrine-Cerulean was derived from a vector encoding double 
tagged TDG (pCAIp Cit-TDG-Ceru), by replacing TDG with a linker sequence encoding 
VQSGGDASGGSSST. The negative controls pCAIp Citrine and pCMIh Cerulean were assembled 
through introduction of the fluorophore sequences into the EcoRI and BamHI sites of the respective 
expression vector. All PCR-amplified fragments were validated by sequencing.  
 
Cell culture and transfection 
All cell lines were incubated at 37°C, 5% CO2 and 100% humidity. Cos7 cells were cultured in 
Dulbecco’s  Modified  Eagle’s  Medium  (DMEM)  supplemented  with  10%  FCS  and  2 mM L-glutamine. 
Murine ES cells were cultivated on feeder cells in DMEM with 15% heat-inactivated FCS, 2mM L-
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glutamine, 1x sodium pyruvate, 1x MEM non-essential amino  acids,  0.1mM  β-mercaptoethanol and 
1000U/mL LIF. Transfections were performed using TransFectin™ (BioRad, Siwtzerland) or   JetPEI™  
(Polyplus Transfection, France) according  to  the  manufacturer’s  manuals. ES cells were transfected 
with TransFectin in suspension after feeder-removal and subsequently plated for further incubation. 
DNA  damage  was  induced  by  adding  30μM  5-FU  or  10μM  BrdU  to  the  culture  medium  followed  by  
24-28h of incubation. 
 
Protein extraction 
Denaturing SDS-extracts were prepared 40-48 h after transfection by adding 100 μL of SDS sample 
buffer (45 mM Tris-HCl pH8, 10% glycerol, 1% SDS, 0.01% bromophenol blue, 50 mM DTT) to one 
35 mm plate, scraping the cells off the surface and transferring the lysate to an Eppendorf tube. The 
samples were heated to 95°C for 10 min and centrifuged at 16’000xg and 4°C for 10 min. 
For native protein extracts, mammalian cells were harvested, washed with PBS and lysed in an 
appropriate volume of NP40 lysis buffer (50 mM sodium phosphate buffer pH8, 125 mM NaCl, 
0.5 mM EDTA pH8, 1% NP40, 1 mM PMSF, 1 mM DTT, 1x Complete EDTA-free Protease Inhibitor 
Cocktail) by vortexing and incubating them on ice for 30 min. To increase cell breakage, samples 
were sonicated 5 times for 20 sec with intervals of 40 sec. After centrifuging at 16’000xg and 4°C for 
20 min, the supernatants were shock-frozen and stored at -80°C. The Bradford Protein Assay (BioRad, 
Switzerland) was used to determine the approximate protein concentration in the cell lysates 
according to the manufacturer’s  instructions. 
 
Denaturing Gel electrophoresis and Western Blotting 
Gels were cast using the Mini-PROTEAN® 3 system (BioRad, Switzerland). For one 0.75 mm minigel, 
5 mL of separating gel were prepared (375 mM Tris-HCl pH8.8, 0.1% SDS, x% Acryl/BisTM 37.5:1, 0.1% 
APS, 0.05% TEMED). To facilitate homogeneous polymerization, the gel solution was overlaid with 2-
propanol. After complete polymerization of the separating gel, the 2-propanol was removed and the 
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stacking gel (125 mM Tris-HCl pH6.8, 0.1% SDS, 0.05% APS, 0.1% TEMED) was cast. 10-15 μL of 
protein samples were loaded in SDS sample buffer (45mM Tris-HCL pH 8, 10% SDS, 0.01% 
bromphenol blue, 50mM DTT) and separated at 30 mA for 1 hour.  
SDS-PAGE separated proteins were transferred onto a nitrocellulose membrane (Schleicher & Schuell 
Bioscience) by the wet-blot technique using the Mini-Transblot system (BioRad, Switzerland). Blotting 
was done at 1 mA per cm2 gel in pre-cooled transfer buffer (25 mM Tris, 192 mM glycine, 20% 
methanol) at 4°C over night. The membrane was blocked with 10% blocking milk in TBS (100 mM 
Tris-HCl pH8, 150 mM NaCl) followed by incubation with the two primary antibodies in 7.5% blocking 
milk in TBS + 0.2% Tween20 (TBST) at 33°C for 1 h (anti-TDG 1:10’000; anti-GFP 1:1’000, Roche 
#11814460001; anti-β-actin 1:10’000, Abcam ab8226). After two rinses in TBST, the membrane was 
washed three times for 10 min in TBST, once at 33°C, twice at room temperature. The fluorescence-
labeled secondary antibodies (goat anti-rabbit IRDye 800CW, LICOR® P/N 926-32211; goat anti-
mouse IRDye 680; LICOR® P/N 926-32220) were diluted 1:5’000 in 5% blocking milk in TBST and 
incubated on the membrane for 30 min, protected from light. After three washes in TBST, the 
membrane was rinsed three times with TBS to remove residual Tween20 and scanned with a LICOR® 
Odyssey scanner (LI-COR, Germany). 
 
Base release assay 
The   heteroduplex   G•T-substrate  was   prepared   by   annealing   the   oligonucleotides   “Subs60uG”   and  
the FITC-labeled “Subs60lT-F” (Supplementary Table 2). The reaction mixture for the base release 
assay contained 1x nicking buffer (50 mM Tris-HCl pH8, 1 mM EDTA, 1 mM DTT, 0.1 mg/mL BSA), 
1 pmol heteroduplex  G•T-substrate and 100 μg NP40 protein extract in a total volume of 50 μL. After 
an overnight incubation at 37°C, the reaction was stopped by adding 10 μg Proteinase K and 
incubating at 37°C for another 30 min. To induce a single-strand break at the product AP-site, 5 μL of 
1 N NaOH was added, the sample was mixed well and heated to 99°C for 10 min. Afterwards, the 
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DNA was precipitated by adding 5 μL 3 M sodium acetate pH5.2, 150 μL of 99% ethanol and 
incubating at -20°C for 2 h. 
After centrifugation at 4°C and 16’000xg for 20 minutes, the supernatant was discarded and the 
pellet washed with 180 μL of 80% ethanol. After another 5 min of centrifugation, the supernatant 
was discarded and the pellet air-dried at room temperature for 5 min. The pellet was finally 
resuspended in 10 μL formamide buffer (90% formamide, 1x TBE), heated to 99°C for 5 min to 
denature the DNA double-strands, and chilled on ice. The cold samples were loaded onto a pre-
warmed and pre-run 15% denaturing DNA gel (2M urea, 500 μL H2O, 1 mL 5x TBE, 1.88 mL 40% PAA 
19:1, 0.05% APS, 7.5 μL TEMED) in pre-warmed buffer. After running the gel at 200 V for 30 min, 
labeled DNA was detected with the blue fluorescence mode of the Typhoon 9400 (GE Healthcare, 
Switzerland) and analyzed by ImageQuant TL software (v7.0 GE Healthcare). 
 
Fluorescent Microscopy and FRET analysis 
Fluorescent images were acquired on a Leica DMI 6000B equipped for live cell imaging with a 
temperature-controlled incubation chamber, using the MetaMorph® software. Cos7 cells transiently 
expressing the FRET constructs were imaged in 3 channels, the CFP- (Cerulean), the YFP- (Citrine) and 
the FRET-channel. The specifications of the filter cubes used for acquisition are listed in 
Supplementary Table 3. Settings were adjusted first roughly on TDG-Citrine and Cerulean-SUMO 
expressing cells and then fine-tuned for each channel to render equal brightness for equal amounts 
of fluorophore using the positive control Citrine-Cerulean. Spectral bleed-through was measured on 
images of cos7 cells expressing either only the donor or only the acceptor fluorophore and calculated 
as BTX=IFRET/IX (I=intensity, X= CFP or YFP) (Xia and Liu 2001). Images were processed in ImageJ using 
the PixFRET plugin (Feige et al. 2005) which calculates FRET values pixel by pixel as FRET= IFRET – 
BTCFP*ICFP – BTYFP*IYFP, normalizes for different intensity levels of the donor and acceptor using the 
formula NFRET= FRET/sqrt(ICFP*IYFP) and visualizes the NFRET value of each pixel in grey scale. As this 
formula normalizes only within certain limits of different intensities, cells exceeding a ratio of 5:1 
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were excluded. NFRET values were measured within a random region in the cell nucleus and 
normalized to the average NFRET of the positive control. All graphs and statistical analyses (Mann-
Whitney T-test) were generated in GraphPad Prism. 
 
 
 
Results 
 
Setup of a FRET system to monitor SUMO1/3 interactions and the conformational switch of TDG 
Biochemical data showed that modification of TDG with SUMO1 or 2/3 induces the dissociation of 
the glycosylase from its product AP-site. Based on these data, we proposed SUMO modification as a 
means to control the hand-over of the fragile AP-site repair intermediate to downstream acting BER 
factors (Hardeland et al. 2002; Steinacher and Schar 2005). To test whether SUMOylation is indeed 
associated with TDG function in the context of DNA repair, we set up a Fluorescence Resonance 
Energy Transfer system to measure the TDG-SUMO-interaction dynamics in live cells (Fig. 1). 
Although crystal structures of SUMOylated TDG were available, they described the core-domain only 
(Baba D et al, 2005 Baba D et al JBC 2006) and therefore, were not suitable to predict an optimal 
placement of the GFP-tag on full-length TDG to achieve the proximity and orientation of the TDG-
fused fluorophore relative to the SUMO-fused fluorophore required for FRET. For this reason, we 
generated constructs for N- and C-terminally Citrine-tagged mouse TdgA (Suppl. Figure 1 A).  
We also wanted to test whether the predicted conformational change TDG undergoes upon binding 
to DNA can be monitored by FRET. For this purpose, we tagged TDG N-terminally with Citrine and C-
terminally with Cerulean. Since in this context a FRET signal could also derive from the formation of 
TDG homodimers, we generated control constructs for Cerulean-tagged TDG in addition to the 
Citrine-TDG fusions described above. All fusion constructs were generated in parallel with a 
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SUMOylation-deficient mutant TdgA K341R (TDG ΔS)   to allow covalent and non-covalent SUMO-
interactions to be distinguished, and with a catalytic-dead mutant TdgA N151A (TDG ∆cat) to allow 
substrate and product AP-site binding to be examined separately. 
The FRET donor, Cerulean, was fused to the flexible N-terminus of SUMO1 and SUMO3 with an HA-
tag as a spacer and additional epitope for antibody detection (Suppl. Figure 1 B). As the C-termini of 
SUMO are engaged in the covalent linkage to target proteins, we refrained from generating C-
terminally tagged SUMO constructs. 
All available FRET constructs are listed in Supplementary Table 1, which also included additional 
control constructs not further described in this study. 
 
Characterization of expression and functionality of the FRET fusion proteins 
To characterize the FRET constructs functionally, we tested whether their transfection into 
mammalian cells resulted in the synthesis of full-length fusion proteins, whether tagged TDG could 
still be modified by endogenous SUMO on one hand and whether tagged SUMO could be covalently 
attached to tagged TDG on the other hand. Protein extracts from transiently transfected cos7 cells 
were subjected to SDS-PAGE and multiplex Western blotting with an anti-GFP (red channel) and an 
anti-TDG antibody (Fig. 2). This revealed that Citrine or Cerulean-tagged TDG (wildtype and mutants) 
were expressed to produce full-length proteins, migrating at approximately 85 kDa (N-terminally 
tagged) or 90 kDa (C-terminally tagged). Notably, the N-terminally tagged TDG fusions were 
consistently expressed at lower levels than the C-terminally tagged ones (Fig. 2B and C). The 
intramolecular FRET constructs (Citrine-TDG-Cerulean) were also expressed in full length, producing 
proteins of approximately 120 kDa (Fig. 2D). 
Western blotting also revealed that tagged TDG  wildtype  and  TDG  Δcat  can  still  be  SUMOylated while 
TDG ΔS  – as expected – is not; N-terminally tagged SUMOylated wildtype and catalytically dead TDG 
migrated at molecular weight of approximately 120 kDa in SDS-PAGE, the C-terminally tagged TDGs 
migrated at approximately 200 kDa, and both these bands were missing in the extracts containing 
Appendix I 
 
- 12 - 
 
the SUMOylation-deficient TDG (Fig. 2B and C). This also confirms that the fluorophore-tags are not 
SUMOylated and fusion to TDG did not produce a new SUMO acceptor site. The intramolecular FRET 
fusion proteins were also still proficient for SUMOylation, evident from additional bands at 180 kDa 
for  TDG  wildtype  and  TDG  Δcat  but  not  TDG  ΔS  (Fig.  2D). 
The Cerulean tag on SUMO1 does not interfere with the SUMO-conjugation process as is evident 
from the appearance of an additional band running above 250 kDa (Fig. 2E). The fact that in the TDG-
channel both bands, the one corresponding to endogenous SUMO attached to TDG-Citrine and the 
one representing Cerulean-SUMO1 linked to TDG-Citrine, show a similarly strong signal suggests that 
SUMOylation efficiency is not reduced by either of the tags (Suppl. Fig. 2). 
We tested further whether a fluorophore tag on TDG has an effect on its glycosylase activity. To this 
end we utilized a standard base-release assay (Fig. 3A), testing the ability of differently tagged TDG to 
process a 60 bp  substrate  oligomer  containing  a  single  G•T  mismatch. This oligomer was incubated 
with native protein extracts from Tdg knockout embryonic stem (ES) cells transiently expressing 
untagged, N-terminally, C-terminally or double-tagged TDG. Tdg-/- ES cells were chosen as they 
tolerate overexpression of TDG (Y. Saito, personal communication) and to start with a clean TDG 
deficient background. Following incubation of the 60mer substrate with the protein extracts, 
quantification of glycosylase activity utilizes a Fluorescein-tag at the  5’  end  of  the  strand  containing 
the mismatched T: heating under alkaline conditions cleaves the AP-site produced by TDG and 
generates a shorter 23-mer, which can be separated by denaturing PAGE from the uncleaved 
substrate (Fig. 3A and B). 
We calculated the relative efficiency of base excision as the ratio between the percentage of 
processed substrate (Fig. 3B) and the relative TDG protein levels in the same extracts as determined 
by Western blotting (Fig. 3C), both normalized to the levels observed for untagged TDG. For testing 
the glycosylase activity of single-tagged TDG, EGFP-fusion constructs analogous to the Citrine-fusion 
ones were used. The N-terminal tag appears to increase the relative  G•T  processing  efficiency of TDG 
approximately 3 fold (Fig. 3D), possibly by interfering with the non-specific DNA-binding capacity of 
Appendix I 
 
- 13 - 
 
the N-terminal domain that keeps TDG firmly attached to the AP-site after base excision and, hence, 
prevents enzymatic turnover. This product-inhibition is further decreased by fusing fluorophores to 
both termini of TDG (Citrine-TDG-Cerulean), thus increasing the relative catalytic activity of TDG 5 
times above the level of untagged TDG. It is likely that the double-tagged TDG cannot efficiently 
switch to or remain in the closed clamp-like conformation and so does not stay firmly attached to the 
AP-site. 
From these results we conclude that the C-terminally tagged TDG FRET construct is similar to 
untagged TDG concerning expression and catalytic activity and would thus be the favorable construct 
for FRET experiments monitoring the SUMO-TDG interaction. 
 
Visualization of the SUMO-interaction of TDG 
To test the subcellular localization of the FRET constructs as well as visualizing the interaction of TDG 
with SUMO, we co-transfected cos7 cells with TDG-Citrine and Cerulean-SUMO1 or -SUMO3, as well 
as with controls: TDG-Citrine + Cerulean, Cerulean-SUMO1 or -SUMO3 + Citrine and TDG ΔS-Citrine + 
Cerulean-SUMO1 or -SUMO3. The nuclear localization of wildtype TDG and TDG ∆S was not 
perturbed by the fluorescence tag (Fig. 4, YFP-channel, line 3, 4, 6 and 7), while the free fluorophores 
were distributed equally between the nucleus and the cytoplasm (Fig. 4, CFP-channel, line 1, YFP-
channel, line 2 and 5). The distribution of Cerulean-SUMO1 and 3, with a bias towards nuclear 
localization (Fig. 4, CFP-channel, line 2-7), is in agreement with previously reported 
immunofluorescence stainings of the endogenous SUMO proteins (Saitoh and Hinchey 2000; 
Evdokimov et al. 2008).  
As similar levels of FRET donor and acceptor are essential for accurate FRET measurement and an 
excess of either one of them results in a false positive FRET signal after normalization, microscope 
settings were adjusted using cells expressing a direct fusion of Citrine and Cerulean, which also 
served as a positive control. Images of cells with similar donor and acceptor levels were acquired in 3 
channels: the CFP (Cerulean), the YFP (Citrine) and the FRET channel. The images were processed 
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using the PixFRET ImageJ plugin (Feige et al. 2005) which calculates FRET values pixel per pixel, 
normalized for different intensity levels of donor and acceptor, and visualizes them in grey scale. As 
this formula is only accurate within certain limits of differential intensity levels, cells with a ratio of 
intensities above 5:1 were excluded. The false positive FRET signal deriving from different intensities 
beyond these limits is evident for instance as a cytoplasmic halo in cells expressing the nuclear TDG-
Citrine and the ubiquitously distributed Cerulean (Fig. 4, NFRET, line 1).  
The FRET signal within the nucleus of cells expressing TDG-Citrine and Cerulean-SUMO3 is increased 
1.5 - 2 fold (p<0.0001, Mann-Whitney test) compared to the   highest   “background”   FRET   signal  
observed in control cells, namely those expressing TDG-Citrine and free Cerulean (Fig. 4 and 5B). The 
same applies for the interaction between TDG and SUMO1 (Fig. 4 and 5A). The fact that cells 
expressing  TDG  ΔS  instead  of  the  wildtype  produces  a  FRET  signal  significantly above the background 
(approximately 1.5 fold, p<0.0001, Mann-Whitney test) and in the same range as wildtype TDG 
indicates that our FRET system does not solely measure the covalent but also the non-covalent 
SUMO-interaction of TDG. TDG ΔS  therefore  functions  as  a  control  to  estimate  which  changes  in  the  
FRET signal derive from covalent and which derive from non-covalent SUMO-interactions. 
 
Induction of DNA damage alters the TDG-SUMO interaction dynamics measured by FRET  
It is noteworthy that a significant part of the cellular TDG pool appears to interact with SUMO1 and 3 
without the presence of DNA damaging agents. To test the hypothesis that SUMOylation of TDG is 
involved in regulating processes during DNA repair, in particular the dissociation of TDG from the 
abasic site, we treated the cells with the base analog 5-FU which, incorporated into the DNA, 
represents a lesion addressed by TDG (Hardeland et al. 2003; Morgan et al. 2007). We have 
previously reported that TDG contributes to the cytotoxic effect of 5-FU by a delayed repair of the 
AP-site after excision of 5-FU from 5-FU•A  mismatches,  possibly  through  a  saturation  of  the  SUMO  
system (Kunz et al. 2009).  
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We treated cells with 30 μM  5-FU and measured the SUMO1- and SUMO3-interactions of TDG. The 
FRET signal observed with wildtype TDG, reflecting the compound signal produced by covalent and 
non-covalent SUMO1-interactions, remained unchanged after treatment with 5-FU. Yet, the FRET 
signal of SUMO1 and TDG  ∆S was significantly decreased in 5-FU-treated cells by approximately one 
third (p<0.0001, Mann-Whitney test) (Fig. 5A), possibly reflecting a previously reported effect that 
DNA associated TDG fails to engage in non-covalent SUMO-interactions (Mohan et al. 2007; Smet-
Nocca et al. 2011).  As 5-FU treatment appears to reduce SUMO1-binding but the FRET signal derived 
from the sum of SUMO1-binding plus SUMO1-modification of wildtype TDG remains unchanged, we 
conclude that SUMO1-modification of TDG is stimulated by the treatment. 
In contrast to SUMO1, SUMO3 shows a significantly higher FRET signal (by approximately 20%, 
p<0.001, Mann-Whitney test) produced by SUMO3 with wildtype TDG compared to SUMO3 with 
TDG ∆S in untreated cells. This suggests that at least 1/5 of the signal observed with wildtype TDG 
represents SUMO3-modified protein. Thus it appears that TDG is preferentially modified by SUMO3 
rather than by SUMO1 in unchallenged cells (Fig. 5B). Treatment with 5-FU, however, does not alter 
the FRET efficiency significantly although we observed certain small trends: the signal derived from 
wildtype TDG and SUMO3 seems to be slightly reduced whereas the one   derived  with   TDG  ∆S is 
mildly increased. 
Taken together, it appears that the interaction of TDG with SUMO1 and SUMO3 occur in the context 
of different processes as SUMO1-binding is influenced by the induction of DNA damage while 
SUMO3-binding remains mostly unaffected at least under the conditions used in this study.  
 
Part of the cellular TDG pool exists as a homodimer 
We fused TDG N- and C-terminally to Citrine and Cerulean with the aim to monitor the 
conformational switch TDG undergoes upon binding to homoduplex DNA. Since there is biochemical 
evidence that suggests the formation of TDG homodimers (Roland Steinacher, personal 
communication), we included single-tagged TDG-donor- and -acceptor fusions as dimerization 
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controls to distinguish between FRET deriving from intramolecular or from intermolecular 
interactions. We found that TDG-Citrine and TDG-Cerulean generated a significant FRET signal, 
similar to but surpassing Citrine-TDG and TDG-Cerulean. Double-tagged TDG produced an even 
higher FRET signal, which   was   significantly   increased   in   TDG   ∆S (Fig. 6).   Assuming   that   TDG   ∆S  
remains longer in the closed conformation, this increase suggests that at least part of the FRET signal 
derives from the conformational switch bringing the donor and acceptor fluorophores closer 
together, although it remains unclear whether this involves one or two TDG proteins.  
Still, the majority of the FRET signal appears to be generated through dimerization of TDG, evident 
from the FRET signal produced by two single-tagged TDG fusion proteins, which is enhanced 
approximately 2-fold by addition of a second fluorophore tag. Moreover, as the two tags appear to 
weaken non-specific DNA interactions of TDG (homoduplex DNA binding), accelerating enzymatic 
turnover of TDG (Fig. 3D), it is likely that the conformational switch is not induced efficiently upon 
DNA binding. We therefore conclude, that this system does not allow a precise quantitative 
monitoring of the conformational switch of TDG as the fluorophore tags may interfere with the 
efficient formation of a clamp-like closed conformation, but we provide the first in vivo evidence of 
TDG homodimerization. Whether this is mediated by DNA remains to be tested. 
 
 
Discussion 
 
TDG operates in the BER pathway which excises and replaces damaged bases that are continuously 
generated in the DNA. For BER to be beneficial for cells, it requires a tight regulation of protein 
complex assembly, of hand-over of potentially hazardous repair intermediates and of the dissociation 
of the factors involved. Post-translational modification with SUMO, in addition to non-covalent 
SUMO-binding of key proteins such as TDG, is likely to function as a platform for protein-protein 
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interactions and as a regulatory switch to control the interplay of proteins and DNA in these 
processes (Geiss-Friedlander and Melchior 2007 ). 
We present a FRET system to monitor the SUMO-interaction dynamics of TDG in living cells, which 
produces a robust FRET signal in cos7 cells (Fig. 4). By including a SUMOylation-deficient mutant TDG, 
our system allows to distinguish between covalent and non-covalent SUMO-binding and, thus, to 
draw conclusions about the dynamics of SUMO modification and interaction of TDG. 
Interestingly, a considerable proportion of the cellular TDG pool appears to interact with SUMO1 and 
SUMO3 non-covalently (TDG   ∆S   in   Fig. 4 and 5). Little is known about the function of the non-
covalent interaction between TDG and SUMO, although it has been found to be essential for its role 
as a co-activator of CBP/p300 and for its translocation to and/or from PML bodies (Takahashi et al. 
2005; Mohan et al. 2007). Examples of other factors harboring an SBM suggest that TDG might 
interact with SUMOylated proteins through its SBM. The transcriptional repressor Daxx, for example, 
was shown to interact with SUMO covalently and non-covalently. The SBM of Daxx is essential for its 
repressor function as it mediates the interaction with other SUMOylated factors (Lin et al. 2004; Kuo 
et al. 2005; Lin et al. 2006). If a similar scenario applies for TDG, its interaction with SUMO-
conjugated proteins might mediate the assembly of downstream acting BER factors, which is then 
followed by SUMOylation of TDG and its release from the AP-site. This hypothesis is supported by 
proteomics approaches that revealed several BER factors to be target of SUMO modification, e.g. 
XRCC1, DNA Ligase III and PARP1 (Gocke et al. 2005; Bruderer et al. 2011). Moreover, non-denaturing 
pull-down of protein complexes with SUMOylated subunits also revealed Polβ, which fills the 
nucleotide gap in the final steps of BER, to be associated with SUMOylated proteins without being a 
target of modification itself (Bruderer et al. 2011). 
Although we can measure solely non-covalent SUMO-binding with our FRET system by using TDG ∆S, 
it is unclear whether the interaction occurs with free or with conjugated SUMO. To provide a means 
to distinguish these two possibilities in the future, we generated a Citrine-tagged mutant SUMO1, in 
which we replaced the C-terminal Gly-Gly motif with Ala-Ala, thus abolishing conjugation capacity. 
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By inducing DNA damage, we were able to alter the interaction dynamics between TDG and SUMO1 
but not with SUMO3. Interestingly, SUMO1 was reported to exist almost exclusively in the 
conjugated form, whereas SUMO2/3 conjugation appears to occur mainly in response to stress 
(Geiss-Friedlander and Melchior 2007). We found 5-FU to boost SUMO1-conjugation but decreases 
non-covalent SUMO1-binding (Fig. 5a). This shift towards SUMOylation can be explained by the 
highly efficient processing of 5-FU by TDG. TDG would repeatedly bind a substrate 5-FU•G of 5-FU•A, 
immediately excise 5-FU and get SUMOylated to dissociate from the abasic site (Hardeland et al. 
2003). The decrease in non-covalent SUMO-binding hints at the disassembly of complexes (involving 
either free or conjugated SUMO) and/or an increased engagement of TDG in DNA repair which shifts 
the balance of covalent and non-covalent interaction towards the covalent modification. 
Furthermore, dissolving any non-covalent SUMO-interactions is necessary to allow DNA-binding, as 
these two were shown to be mutually exclusive (Smet-Nocca et al. 2011).  
The fact that the SUMO3-interaction of TDG remains mostly unaffected by the incorporation of 5-FU 
into the DNA (Fig. 5b) suggests that the interaction with this SUMO variant may be involved in 
another pathway. Given the recent findings that TDG may be involved in processes other than 
classical DNA repair, e.g. the maintenance of epigenetic stability of CpG islands (reviewed in (Jacobs 
and Schar 2012)), it is likely that SUMO in general and the SUMOylation of TDG in particular play an 
essential role in regulating the interactions and conformational changes needed in these epigenetic 
pathways. SUMO1 and SUMO3 may play distinct roles in assembling different TDG-associated 
complexes, and our FRET system provides a tool to elucidate their functions as it allows monitoring 
these interactions under various conditions in live cells.  
We also designed the TDG-FRET system to monitor the predicted conformational switch of TDG from 
an open to a closed form upon DNA interaction. These attempts, however, were complicated by the 
fact that the N- and C-terminal fluorophore tags needed for FRET appeared to interfere with the 
formation of the predicted clamp-like configuration, as inferred from an increased relative efficiency 
of the double-tagged TDG in G•T  mismatch  processing (Fig. 3d).  
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However, data we obtained from pilot FRET analyses with these double-tagged fusion proteins 
provide evidence that TDG may form homodimeric complexes in living cells (Fig. 6): The dimerization 
controls included to distinguish between intra- and intermolecular FRET showed clearly that TDG 
interacts with itself in vivo (Fig. 6). The biological function of this interaction may be further 
stabilization of the fragile AP-site and its direct vicinity (discussed below). 
Whether this interaction really involves only two TDG proteins or more and if the orientation of TDG 
within these dimers is parallel or anti-parallel is not clear. If DNA-binding mediates this interaction, it 
is possible that the termini of two TDG molecules in a closed conformation bring the donor and 
acceptor fluorophores in a suitable proximity and orientation for FRET. A published crystal structure 
of DNA-bound TDG indeed suggests that TDG homodimers might assemble on DNA (Maiti et al. 2008; 
Morgan et al. 2011). 
Further studies are necessary to test whether DNA- and SUMO-binding are involved in TDG 
dimerization and what the biological function of this interaction is. Assuming for example the binding 
of a second TDG opposite an AP-site-bound TDG, such an interaction might support stabilization of 
this fragile site, possibly by interfering with repair processes addressing damage in the opposing 
strand. Such a function of TDG dimerization appears plausible in the light of recent findings 
implicating TDG in active DNA demethylation (He et al. 2011; Maiti and Drohat 2011). Methylated 
cytosine 5-mC occurs (in most cases) symmetrically in palindromic CpG dinucleotides. During BER-
coupled DNA demethylation, mechanisms must be in place to inhibit simultaneous generation of AP-
sites as demethylation intermediates on both strands. The generation of a second AP-site in the 
opposing strand would inevitably result in the formation of a double-strand break which would have 
to be avoided at all costs. Other repair pathways, i.e. long-patch BER, nucleotide excision and 
mismatch repair, involve the degradation of a whole stretch of single-strand containing a mismatch 
or lesion, which would also have to be avoided vis-à-vis an ongoing BER process. It is thus likely that 
mechanisms evolved to avoid the clash of two repair events on opposing strands, and these might 
include the SUMO coordinated binding and release of repair proteins to and from the DNA. 
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In conclusion, our FRET system provides a powerful tool to investigate the dynamic SUMO- and auto-
interactions of TDG in DNA repair and other processes, i.e. DNA demethylation and maintenance of 
epigenetic stability. 
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Figure Legends 
 
Fig. 1: Measuring SUMO interactions and conformational changes of TDG in the process of base 
excision by FRET. A: Structure-function model of TDG action. In the open and unmodified form, TDG 
has a high affinity for DNA, facilitating the search for and binding of a substrate base. Upon binding 
to double-stranded DNA, TDG undergoes a conformational change involving the N-terminal domain, 
switching to a closed form. Upon excision of the substrate base, involving the catalytically essential 
N141 (N), TDG stays firmly bound to the abasic site. SUMOylation of K341 (K) facilitates dissociation 
of TDG by switching it back to an open form, thus reducing its affinity to DNA. Fusion of TDG with 
Citrine and SUMO with Cerulean allows for measuring their interaction following base-release, since 
SUMOylation of TDG brings the two fluorophores in the required proximity for FRET. B: Rationale of 
the intramolecular FRET approach; fusing TDG N- and C-terminally to Citrine and Cerulean 
respectively will allow measuring intramolecular FRET if the N- and the C-terminus of the closed form 
bring the donor and acceptor fluorophore in a suitable proximity for the energy transfer. 
 
Fig. 2: Analysis of expression of the FRET constructs and SUMOylation efficiency.  SDS-extracts of 
cos7 cells transiently expressing the indicated constructs were separated by SDS-PAGE, blotted and 
probed with anti-GFP (red channel) and anti-TDG (green channel) antibodies. Shown are overlays of 
both channels. A: Schematic overview of the constructs. B and C: Test for full-length expression and 
SUMOylation of Citrine- or Cerulean-tagged TDG, comparison of N- and C-terminally tagged TDG, C: 
test for full-length expression of double-tagged TDG (Citrine-TDG-Cerulean), D: test for full-length 
expression and ability of HA- and Cerulean-tagged SUMO1 to modify Citrine-tagged TDG; numbers 
represent molecular weight in kDa; the asterisk indicates a truncated peptide recognized by the anti-
GFP antibody. 
 
Fig. 3: Glycosylase activity of the wildtype TDG-fluorophore fusion proteins. Shown are the results 
of a base-release assay (Hardeland et al. 2000) with native whole cell extracts of murine ES cells 
transiently expressing the fusion constructs. A: Schematic overview of the base-release assay. A 60-
mer G•T-heteroduplex DNA substrate (green star, Fluorescein-label) was incubated with cell extract. 
Functional TDG excises the T from the G•T mismatch. The resulting AP-site was cleaved by heating 
under alkaline conditions, inducing β-δ-elimination. The nicked substrate DNA strand was separated 
from the unprocessed oligomeres by denaturing PAGE. The Fluorescein-labelled DNA was detected 
by fluorescence scanning. B: Results of the base-release assay; TDG activity is indicated by a 
shortened DNA substrate strand (23 nt). Depending   on   the   3’   moiety   (OH   or   P),   the   shortened  
substrate DNA strands migrate slightly differently, giving rise to a double band. Overexpressed TDGB 
was used as positive control; negative control, no extract; Cit, Citrine; Ceru, Cerulean; mock 
transfected, without DNA; C: Western blot of native ES cell extracts to estimate relative expression 
level; green channel anti-TDG (upper), red channel anti-β-actin (lower). The asterisk indicates 
SUMOylated TDG. D: quantification of the relative catalytic activity of the wildtype TDG-fluorophore 
fusion   proteins  on   a  G•T-substrate, calculated as the ratio between relative amount of processed 
substrate and relative expression level, both normalized to the values of untagged TDG. 
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Fig. 4: Normalized FRET images of cos7 cells transiently expressing the indicated FRET constructs. 
Images of cells with similar expression levels were analysed with the PixFRET plugin for ImageJ, 
calculating normalized FRET values pixel by pixel, visualizing them in grey scale. An imbalance of 
donor and acceptor expression causes a false positive FRET signal; the halo in the cell expressing 
TDG-Citrine and Cerulean (upper row) is caused by TDG being restricted to the nucleus while 
Cerulean is ubiquitously distributed.  
 
Fig. 5: FRET analysis of the SUMO1 and 3-interactions of TDG upon induction of DNA damage. Cos7 
cells were transiently transfected with the indicated constructs. A: Cells were incubated with 30 μM 
5-FU for 24 h prior to FRET analysis, n=26-37. B: as A, n=33–99. Relative NFRET, percent of the 
average of the positive control, each dot representing one cell. **, p < 0.005, ***, p < 0.0001, Mann-
Whitney test. 
 
Fig. 6: The majority of the FRET signal of double-tagged TDG derives from homodimer formation. 
cos7 cells were transiently transfected with the indicated constructs. n=34-39. Relative NFRET, 
percent of the average of the positive control, each dot representing one cell. ***, p < 0.0001, Mann-
Whitney test. 
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FIGURES 
 
 
 
 
Figure 1: Measuring SUMO interactions and conformational changes of TDG in the process of base 
excision by FRET.  
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Fig. 2: Analysis of expression of the FRET constructs and SUMOylation efficiency.   
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Fig. 3: Glycosylase activity of the wildtype TDG-fluorophore fusion proteins.  
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Fig. 4: Normalized FRET images of cos7 cells transiently expressing the indicated FRET constructs.  
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Fig. 5: FRET analysis of the SUMO1 and 3-interactions of TDG upon induction of DNA damage.  
 
 
 
Fig. 6: The majority of the FRET signal of double-tagged TDG derives from homodimer formation.  
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Supplementary Figures 
 
 
 
 
 
 
 
 
 
 
 
Suppl. Figure 1: Cloning strategy for the TDG- and SUMO-fluorophore fusion constructs. A: 
TdgA (wildtype,  ∆cat,  ∆S) was digested with the indicated restriction enzymes and inserted into the 
mammalian expression vector pCAIp, containing an internal ribosome entry site (IRES), a eukaryotic 
Puromycin and a prokaryotic Ampicillin resistance cassette (PuroR and AmpR), as well as the chicken 
actin promoter (PCAG). In a second step, the DNA fragments coding for the fluorophores (left panel: 
XFP = EGFP and Citrine; right panel: Ceru = Cerulean) were digested and inserted into the vector via 
the indicated restriction sites. The linker between TDG and the N-terminal tag codes for the amino 
acids NVQST for XFP, for ASSVQST for Ceru. The linker between TDG and the C-terminal tag codes 
for SSSRLEFA for XFP, for SSSST for Cerulean. The original amino acid sequence of TDG was 
extended by four serine residues, the first three of which are part of the spacer between TDG and the 
C-terminal tag. B: The PCR-amplified SUMO1 and SUMO3 genes were inserted into the expression 
vector pCMIh, containing an internal ribosome entry site (IRES), a eukaryotic Hygromycin and a 
prokaryotic Ampicillin resistance cassette (HptII and AmpR), as well as the cytomegalovirus promoter 
(PCMV). In a second step, the DNA fragments coding for the fluorophores (XFP = EGFP and Citrine, 
Ceru = Cerulean) were inserted into the vector via the indicated restriction sites. The linker between 
XFP and SUMO codes for the amino acids NVQT, between Cerulean and SUMO1 for ASSVQT. 
Asterisks indicate the position of the stop codons.  
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Suppl. Figure 2: Modification of Citrine-tagged TDG with Cerulean-SUMO1 is not hindered by either 
of the fluorophore tags. SDS-extracts of cos7 cells transiently expressing the indicated constructs 
were separated by SDS-PAGE, blotted and probed with anti-GFP (red channel) and anti-TDG (green 
channel) antibodies. HA- and Cerulean-tagged SUMO1 can modify Citrine-tagged TDG with an 
efficiency equal to that of endogenous SUMO; numbers represent molecular weight in kDa. 
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Supplementary Tables 
 
Supplementary Table 1: Constructs generated in this study 
  
N-terminal C-terminal Promoter Selection Name 
controls 
Citrine-Cerulean pCAG Puromycin pCAIp Cit-Ceru 
Citrine pCAG Puromycin pCAIp Cit 
Cerulean CMV Hygromycin pCMIh Ceru 
TDG 
TDG wt Citrine - pCAG Puromycin pCAIp Cit-TDG wt 
TDG wt - Citrine pCAG Puromycin pCAIp TDG wt-Cit 
TDG wt Citrine Cerulean pCAG Puromycin pCAIp Cit-TDG wt-Ceru 
TDG wt Cerulean - pCAG Puromycin pCAIp Ceru-TDG wt 
TDG wt - Cerulean pCAG Puromycin pCAIp TDG wt-Ceru 
TDG wt EGFP - pCAG Puromycin pCAIp GFP-TDG wt 
TDG wt - EGFP pCAG Puromycin pCAIp TDG wt-GFP 
TDG K341R Citrine - pCAG Puromycin pCAIp Cit-TDG  ∆S 
TDG K341R - Citrine pCAG Puromycin pCAIp  TDG  ∆S-Cit 
TDG K341R Citrine Cerulean pCAG Puromycin pCAIp Cit-TDG  ∆S-Ceru 
TDG K341R Cerulean - pCAG Puromycin pCAIp Ceru-TDG  ∆S 
TDG K341R - Cerulean pCAG Puromycin pCAIp  TDG  ∆S-Ceru 
TDG K341R EGFP - pCAG Puromycin pCAIp GFP-TDG  ∆S 
TDG K341R - EGFP pCAG Puromycin pCAIp  TDG  ∆S-GFP 
TDG N141A Citrine - pCAG Puromycin pCAIp Cit-TDG  ∆cat 
TDG N141A - Citrine pCAG Puromycin pCAIp  TDG  ∆cat-Cit 
TDG N141A Citrine Cerulean pCAG Puromycin pCAIp Cit-TDG  ∆cat-Ceru 
TDG N141A Cerulean - pCAG Puromycin pCAIp Ceru-TDG  ∆cat 
TDG N141A - Cerulean pCAG Puromycin pCAIp  TDG  ∆cat-Ceru 
TDG N141A EGFP - pCAG Puromycin pCAIp GFP-TDG  ∆cat 
TDG N141A - EGFP pCAG Puromycin pCAIp  TDG  ∆cat-GFP 
SUMO 
SUMO1 Cerulean-HA - pCMV Hygromycin pCMIh Ceru-SUMO1-GG 
SUMO1 Citrine-HA - pCMV Hygromycin pCMIh Cit-SUMO1-GG 
SUMO1 EGFP-HA - pCMV Hygromycin pCMIh EGFP-SUMO1-GG 
SUMO1-AA Citrine-HA - pCMV Hygromycin pCMIh Cit-SUMO1-AA 
SUMO3 Cerulean-HA - pCMV Hygromycin pCMIh Ceru-SUMO3-GG 
SUMO3 Cit-HA - pCMV Hygromycin pCMIh Cit-SUMO3-GG 
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Supplementary Table 2: Oligonucleotides* 
Name Use Sequence 5'--> 3' 
Ceru fw X X +K PCR of Cerulean GCGCTCTAGACTCGAGCACCATGGTGAGCAAGGGCGA 
GGAGC 
Ceru rev N*C PCR of Cerulean CGCATCGATGTTAGCTAGCCTTATACAGCTCGTCCATGC 
CGAGAGTGA 
EGFP fw X E +K PCR of EGFP and Citrine GCGCGCTCGAGGCTCGAATTCGCCATGGTGAGCAAGGG 
CGAGGAGC 
EGFP rev B*B PCR of EGFP and Citrine GCGCGGATCCATGCATCTATTGTACATTGTATAGCTCGT 
CCATGCCGAGAGTGATC 
HA fw XhoNheBsrGI PCR of HA-SUMO1 and 3 ATCCTCGAGTAGCTAGCAGTGTACAGACCATGGCTTCAT 
ATCCTTACG 
Linker B N X fw Spacer for Cit-Ceru GTACAGAGCGGTGGCAATGCATCAGGAGGTAGC 
Linker B N X rev Spacer for Cit-Ceru TCGAGCTACCTCCTGATGCATTGCCACCGCTCT 
mTDGa fw E N B +K PCR of mTdgA CGCGAATTCTAGCTAGCAGTGTACAGAGCACCATGGAC 
GCAGAGGCCGC 
mTDGa rev X*C B PCR of mTdgA CGCGGATCCATCGATTAGCTCGAGCTAGAAGCGTGGCT 
CTCTTCTTCCTG 
SP6 PCR of HA-SUMO1 and 3 TGAATTTAGGTGACACTATAG 
SUMO1AA rev*N PCR of HA-SUMO1-AA GCGTATCAGCGGCCGCCTAAGCCGCCGTTTGTTCCTGATAAAC 
Subs60lT-F Base release assay CGGAATTCGTCTAGGTTTGAGGTTGACATCGGATCCATG 
GTACCTCGAGGGCAATGTCTA 
Subs60uG Base release assay TAGACATTGCCCTCGAGGTACCATGGATCCGATGTCGAC 
CTCAAACCTAGACGAATTCCG 
 
  
*all oligonucleotides were provided by Microsynth AG, Switzerland 
 
Supplementary Table 3: Filter cube* specifications for fluorescent microscopy 
Name Excitation band Excitation filter Dichroic mirror Emission band Emission filter 
Dapi 325-375 nm 350/50 400 435-485 nm 460/50 
GFP 450-490 nm 470/40 495 500-550 nm 525/50 
CFP 418-442 nm 430/24 455 458-482 nm 470/24 
YFP 510-530 nm 500/20 515 520-550 nm 535/30 
FRET 418-442 nm 430/24 455 520-550 nm 535/30 
*source: Chroma Technology Corp® 
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Embryonic lethal phenotype reveals a function of
TDG in maintaining epigenetic stability
Daniel Corta´zar1*, Christophe Kunz1*, Jim Selfridge2, Teresa Lettieri3{, Yusuke Saito1, Eilidh MacDougall2, Annika Wirz1,
David Schuermann1, Angelika L. Jacobs1, Fredy Siegrist4, Roland Steinacher1{, Josef Jiricny3, Adrian Bird2 & Primo Scha¨r1
Thymine DNA glycosylase (TDG) is a member of the uracil DNA
glycosylase (UDG) superfamily of DNA repair enzymes. Owing to
its ability to excise thymine when mispaired with guanine, it was
proposed to act against the mutability of 5-methylcytosine (5-mC)
deamination in mammalian DNA1. However, TDG was also found
to interact with transcription factors2,3, histone acetyltransferases4
and de novo DNAmethyltransferases5,6, and it has been associated
with DNA demethylation in gene promoters following activation
of transcription7–9, altogether implicating an engagement in gene
regulation rather than DNA repair. Here we use a mouse genetic
approach to determine the biological function of this multifaceted
DNA repair enzyme. We find that, unlike other DNA glycosylases,
TDG is essential for embryonic development, and that this pheno-
type is associated with epigenetic aberrations affecting the expres-
sion of developmental genes. Fibroblasts derived from Tdg null
embryos (mouse embryonic fibroblasts, MEFs) show impaired
gene regulation, coincident with imbalanced histone modification
and CpG methylation at promoters of affected genes. TDG asso-
ciates with the promoters of such genes both in fibroblasts and in
embryonic stem cells (ESCs), but epigenetic aberrations only appear
upon cell lineage commitment. We show that TDG contributes to
the maintenance of active and bivalent chromatin throughout
cell differentiation, facilitating a proper assembly of chromatin-
modifying complexes and initiating base excision repair to counter
aberrantdenovomethylation.WethusconcludethatTDG-dependent
DNA repair has evolved to provide epigenetic stability in lineage
committed cells.
TDG is one of four enzymes with UDG activity inmammalian cells,
but its biological function has remained enigmatic10.We thus set out to
generate and phenotypically investigate a Tdg knockout mouse (Sup-
plementary Fig. 1a–c). ESC clones carrying the targeted allele gave rise
to healthy heterozygous Tdg knockout mice but attempts to generate
homozygous null mutants failed, indicating that TDG-deficiency may
cause embryonic lethality. This was unexpected, given the generally
mildphenotypeofotherDNAglycosylase knockouts11. In timedmatings,
Tdg null embryos isolated up to embryonic day (E) 10.5 appeared alive
and normal, whereas those isolated at E12.5 were dead, and none were
detectable at E16.5 (Fig. 1a andSupplementaryFig. 1d).Tdgnull embryos
at E10.5 produced viable fibroblasts (MEFs) but only a third of E11.5
embryos did so, suggesting that by this stagemost of themwere dead.We
thus concluded that lethality in Tdg null embryos occurs around E11.5.
For the actual cause of lethality, closer examination of the Tdg null
embryos at E10.5 indicated internal haemorrhage, and evidence for
haemorrhagic necrosis (data not shown), but otherwise did not reveal
an informative pathology.
We then explored the essential function of TDG inMEFs and ESCs,
first addressing a potential DNA repair defect by classical genotoxicity
and mutator analyses. The TDG status did not affect cell survival
following ionizing radiation or H2O2 exposure, both of which induce
DNA base lesions processed by TDG in vitro10, nor did it affect muta-
tion frequencies in a Big Blue transgenic mutation assay (Supplemen-
tary Fig. 2). We therefore concluded that the role of TDG in the repair
of canonical base damage is minor and therefore unlikely to account
for its essential function in mouse embryogenesis.
We next investigated a possible involvement of TDG in gene regu-
lation by expression profiling of TDG-proficient and -deficient MEFs.
To limit potential clonal biases, we compared the transcriptomes of
early passages of litter-matched populations of SV40 immortalized
MEFs. This identified 461 differentially transcribed genes (P# 0.05,
fold change (FC)$ 1.5, Fig. 1b), comprising many transcription
factors and, thus, likely reflecting both direct and indirect con-
sequences of TDG loss. Global pathway analyses revealed gene net-
works associated with embryogenesis and development as being most
significantlymisregulated in theabsenceofTDG(SupplementaryFig.3a).
Four out of six target genes analysed showed TDG-dependent differ-
ential expression also in independently isolated primary MEFs (Sup-
plementary Fig. 3b).
Considering its putative involvement in DNA demethylation7–9, we
next investigated a possible occurrence of aberrant promoter methyla-
tion in TDG-deficient cells. We examined the CpG islands in the pro-
moters of Hoxa10, Hoxd13, Sfrp2, Twist2 and Rarb, all of which were
downregulated in TDG-deficient MEFs (Fig. 1b and Supplementary
Fig. 3a). These genes are developmentally regulated by the polycomb
repressive system12 and their promoter CpG islands are unmethylated
in most normal tissues but subject to aberrant de novomethylation in
human cancers13,14. Na-bisulphite sequencing of the respective CpG
islands revealed an increased occurrence of de novo methylation in
the TDG-deficient MEFs (Fig. 1c and Supplementary Figs 4 and 5a).
The patterns and frequency of these methylation events indicated that
the loss of TDG generates hotspots of de novo methylation in certain
gene promoters. We then used chromatin immunoprecipitation
(ChIP) to examine a possible association of TDG with the promoters
of these and additional differentially expressed genes. Comparedwith a
randomly chosen intergenic sequence or the silent promoters of Oct4
and Tuba3, DNA fragments surrounding the promoters of all genes
examinedwere significantly enriched in the TDGprecipitates (Fig. 1d).
This indicated thatTDG is targeted to specific gene promoters, possibly
toprotect them fromacquiring aberrantCpGmethylation and eventual
epigenetic silencing. Consistently, further examination of the chro-
matin status revealed a general loss of activating (H3K4me2) and a
concomitant increase of repressive histone marks (H3K27me3,
H3K9me3) in TDG-deficient cells with promoter-specific patterns
(Fig. 1e): a complete loss of H3K4 dimethylation was accompanied
by a strong increase of H3K27 and/or H3K9 trimethylation at the
Hoxd13 and Hoxa10 promoters; a partial reduction of H3K4me2
coincided with an enrichment of H3K27me3 but not H3K9me3 at
*These authors contributed equally to this work.
1Institute of Biochemistry andGenetics, Department of Biomedicine, University of Basel, 4048Basel, Switzerland. 2TheWellcomeTrust Centre for Cell Biology, University of Edinburgh, Edinburgh EH93JR,
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Appendix II
the Sfrp2 and Twist2 promoters; and reduction of H3K4me2 was
coupled with an increase in H3K9me3 but not H3K27me3 at the
Rarb promoter. Thus, promoter de novomethylation in TDG-deficient
cells is associatedwith a loss ofH3K4dimethylation and a concomitant
increase in trimethylation of H3K27 more than H3K9.
Stable expression of a TDG encoding complementaryDNA (cDNA)
in Tdg2/2MEFs (Supplementary Fig. 1f) restored activity to the Sfrp2
and Twist2 genes (Fig. 2a). This correlated with a loss of H3K27
trimethylation in their promoters and an increase in H3K4 dimethyla-
tion in the case of Twist2 (Fig. 2b). Expression ofHoxd13 andHoxa10,
however, was not restored although a partial reduction of H3K27
trimethylation also occurred. This indicated that, once H3K4methyla-
tion is lost (Hoxd13,Hoxa10), the repressive chromatin maintained by
H3K9 and H3K27 methylation and aberrant CpG methylation cannot
be reversed to an active state by re-expression of Tdg. If residual H3K4
methylation is present, however, promoter reactivation is possible, and
this requires the catalytic function of TDG15 as shown for Sfrp2 and
Twist2 (Fig. 2a).
To address the origin of the epigenetic aberrations inTdgnullMEFs,
we investigated gene expression and chromatin states in TDG-
proficient and -deficient ESCs before and after retinoic-acid-induced
in vitro differentiation to neuronal progenitor cells16 (Supplementary
Fig. 6a). Strikingly, gene expressiondifferences wereminor in ESCs (16
genes, P# 0.05, FC$ 1.5) but increased significantly upon differenti-
ation to neuronal progenitor cells (297 genes, P# 0.05, FC$ 1.5)
(Fig. 3a). This was not due to an inability of TDG-deficient ESCs to
respond transcriptionally to retinoic acid (Supplementary Fig. 6b),
although they showed somewhat faster kinetics of silencing pluri-
potency genes (Oct4, Nanog) and activating developmental genes (for
example,Gata6,Pax6) (Supplementary Fig. 6c). Similar to the situation
in MEFs, the genes most significantly misregulated in TDG-deficient
neuronal progenitor cells control developmental functions, most of
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Figure 2 | Complementation of the loss of gene expression depends on the
chromatin state of the promoter. a, Hoxd13, Hoxa10, Sfrp2 and Twist2
expression in Tdg1/1 and Tdg2/2MEFs complemented with vectors
expressing either a wild-type (pTdg) or a catalytically deficient Tdg (pTdgcat-,
N151A), or a vector control (pV). Target-specific messenger RNA (mRNA)
levels were assessed by qRT–PCR and normalized to Gapdh mRNA; values
represent arbitrary units (means6 s.d.; n$ 3; *P, 0.05; unpaired Student’s
t-test). b, ChIP–qPCR analyses to detect H3K27me3 and H3K4me2 marks at
the gene promoters indicated in chromatin of Tdg1/1, Tdg2/2 and Tdg2/2
MEFs complemented with a wild-type Tdg cDNA. IAP and theHprt promoter
were used as normalizers for active and repressive chromatin marks,
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t-test).
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them having CpG islands in their promoters and being targets of the
polycomb repressive system (Supplementary Fig. 7a). Using ChIP, we
confirmed an enrichment of TDG at the promoters of differentially
expressed genes both in ESCs and in neuronal progenitor cells (Fig. 3b).
This also revealed that TDG associates with the promoters ofOct4 and
Nanog in ESCs but not in neuronal progenitor cells and MEFs (Fig. 3b
and Supplementary Fig. 6d), suggesting that its interaction is lost upon
heterochromatinization of these promoters. Notably, the inability to
associate with heterochromatized promoters may explain why re-
expression of TDG in Tdg null MEFs failed to restore Hoxd13 and
Hoxa10 transcription (Fig. 2).
Next, we examined the status of CpG methylation in gene pro-
moters downregulated in TDG-deficient neuronal progenitor cells,
making use of Na-bisulphite (pyro)sequencing and methylated
DNA-immunoprecipitation (MeDIP). AlthoughMeDIP only detected
trends for methylation differences at specific promoters (Supplemen-
tary Fig. 7b and unpublished observations), pyrosequencing revealed
significantly increased DNA methylation in Tdg null neuronal pro-
genitor cells at three out of five gene promoters tested (Hoxa10, Pax6,
Tgfb2). Notably, these methylation differences were not present in
ESCs nor in freshly dissociated embryonic bodies, they arose within
48 h of cultivation of the neuronal progenitor cells in progenitormedium
(Fig. 3c and Supplementary Fig. 7c), and the phenotype was comple-
mentedby ectopic expressionofTdgduring cell differentiation. Similarly,
histone methylation marks were not different between TDG-proficient
and -deficientESCsbut arose inneuronal progenitor cellswithanenrich-
ment of H3K27me3 at the promoters of Hoxd13, Hoxa10 (Supplemen-
tary Fig. 8) and Pdgfra (unpublished observations). Thus, differences in
DNA methylation and histone modifications became apparent at the
neuronal progenitor cell stage but were not as pronounced as in MEFs,
indicating an epigenetic phenotype that may progress upon further dif-
ferentiation and/or cultivation. Consistently, attempts to differentiate
TDG-deficient neuronal progenitor cells to terminal neurons failed
because of a rapid loss of cell viability in neuronal-rich medium.
We thenwonderedwhether this epigenetic functionofTDG involves
active DNA repair, as implicated by the inability of a catalytic-dead
TDG (N151A) to complement the loss of Sfrp2 and Twist2 expression
in Tdg null MEFs (Fig. 2). To monitor a possible engagement of down-
streambase excision repair, we first performedChIP for XRCC117. This
revealed a specific, TDG-dependent enrichment of this critical base
excision repair protein at the Hoxd13, Hoxa10, Sfrp2 and Twist2 pro-
moters in MEFs but not in ESCs (Fig. 4a and Supplementary Fig. 5b).
Hence, in MEFs, where TDG helps maintain these promoters in an
active state, its presence correlates with an enrichment of XRCC1. In
ESCs, however, where TDG also associates with these promoters but
does not affect their chromatin status, XRCC1 enrichment is not
observed. Besides XRCC1, we also found APE1, another component
of base excision repair, to associate with these promoters in a TDG
dependentmanner inMEFs (Fig. 4a).Moreover, retinoic acid treatment
of ESCs for 8 h increased the number of chromatin-associated XRCC1
foci in the presence but not in the absence of TDG (Supplementary Fig.
9), and TDG-proficient cells were significantly more sensitive to
poly(ADP-ribose) polymerase (PARP) inhibition than TDG-deficient
cells upon retinoic-acid-induceddifferentiation (Supplementary Fig. 10).
These observations strongly suggest that cell differentiation-induced
TDG activity feeds into PARP and XRCC1-dependent DNA single-
strand break repair18.
Addressing thephenotypeonhistonemodifications,we then foundby
ChIP that the absence of TDG also compromises the association of the
H3K4-specific methyltransferase MLL1 with the promoters ofHoxd13,
Hoxa10, Sfrp2 and Twist2 (Fig. 4b). This was apparent in TDG-deficient
MEFs but not in ESCs, with the former indeed showing a loss of H3K4
methylation and an occurrence of aberrant CpG methylation at gene
promoters reminiscent of the phenotype of MLL defects19–21. Similar to
MLL, the binding of CBP/p300 to these promoters was significantly
reduced in the Tdg null MEFs (Fig. 4b). CBP/p300 is a transcription-
activating histone acetyltransferase known to interact with TDG4 and,
notably, its associationwith gene promoters has been reported to protect
from polycomb-mediated H3K27 trimethylation22.
Taken together, our data suggest structural and catalytic functions of
TDG in epigenetic maintenance (Fig. 4c). As a structural component,
TDG complexes with activating histone modifiers (for example, MLL,
CBP/p300) to maintain states of active (H3K4me2) and bivalent
(H3K4me2, H3K27me3) chromatin during cell differentiation. In
the absence of TDG, the assembly and function of such complexes is
distorted and, consequently, chromatin modifications imbalanced
towards repressive states. TDG also provides DNA repair capacity to
erase CpGmethylation locally. Aberrantmethylation arises at GC-rich
promoters in TDG-deficient cells following lineage commitment, and
the frequencies and patterns of these events indicate an underlying
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Figure 3 | TDG-dependent differences in gene expression and chromatin
status arise during cell differentiation. a, Scatter plots comparing gene
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stochastic process of de novomethylation. Hence, TDG keeps de novo
DNMT activities in check to avoid erroneous methylation, and the
engagement of XRCC1 and APE1 suggests that it operates through
base excision repair. Several previous studies have implicated TDG in
active DNA demethylation8,9,23. Mechanistically, it may do so on its
own, acting as a 5-mC DNA glycosylase23, or it may cooperate with a
5-mC deaminase (for example, AID/Apobec24,25 or DNMTs8), or a
5-mC hydroxylase (for example, TET126,27) that would convert 5-mC
into a favourable substrate for TDG. Numerous efforts to reproduce
5-mC glycosylase activity for mouse and human TDG have failed
(Supplementary Fig. 11 and unpublished observations). We therefore
consider a deamination or hydroxylation-mediated, TDG-dependent
repair process a preferable model for active cytosine demethylation.
The mouse Tdg knockout phenotype shows that such an epigenetic
control system has evolved to protect critical DNA sequences from de
novomethylation and heterochromatinization during development.
METHODS SUMMARY
Tdg knockout mouse and cell lines. The Tdg-targeting construct (Supplemen-
tary Fig. 1)was generated by replacement of aNarI–PacI fragment enclosing exons
6 and 7 by a neomycin resistance cassette in a cloned fragment spanning exons
5–10 of theTdg locus. This construct was used to target theTdg allele in 129mouse
ESCs, which were then used to generate chimaeras and, ultimately, Tdg1/2
heterozygotes by backcrossing to C57BL/6. The generation and establishment of
MEFs and Tdg2/2 ESCs was previously described28.
In vitro differentiation. In vitro differentiation of ESCswas performed essentially
according to the protocol published in ref. 16. RNA isolation for transcriptome
analysis of MEFs or ESCs and neuronal progenitor cells was performed using the
RNeasy Mini Kit (Qiagen) or the Trizol reagent (Invitrogen), respectively.
Antibodies and sequences of oligonucleotides used for PCR with reverse tran-
scription (RT–PCR), bisulphite sequencing and ChIP are listed in Supplementary
Tables 1–4.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
Received 22 February; accepted 17 November 2010.
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Figure 4 | Structural and catalytic functions of TDG in epigenetic
maintenance. a, ChIP–qPCR analysis of XRCC1 and APE1 association with
the gene promoters indicated in chromatin of TDG-proficient and -deficient
MEFs and ESCs. Shown are relative enrichments of XRCC1 and APE1 at these
promoters normalized to a randomly chosen intergenic control region
(means6 s.e.m.; n$ 3; *P, 0.05; **P, 0.01; unpaired Student’s t-test).
b, ChIP–qPCR analysis of MLL1 and CBP/p300 association with the gene
promoters indicated in chromatin of TDG-proficient and -deficient MEFs and
ESCs. Shown are relative enrichments of MLL1 and CBP/p300 at these
promoters normalized to a randomly chosen intergenic control region
(means6 s.e.m.; n$ 3; *P, 0.05; **P, 0.01; unpaired Student’s t-test).
c, Model summarizing epigenetic aberrations and implicated functions
observed in the absence of TDG. In ESCs TDG associates with gene promoters
in an active ‘open’ (H3K4me2, for example; Sfrp2 and Twist2, left side) or
transiently silent ‘bivalent’ chromatin conformation (H3K4me2 and
H3K27me3, for example;Hoxd13 andHoxa10, right side). In active chromatin,
the lack of TDG results in a partial loss of H3K4 dimethylation and a gain of
H3K27 trimethylation as well as in sporadic DNAhypermethylation (red balls)
upon cell differentiation. Differentiation-associated activation of promoters in
‘bivalent’ chromatin involves the demethylation of H3K27me3 and
transcription factor binding. The absence of TDG results in an aberrant loss of
H3K4 dimethylation accompanied by a gain in repressive H3K9 and H3K27
trimethylation and in DNA methylation, eventually directing irreversible
transcriptional silencing. In both cases, the loss of active and the gain in
repressive histone marks can be accounted for by a failure of TDG-deficient
cells to targetMLL and CBP to these promoters. We propose that TDG, as part
of transcription regulatory complexes, assures the establishment and the
maintenance of proper epigenetic states at developmentally regulated gene
promoters. As a DNA glycosylase, it protects these regions from aberrant CpG
methylation in a process that engages XRCC1 and APE1, factors essential for
downstream base excision repair.
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METHODS
Tdg knockout strategy. The Tdg-targeting construct (Supplementary Fig. 1) was
generated by replacement of a NarI–PacI fragment enclosing exons 6 and 7 by a
neomycin resistance cassette in a cloned fragment spanning exons 5–10 of theTdg
locus. This construct was used to target the Tdg allele in 129 mouse ESCs, which
were then used to generate chimaeras and, ultimately, Tdg1/2 heterozygotes by
backcrossing to C57BL/6. The generation and establishment of MEFs and Tdg2/2
ESCs was previously described28.
Cell culture and ESC differentiation. SV40-immortalized MEF cell lines were
previously described29 and cultivated in growthmedium(DMEM, 10%FCS, 2mM
L-glutamine) at 37 uC in a humidified atmosphere containing 5%CO2. For growth
of cell lines complemented with Tdg-expressing vectors, the growth medium was
additionally supplemented with 1mgml21 puromycin.
For isolation of primary MEFs, 10.5 days post-coitum embryos were dissected,
homogenized and cells dissociated in 0.05% trypsin-EDTA for 5min before plat-
ing inmodified ES cell mediumwithout LIF (DMEM, 10% FCS seraplus, 13 non-
essential amino acids, 1mM sodium pyruvate, 2mM L-glutamine and 50mM
b-mercaptoethanol, 13 penicillin/streptomycin) and cultivation for 10 days.
ESCs were grown in the presence of feeder cells at 37 uC in ES cell medium
(ECM: DMEM, 15% heat-inactivated FCS, LIF (1,000Uml21), 13 non-essential
aminoacids, 1mMNa-pyruvate, 2mML-glutamine and90mMb-mercaptoethanol)
in a humidified atmosphere containing 5% CO2.
Before starting retinoic-acid-induced differentiation , ESCs were grown in the
absence of feeder cells for two passages. For embryoid body formation during
neuronal differentiation, 43 106 Tdg1/2 or Tdg2/2 ESCs were plated into non-
adherent bacterial dishes (Greiner Bio-one) in differentiation medium (ECM
without LIF and with 10% FCS) and grown at 37 uC with a medium exchange
after 2 days. After 4 days, 5mM all-trans retinoic acid was added and cells were
further incubated for 4 days with a medium exchange after 2 days. Embryoid
bodies were washed twice with 13 PBS and dissociated with freshly prepared
trypsin solution (0.05% TPCK-treated trypsin in 0.05% EDTA/13 PBS) at
37 uC for 3min. Dissociated embryoid bodies were re-suspended in 10ml differ-
entiation medium and collected by centrifugation at 700g for 5min at room
temperature. The pellet was re-suspended in N2 medium (DMEM-F12 nutrient
mixture 1:1, 13N2 supplement) and the cell suspension filtered through a 40-mm
nylon cell strainer (BD). Filtered cells were immediately plated onto poly-L-lysine
and laminin-coated dishes at a density of 53 106 cells per 60-mmdish or 1.53 107
cells per 100-mm dish. The N2 medium was exchanged 2 and 24h after plating,
and cells were collected after 4 and 48h for further analysis.
Retinoic-acid-induced differentiation of ESCs for time course, PARP inhibitor
and immunofluorescence experiments was induced in ECM without LIF in the
presence of 1 or 5mM retinoic acid. The retinoic-acid-containing medium was
exchanged every 24 h, and cells were collected at the indicated time points. For
immunofluorescence experiments, 105 ESCs were seeded onto gelatin-coated
cover slips 1 day before differentiation. For the analysis of PARP inhibition on
cell survival during differentiation, 105 ESCswere seeded into gelatin-coated 12-well
dishes, 1 day before the addition of 5mMretinoic acid or further cultivation in ECM.
After 24 h, increasing concentrations of the PARP inhibitor AG-014699 (a gift of
SelleckChem)were added and cell numbers determined 24h laterwith theCASYcell
counter. The 50% lethal dose of the inhibitor and statistical differences betweenTdg-
proficient and -deficient cells were calculated on triplicate experiments by linear
regression with 95% confidence intervals using GraphPad Prism software.
Microarray gene expression analysis. For the analysis of differential gene
expression between Tdg1/2 and Tdg2/2MEFs, total RNAwas isolated from three
independent cultures of each cell line using the RNeasy Mini Kit (Qiagen), cDNA
synthesized from 13mg RNA with the SuperScript double-Stranded cDNA
Synthesis Kit (Invitrogen) followed by in vitro transcription reactions using the
MEGA Script T7 Kit (Ambion) supplemented with 1.5mMBio-11-CTP and Bio-
16-UTP (Enzo Life Sciences). cDNAs and cRNAs were purified using the
GeneChip Sample Cleanup Module (Qiagen). cRNA (15mg) was fragmented
and hybridized to GeneChip Mouse Expression Arrays 430A (Affymetrix).
Hybridized arrays were stained and washed according to the manufacturer’s pro-
tocol and scanned with an Affymetrix Scanner 3000 7G. Scanned images were
processed with Microarray Suite software and obtained ‘cel’-files used for further
data analysis.
For gene expression analysis of ESCs and in vitro differentiated neuronal pro-
genitor cells, total RNA was extracted from independent triplicates using the
Trizol reagent (Invitrogen). RNA was quantified using the Quant-iT RiboGreen
RNAAssay (Invitrogen) and500ng of total RNA subjected to cDNAsynthesis and
subsequent in vitro transcription to biotiylated cRNA using the Illumina
TotalPrep RNAAmplification Kit (Ambion, USA). cRNA (1.5mg) was hybridized
to MouseWG-6v2 slides (Illumina) according to the manufacturer’s protocol.
Bead arrays were washed and stained using FluoroLink Cy3 Streptavidin (GE
Healthcare). Fluorescent signals were imaged using the iScan system (Illumina).
Scanner images files were processed to probe intensity files by the manufacturer’s
software and further processedwith the genome studio software (Illumina)without
normalization and background correction.
Affymetrix data and Illumina probe intensity data were either processed by
robust multi-array average or variance stabilization transformation, respectively,
using R/Bioconductor software and ‘affy’ or ‘lumi’ libraries, followed by quantile
normalization. Significanceof effects for probes (Illumina) or probe-sets (Affymetrix)
was tested in R/Bioconductor (‘limma’ library) using a moderated t-test and the
false discovery rate (55%)methodofBenjamini andHochberg formultiple testing
correction. No unspecific filter was applied and multiple probe-sets per gene or
probe-sets with ambiguous genomic targets were retained.
Methylation analyses.GenomicDNA fromMEFs, ESCs and neuronal progenitor
cells was isolated with the QIAamp DNA Mini Kit (Qiagen). DNA (2mg) was
subjected to bisulphite conversion using the EZ DNA Methylation Kit (Zymo
Research). Respective target regions were amplified from bisulphite-treated DNA
withTrueStartTaqpolymerase (NewEnglandBiolabs). For conventionalbisulphite
sequencing, Hoxd13 or Sfrp2 promoter regions were amplified from converted
DNA and cloned into the XhoI and BamHI restriction sites of pBluescript SK-
before sequencing of individual clones. For pyrosequencing, potential regions of
hypermethylation were first identified by COBRA. Pyrosequencing primers
(Supplementary Table 1) were designed using the PyroMark Assays Design soft-
ware (version 2.0.1.15, Qiagen). Primer pairs included either one biotinylated
primer or one primer containing a universal region. In the latter case, products
were subjected to a second amplification using a biotinylated universal primer and
Phusion Hot Start High-Fidelity DNA Polymerase (Finnzymes). PCR products
were purified using the QIAquick PCR Purification Kit (Qiagen), quantified and
300–500ng were used for pyrosequencing in a PyroMark Q24 (Qiagen). Reactions
were analysedusingPyroMarkQ24 software (version 2.0.6,Qiagen). Significanceof
methylation differences between different Tdg-proficient and -deficient cell lines at
individual CpG sites was evaluated by unpaired, two-tailed t-tests.
ChIP. To crosslink protein-bound DNA, MEFs, ESCs and neuronal progenitor
cells were incubated in freshly prepared crosslinking solution (PBS pH 7.4, 1%
formaldehyde) at room temperature. The reaction was quenched after 10min by
addition of glycine to a final concentration of 125mM. After washing twice with
cold PBS, cells were collected using a cell scraper and subsequent centrifugation at
600g and 4 uC. Nuclei were isolated by incubation in 200ml of cold ChIP Buffer I
(10mM HEPES pH 6.5, 10mM EDTA, 0.5mM EGTA, 0.25% Triton X-100) for
5min on ice followed by two incubations of 5min on ice in 200ml cold ChIP buffer
II (10mMHEPES pH 6.5, 1mM EDTA, 0.5mM EGTA, 200mMNaCl). Pelleted
nuclei were lysed in 400ml ChIP buffer III (50mMTris-HCl pH 8.0, 1mMEDTA,
0.5%TritonX-100, 1%SDS, 1mMPMSF) for 10min on ice followed by sonication
for 15min (15 s on, 30 s off, power high) using a Bioruptor sonicator (Diagenode)
to produce random chromatin fragments ranging from 300 to 1,000 base pairs.
The solution was cleared by centrifugation at 14,000g and 4 uC for 10min and the
concentration of chromatin was estimated by absorbance at 260nm. For ChIP of
TDG, MLL and APE1 100–150mg of chromatin were diluted ten times in ChIP
dilution buffer I (50mM Tris-HCl pH 8.0, 1mM EDTA, 150mM NaCl, 0.1%
Triton X-100, 1mM PMSF). For histone ChIPs, 25–75mg of chromatin were
diluted in ChIP dilution Buffer II (16.7mM Tris-HCl pH 8.0, 1.2mM EDTA,
167mM NaCl, 1.1% Triton X-100, 0.01% SDS, 1mM PMSF). Diluted chromatin
was pre-cleared at 4 uC for 1 h with 40ml of a 50% slurry of magnetic Protein G
beads (Invitrogen) preblocked with 1mgml21 BSA and 1mgml21 tRNA (TDG,
XRCC1, APE1 and MLL-ChIPs) or salmon sperm single-stranded DNA (histone
ChIPs). Precleared chromatinwas incubatedwith 2–5mg of the respective antibody
(Supplementary Table 2) overnight at 4 uC under slow rotation. Immuno-
complexes were precipitated with 40ml of a 50% slurry of blocked Protein G beads
and further incubated at 4 uC for 2 h. Beads were then serially washed with 500ml
ChIP wash buffer I (20mM Tris-HCl pH 8.0, 2mM EDTA, 150mM NaCl, 0.1%
SDS, 1%TritonX-100), 500ml ChIPwash buffer II (20mMTris-HCl pH8.0, 2mM
EDTA, 500mMNaCl, 0.1%SDS, 1%TritonX-100) and 500ml ChIPwash buffer III
(10mM Tris-HCl pH 8.0, 1mM EDTA, 250mM LiCl, 1% sodium deoxycholate,
1%NP-40). For TDG, APE1 andMLL ChIPs, beads were washed once with 500ml
ChIP wash buffer I and twice with 500ml ChIP wash buffer II. After two additional
washes with 500ml TE buffer (10mM Tris-HCl pH 8.0, 1mM EDTA), bound
complexes were eluted by two sequential incubations with 150ml elution buffer
(1% SDS, 0.1 M NaHCO3) at 65 uC for 10min. Crosslink reversal of eluates and
respective input samples (1% of chromatin used for ChIP)was done in the presence
of 200mMNaCl at 65 uC for 4 h followed by proteinase K digestion (50mgml21) in
the presence of 10mM EDTA at 45 uC for 1 h. DNA was purified by phenol/
chloroform extraction and Na-acetate/ethanol precipitation, and re-suspended
in 10mM Tris-HCl pH 8.0. qPCR analysis with target specific primers (Sup-
plementary Table 3) was performed using Quantitect SYBR Green (Qiagen) with
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a Rotor-Gene 3000 thermocycler (Qiagen). The significance of different ChIP
efficiencies among Tdg-proficient and -deficient cell lines was evaluated from
triplicate experiments by non-paired, two-tailed t-tests.
MeDIP. MeDIP assays were performed as described in ref. 30. Briefly, genomic
DNA was prepared from 53 106 cells by incubation in lysis buffer (20mM Tris-
HCl pH 8.0, 4mM EDTA, 20mM NaCl, 1% SDS and 1mgml21 proteinase K) at
55 uC for 5 h and subsequent phenol/chloroformextraction andNa-acetate/ethanol
precipitation. DNA pellets were re-suspended in TE containing 20mgml21 RNase.
DNA was sonicated as described for ChIP followed by NaCl (400mM)/EtOH
precipitation in the presence of glycogen-carrier. Fragmented DNA (4mg) in
450ml TE was denatured at 95 uC for 10min and immediately chilled on ice.
After addition of 103 immunoprecipitation buffer (100mM sodium phosphate
pH 7.0, 1.4 M NaCl, 0.5% Triton X-100), the DNA was incubated with 10mg of a
monoclonal anti 5-methylcytidine antibody (clone 33D2, Eurogentec) at 4 uC for
2 h. Immuno-complexes were precipitated by the addition of 40ml M-280 sheep
anti mouse IgG antibody coupled Dynabeads (Invitrogen) and incubation at 4 uC
for 2 h followedby threewashes in 700ml IPbuffer. Boundmaterialwas treatedwith
250ml proteinase K digestion buffer (50mMTris-HCl pH 8.0, 10mMEDTA, 0.5%
SDS and 0.25mgml21 proteinase K) at 50 uC for 3 h. Immunoprecipitated methy-
lated DNA was purified by phenol/chloroform extraction followed by Na-acetate/
ethanol precipitation and re-suspended in TE. qPCR analysis of sonicated genomic
inputDNA andMeDIPDNAwith target specific primers (Supplementary Table 3)
was performed as described for ChIP, and significance ofMeDIP efficiencies tested
by non-paired, two-tailed t-tests.
Quantitative RT–PCR analyses. Total RNA (2–4mg) extracted by RNeasy Mini
Kit or by Trizol methods was reverse transcribed with the RevertAid H Minus
M-MuLV Kit (Fermetas) according to the manufacturer’s protocol. qPCR with
target specific primers (Supplementary Table 4)was performed using Power SYBR
Green Master Mix (Applied Biosystems) with a Rotor-Gene 3000 thermocycler.
Conditions for each target were validated by standard andmelting curve analyses.
Target-specific amplificationswere normalized to aGAPDHcontrol and data of at
least three independent experiments were analysed by unpaired, two-tailed t-tests.
Tdg genotype-specific target gene expression in primaryMEFswas analysed by the
non-parametric Kruskal–Wallis test and post hoc Dunn’s multiple comparison.
Western blot analyses.Whole-cell extractswerepreparedbycell lysis in lysis buffer
(50mM Na-phosphate pH 8.0, 125mM NaCl, 1% NP-40, 0.5mM EDTA, 1mM
PMSF, 1mM DTT, 13 complete protease inhibitor, 23 phosphatase inhibitor
cocktail 1 and 2) on ice for 30min and clarification by centrifugation (15min,
20,000g, 4 uC). Chromatin extracts were isolated as described for ChIP assays.
Soluble proteins (50mg) were separated on 7% or 10% SDS–polyacrylamide gels
and transferred to a nitrocellulosemembrane (Millipore).Membranes were washed
once with TBS-T (100mM Tris-HCl pH 8.0, 150mM NaCl, 0.1% Tween-20),
blocked with blocking buffer (TBS-T, 5% dry milk) at room temperature for 1 h
and incubated with the primary antibody at 33 uC (anti-mTDG) or room temper-
ature (anti-DNMT1, anti-DNMT3a, anti-XRCC1, anti-APE1, anti-MLL, anti-b-
actin) for 1 h in blocking buffer. Dilutions were 1:10,000 for the rabbit anti-
mTDG, the mouse anti-b-actin and the anti-DNMT1 antibodies; 1:1,000 for the
anti-DNMT3a and anti-XRCC1 antibodies; 1:500 for the anti-APE1 and anti-MLL
antibodies.Washing steps after hybridization were once at 33 uC and twice at room
temperature for 15min for anti-mTDG, or three times at room temperature for
10min for all other antibodies. Membranes were incubated with secondary HRP-
conjugated antibodies diluted 1:5,000 in blocking buffer and at room temperature
for 1 h. After three washing steps of 10min at room temperature, detection of the
signals was performed using the Immobilon Western Chemiluminescent HRP
Substrate (Millipore).
Cytotoxicity assays. For measurement of c-ray sensitivity, MEF single-cell sus-
pensions at a cell density of 23 105 cellsml21 in PBS were irradiated with the
indicated doses in a Gammacell 40 irradiator using 137Cs as a radioactive source.
Irradiated cells were plated in 96-wellmicrotitre plates at a density of 1000 cells per
well in growth medium, and survival was measured after 3 days using the Cell
Counting Kit-8 (Dojindo). Alternatively, survival was determined by clonogenic
growth by plating 500–2000 cells in triplicate in 10-cm dishes containing growth
mediumand counting ofGiemsa-stained colonies after 10 days. Tomeasure sensi-
tivity to H2O2, cells were plated at 2,500 cells per well in 96-well plates. After 24 h
cells were treated for 15min with the indicated concentrations of H2O2, washed
with PBS and incubated in fresh growth medium for a further 24 h before mea-
surement of survival with the Cell Counting Kit-8. Survival was determined as the
percentage of mock-treated cells.
Base release assay. For base release assays, 25–50mg of ESC whole-cell extracts
were incubatedwith 0.5 pmol of a fluorescein-labelledGC/TG,GCm/CGorGCm/
mCG DNA substrate in reaction buffer (50mM Tris-HCl pH 8.0, 1mM EDTA,
1mM DTT, 1mgml21 BSA) at 37 uC for 1 h (GC/TG) or overnight (methylated
substrates). Resulting AP-sites were cleaved by the addition of NaOH to a final
concentration of 100mMandheating to 95 uC for 10min. Subsequently,DNAwas
ethanol-precipitated overnight at220 uC in the presence of 0.3M Na-acetate pH
5.2 and 0.4mgml21 carrier t-RNA. DNAwas collected by centrifugation (20min,
20,000g, 4 uC) and washed with 80% ethanol. Air-dried pellets were re-suspended
in loading buffer (13 TBE, 90% formamide), heated at 95 uC for 5min and
immediately chilled on ice. Reaction products were separated on denaturing
8M urea/15% polyacrylamide gels in 13 TBE. The fluorescein-labelled DNA
was visualized with a Typhoon 9400 and quantified using ImageQuant TL soft-
ware (GE Healthcare).
Immunofluorescence. For detection of XRCC1 foci during retinoic acid stimu-
lation, cells were fixed in ice-cold methanol for 5min, then permeated in 0.2%
Triton X-100/PBS pH 7.4 and 0.2% Triton X-100/0.2%NaBH4/PBS pH 7.4 on ice
for 5min each. The induceability of XRCC1 foci formation in ESCs was tested by
incubationwithH2O2 (50mMinPBS) or PBS for 15min at 37 uCandan additional
5min in ECM with LIF before further processing. Coverslips were blocked in
blocking buffer (1% BSA/0.05% Tween20/PBS pH 7.4), stained with rabbit anti-
XRCC1 antibody (1:100 in blocking buffer) at room temperature for 1 h and
washed three times for 10min with blocking buffer before labelling with goat
anti-rabbit Alexa Fluor 594 (1:200 in blocking buffer) for 30–60min. After two
washes of 10min with blocking buffer, cells were again fixed in 220 uC cold
methanol, incubated in blocking buffer for 1 h and stained with a mouse mono-
clonal anti-PCNA antibody (1:100 dilution) in blocking buffer overnight at 4 uC.
Slides were counterstained for DNA with 50ng ml21 DAPI and mounted in
VectaShieldmountingmedium (Vector Lab). Slides were randomized and blinded
before z-stacks were acquired on a Leica SP5with the 405-nmdiode, argon 488nm
and He–Ne 594-nm laser lines. XRCC1 foci numbers for individual cells were
determined by visual inspection of the three-dimensional stacks. One hundred
and fifty (retinoic acid stimulation) or 50 (H2O2) cells per sample were analysed.
For co-staining of PAR and XRCC1 during retinoic acid differentiation, cells were
fixedwith2% formaldehyde/PBS at roomtemperature for 30minandpermeabilized
with PBS/0.2% Triton-X100 for 30min. Antigene detection was done with a 1:250
diluted monoclonal a-PAR antibody 10H (Enzo Life Sciences) and a polyclonal
a-XRCC1 as described above, but using 1:250 diluted anti-rabbit Alexa Fluor 594
and anti-mouse Alexa Fluor 488 secondary antibodies (Invitrogen). Pictures were
acquired with a Nikon Diaphot 300 epifluorescence microscope using identical
settings for all slides.
29. Kunz, C. et al. Base excision by thymine DNA glycosylase mediates DNA-directed
cytotoxicity of 5-fluorouracil. PLoS Biol. 7, e91 (2009).
30. Weber,M.et al.Chromosome-wideandpromoter-specific analyses identify sites of
differential DNA methylation in normal and transformed human cells. Nature
Genet. 37, 853–862 (2005).
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Summarizing Figure. The role of TDG in epigenetic control. TDG sustains proper 
(permissive) epigenetic states at gene promoters. As a structural component of 
transcription regulatory complexes, it contributes to the establishment and/or 
maintenance of accurate histone modification patterns (1), as a DNA repair enzyme, it 
corrects occasional aberrant de novo methylation of cytosine bases (2). 
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Supplementary Figure 1 | Tdg knockout strategy and validation. a, Schematic of the 
mouse Tdg locus representing exons 5-10. The insertion of the neomycin-resistance 
cassette to replace exons 6-7 is indicated, as well as the positions of probes used for 
Southern blotting (b) and primers for genotyping (c). b, Southern blot of EcoRI digested 
genomic DNA extracted from three E14 ESC clones (C49, C57, C77) with targeted Tdg 
locus. EcoRI digestion generated 9 kbp and 7.8 kbp DNA fragments for the wild-type 
and targeted Tdg alleles, respectively, here detected with a flanking probe external to 
the targeting construct as indicted in (a). c, PCR genotyping of Tdg knockout embryos. 
DNA was isolated from portions of embryos and analyzed by PCR using a primer pair 
amplifying both the targeted (1.7 kbp) and wild-type Tdg alleles (1.1 kbp). Shown are 
the PCR results of consecutive samples representing two Tdg+/+, one Tdg+/- and two Tdg-
/- genotypes. d, Pre-natal recovery of Tdg+/+, Tdg+/- and Tdg-/- embryos after timed 
matings. Note that the Tdg null embryos isolated at E12.5 were all dead. e, Northern 
blot analysis of Tdg expression in MEFs isolated from Tdg+/+, Tdg+/-, and Tdg-/- embryos. 
Blots were probed using a cDNA fragment spanning Tdg exons 8 to 10, amplified by 
RT-PCR. e, Western blot analysis of whole-cell protein extracts derived from SV40 
immortalized Tdg+/+ and Tdg-/- MEFs and Tdg-/- complemented with wild-type (pTdg) 
and catalytically deficient (pTdgcat) TDG or a vector control (pC). TDG was stained 
with a highly specific polyclonal anti-mouse TDG antibody (TDG) and staining for β-
ACT served as loading control. 
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Supplementary Figure 2 | Lack of DNA repair associated phenotypes in TDG 
deficient cells. a, Sensitivities towards ionizing radiation (ɣ-ray) or hydrogen peroxide 
(H2O2) of Tdg+/-, Tdg-/- or complemented Tdg-/- MEFs. Shown are survival curves as 
percentages of mock-treated cells (means ± s.e.m., n=3). pV, vector control; pTdg, Tdg-
expressing vector. c, cII mutation frequencies in Tdg and Mbd4 single or double mutant 
MEFs. The cII mutant frequency is the ratio of cII− plaques to the total number of λ 
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phage screened. Shown are mutation frequencies with 95% confidence intervals as 
calculated from the binominal proportions, with M indicating the actual number of 
mutant plaques scored for each genotype. 
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Appendix II
Supplementary Figure 3 | Gene ontology analysis and expression of selected targets 
in primary MEF isolates. a, Gene ontology (GO) annotations of the 200 most 
differentially regulated genes (p<0.05) reveal a significant enrichment of developmental 
pathways (Ingenuity Pathway Analysis). b, Expression levels of selected genes in 
primary MEFs isolated from Tdg+/+, Tdg+/-, and Tdg-/- embryos at 10.5 dpc and cultured 
for 10 days. Gene expression was assessed by qRT-PCR, mRNA levels were 
normalized to Gapdh mRNA. Values represent arbitrary units with medians of six 
independent MEF isolates indicated by horizontal bars. 
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Supplementary Fig. 4
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Appendix II
Supplementary Figure 4 | CpG methylation states of selected target promoters in 
MEFs. DNA methylation analysis by bisulfite pyrosequencing of Hoxd13, Twist2, 
Hoxa10 and Rarb promoter regions in Tdg+/+, Tdg+/- and Tdg-/- MEFs. Promoter regions 
are depicted schematically with vertical tick marks indicating CpG sites, bent arrows 
denoting transcription start sites, and horizontal brackets highlighting the CpGs for 
which methylation data is presented in the graphs below. Methylation levels are given 
as percentage of methylated cytosines at each CpG analyzed. Shown are means with 
95% confidence intervals (bars) as obtained from at least 3 independent DNA isolations 
and bisulfite conversions for each genotype. *, p<0.05; **, p<0.01; ***, p<0.001; 
unpaired Student’s t-test. 
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Supplementary Fig. 5
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Supplementary Figure 5 | Validation of proteins levels and ChIP analysis of 
DNMT3a in TDG proficient and deficient MEFs. a, Western blots showing protein 
levels of TDG, DNMT1 and DNMT3a in whole cell extracts (WCE) of Tdg+/+, Tdg+/- 
and Tdg-/- MEFs with β-ACT as loading control. 50 µg of WCE were loaded in parallel 
on 10% (TDG, β-ACT) or 7% (TDG, DNMT1, DNMT3a) polyacrylamide gels and 
proteins detected with the respective antibodies after protein transfer. b, Western blots 
showing XRCC1, APE1 protein levels in 50 µg chromatin extract of Tdg+/+, Tdg+/- and 
Tdg-/- MEFs and Tdg+/- and Tdg-/- ESCs. β-ACT was used as loading control. c, Western 
blot showing MLLc protein levels in 50 µg of chromatin extracts of Tdg+/+, Tdg+/- and 
Tdg-/- MEFs and Tdg+/- and Tdg-/- ESCs with β-ACT as loading control. 
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Supplementary Figure 6 | In vitro differentiation of ESCs to the neuronal lineage. 
a, Schematic of the protocol used for in vitro differentiation of ESCs to NPs. ESCs were 
differentiated into embryoid bodies (EB) in the absence of LIF. EBs were treated with 
RA prior to dissociation and plating in N2 medium. ESCs and NPs at 4 or 48 hours after 
EB dissociation and plating were harvested for ChIP, DNA methylation and gene 
expression analyses. All differentiation experiments were done in biological triplicates. 
LIF, leukemia inhibitory factor; RA, all-trans retinoic acid. b, Scatter plots comparing 
gene expression before and after differentiation of Tdg+/- or Tdg-/- ESCs to NPs. Green 
(p<0.05) and red (p<0.01) dots represent differentially expressed genes. c, Validation of 
regulation of Oct4 and Gata6 expression following a time course of RA-induced cell 
differentiation. Shown are expression levels (qRT-PCR) relative to undifferentiated 
ESCs of the same genotype (mean±s.e.m., n=3, * p<0.05, unpaired Student’s t-test). d, 
ChIP analysis of TDG association with the promoters of Hoxd13, Oct4 and Nanog in 
chromatin of Tdg+/- and Tdg-/- ESCs, 48h NPs and MEFs. Shown are relative 
enrichments normalized to a random intergenic control region as determined by qPCR 
(mean±s.e.m., n=3; *, p<0.05; **, p<0.01; unpaired Student’s t-test). 
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Supplementary Figure 7 | Gene ontology and DNA methylation analyses of TDG 
controlled genes during ESC - NP differentiation. a, Gene ontology (GO) 
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annotations of the 200 most differentially regulated genes (all p<0.05) reveal a 
significant enrichment of developmental pathways (Ingenuity Pathway Analyses). b, 
The DNA methylation status at the Oct4, Pax6, Pdgfra, Gata6 and Tgfb2 promoters was 
analysed by MeDIP-qPCR in Tdg+/- and Tdg-/- ESCs and 4h NPs. The promoter region of 
Gapdh was used as internal normalizer (means±s.e.m., n=3, **p<0.01, unpaired 
Student’s t-test), T, target region; C, control region. c, Bisulfite pyrosequencing analysis 
of CpG methylation in the Tgfb2 promoter region in ESCs and NPs at 4 and 48h after 
plating of embryoid bodies in N2 medium. Promoter regions are depicted schematically 
with vertical tick marks indicating CpG sites, bent arrows denoting transcription start 
sites, and horizontal brackets highlighting the CpGs for which methylation data is 
presented in the graphs below. Methylation levels are given as percentage of methylated 
cytosines at each CpG analyzed. Shown are means with 95% confidence intervals (bars) 
as obtained from three differentiation experiments. *, p<0.05; **, p<0.01; ***, p<0.001 
(unpaired Student’s t-test). 
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Supplementary Fig.8
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Supplementary Figure 8 | Histone modification states in TDG deficient ESCs and 
NPs. ChIP-qPCR analyses performed on chromatin derived from Tdg+/- and Tdg-/- ESCs 
and NPs to assess the chromatin status at the TDG target promoters indicated. Data is 
expressed as relative enrichment normalized to Iap and the Hprt promoter for active and 
repressive chromatin marks, respectively (means±s.e.m., n=3; *, p<0.05; unpaired 
Student’s t-test). T, target region; C, control region. 
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Supplementary Fig. 9
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Supplementary Figure 9 | TDG dependent DNA repair activity upon RA induced 
ESC differentiation. Immunofluorescence staining of XRCC1 and PCNA in Tdg+/- and 
Tdg-/- ESCs before (RA-, LIF+) and after 8 hours induction of differentiation by 5 µM 
retinoic acid (RA+, LIF-). a, Maximum intensity projections of confocal z-stacks for 
XRCC1 and PCNA immunofluorescence and for DNA counterstaining with DAPI. 
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PCNA staining was used as an indicator of S-phase cells to monitor and control for 
potential proliferation difference. b, Induction of XRCC1 foci following RA exposure. 
Shown are numbers of XRCC1 foci per cell as determined in 5 independent 
experiments. 150 cells per sample and experiment were analyzed for the number of 
XRCC1 foci. c, Positive control of damage dependent induction of XRCC1 foci. Shown 
are numbers of XRCC1 foci per cell after treatment with 50 µM H2O2 in PBS (+) or 
PBS alone (-), as determined in 3 independent experiments. 50 cells per sample and 
experiment were analyzed. Note that the higher background of XRCC1 foci in the H2O2 
experiments results from the prolonged incubation of the cells in PBS. Dots indicate 
individual cells, red lines the medians, and asterisks statistical significance determined 
by the Mann-Whitney-U-test (*, p<0.05; **, p<0.01; ***, p< 0.001). 
!
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Supplementary Fig. 10
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Supplementary Figure 10 | TDG sensitizes differentiating cells to the inhibition of 
PARP activity. a, ES cells were kept undifferentiated (+LIF, -RA) or differentiated (-
LIF, +5 µM RA) for 48 hours in the presence of increasing concentrations of the PARP 
Appendix II
inhibitor (PARPi) AG-014699. Survival of Tdg proficient and deficient cells was 
measured and the LD50 determined by regression analysis (box, 95% confidence 
interval; line, LD50; *, p<0.05). Shown are representative epifluorescence images (100x 
magnification) of immunostainings for XRCC1 and poly(ADP)-ribose (PAR) in TDG 
deficient ES (b) and differentiating cells (c) treated without or with 10 µM PARP 
inhibitor. 
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Supplementary Figure 11 | TDG has no 5-mC DNA glycosylase activity on its own. 
Base release assays with whole cell extracts from Tdg+/-, Tdg-/- and Tdg-/- ESC 
expressing either TdgA, TdgB or harbouring the vector only. Synthetic 60-mer DNA 
duplexes containing either a GC/TG mispair (left panel), or hemi- (GCm/CG) or fully 
methylated (GCm/CmG) CpGs (right panel) were incubated with 25 µg and 50 µg of cell 
extracts at 37°C for 1 hour or overnight, respectively. Shown is a representative 
denaturing polyacrylamide gel showing the intact substrate (S) and cleaved product (P) 
at the top and bottom respectively with numbers at the bottom of the lanes representing 
the amounts of cleaved substrate (%). Neg. control = no extract. 
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Supplementary Table 1: Pyrosequencing primers 
Primer 5’-3’ Sequence 
HoxA10 F GAGGGGTAGGGAGGAAAAGTGGT 
HoxA10 R b-AACCATTCCTAAATTTTCAACTCTAAACCCA 
HoxA10 S TTTGTAAGGTATTTAAAATAAGTAG 
HoxD13 F GGGTTATGAGTAGTTAGGGGATTTGGGATATGGATGG 
HoxD13 R GTCAGTCCAGTCCAGGTCAGGGTGAAGTATAGTATAGAGGTTGAGGTTGAATTTTAAAT 
HoxD13 S1 GGGGATTTGGGATATG 
HoxD13 S2 GTAGTAGAGTTTGGTTAG 
Pax6 F GAGTGGGGTGGGGGGAAAAT 
Pax6 R b-TTCACCCTAACTTCCCACCCCTTATCC 
Pax6 S1 GGGAAAATGGGTAGG 
Pax6 S2 GGTTTAGGTATAGTTGTGTTA 
Rarß F GTTAGATTGGTTGGGTTATTTGAAGGTTAG 
Rarß R GTCAGTCCAGTCCAGGTCAGGATCTTTTTCCCAACCCCCAATCATAAATTATAACAA 
Rarß S1 GGGTTATTTGAAGGTTAGTA 
Rarß S2 GTTTGGAAGGGAGAAT 
Rarß S3 GATTGGGATGTAGAGG 
Rarß S4 GGGGGGATTAGAGTTT 
Tgfß2 F TAATAGTATTAGGGATTTATTGTAGGAGAAGGTAAG 
Tgfß2 R b-AATTTACAAACCTATAAATCCCTCTCCATC 
Tgfß2 S GGGATTTATTGTAGGAGAAG 
Twist2 F GTCAGTCCAGTCCAGGTCAGGGTTGTGATGTTTAAGTTATAAAGTATTTAGGGGGTAG 
Twist2 R TCTCCTAAAACAAATTTAACCCTACCAAAATTC 
Twist2 S1 TTTCTAAACTACTTCAACCTA 
Twist2 S2 CCAAACCCAAATATACTC 
Unique b-GTCAGTCCAGTCCAGGTCAGG 
b-, biotinylated primer; F, forward primer; R, reverse primer; S, sequencing primer; underlined 
sequence, universal primer 
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Supplementary Table 2: Antibodies  
Antibody Product Nr.   Manufacturer 
Anti-H3K4me2 07-030  Millipore, USA 
Anti-H3K9me3 pAb-056-050 Diagenode, UK 
Anti-H3K27me3 07-449 Millipore, USA 
Anti-MLLc 05-765 Millipore, USA 
Anti-Ref-1 (APE1; C-20) sc-334 Santa Cruz Biotechnology, Inc., USA 
Anti-Dnmt3a (H-295) sc-20703 Santa Cruz Biotechnology, Inc., USA 
Anti-CBP (A-22) Sc-369 Santa Cruz Biotechnology, Inc., USA 
Anti-Dnmt3a  ab2850 Abcam, UK 
Anti-Dnmt1 ab5208 Abcam, UK 
Anti-beta Actin ab8226 Abcam, UK 
Anti-5-MeCyd (33D2) BI-MECY-0100 Eurogentec, Belgium 
Anti-XRCC1  X0629 Sigma-Aldrich, USA 
Anti-PAR (10H) ALX-804-220 Enzo Life Sciences 
Anti-PCNA-Fluorescein P105 Leinco Technolgies, USA 
Anti-rabbit-HRP NA934 GE Healtcare, USA 
Anti-mouse-HRP NXA931 GE Healtcare, USA 
Anti-rabbit-Alexa594 A-11012 Invitrogen, USA 
Anti-mouse-Alexa488 A-11017 Invitrogen, USA 
 
Supplementary Table 3: ChIP and MeDIP primers 
Primer 5’-3’ Sequence 
pHoxD13F TGGGCTATGGCTACCACTTC 
pHoxD13R GACACTTCCTTGGCTCTTGC 
pHoxA10F CACTCCCAGTTTGGTTTCGT 
pHoxA10R GGGGGTACAGGTTCAAGAGC 
pSfrp2F GACTTTCGTTGCCTCCTCCT 
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pSfrp2R AGGCCGGTCACTACTTTCTG 
pTwist2F TCGCTGTGATGCCTAAG 
pTwist2R CACGATCTCGCCTCTAGGAT 
pRarßF GGGAGTTTTTAAGCGCTGTG 
pRarßR CGGAGCAGCTCACTTCCTAC 
pTgfß2F AAGGGACGAGACGAGAAGGT 
pTgfß2R ACATCCACACGCACACTCAT 
pPax6F CGGTGAAAGAAGCCACTAGG 
pPax6R TAGGGCGTTTGTTTCCAAAT 
pOct4F GTGAGGTGTCGGTGACCCAAGGCAG 
pOct4R GGCGAGCGCTATCTGCCTGTGTC 
pGata6F AGTTTTCCGGCAGAGCAGTA 
pGata6R AGGAGGAAACAACCGAACCT 
pDnm1F ATTCGCGGACTGGTCACTAT 
pDnm1R TTAGCACCCCTAGCCATCAC 
pPdgfraF GGACGAGCGATCTGGAATAA 
pPdgfraR CCGTGCAGAAAAGACTCCAC 
pFgfr2F CTTCCAGAATCCAAGGACCA 
pFgfr2R CATCCCAATGCTGACATCTG 
IapF CTCCATGTGCTCTGCCTTCC 
IapR CCCCGTCCCTTTTTTAGGAGA 
pHprtF CCAAGACGACCGCATGAGAG 
pHprtR CAACGGAGTGATTGCGCATT 
Chr2negF AGCACAGCCTGAAGCCTCTA 
Chr2negR AGAGGGCATTTCCGTCTTTT 
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Supplementary Table 4: qRT-PCR primers 
Primer Name  5’-3’ Sequence 
GapDH(U) TGCACCACCAACTGCTTA 
GapDH(R) GGATGCAGGGATGTTC 
HoxA10a RT F CTCCCTGGGCAGTTCCAAAG 
HoxA10a RT R CGCTACGGCTGATCTCTAGG 
HoxD13 RT1 F CGACATGGTGTCCACTTTTG 
HoxD13 RT1 R TGGTGTAAGGCACCCTTTC 
RT Sfrp2 fw3 GCCGGCCACAGAGGAAGCTC 
RT Sfrp2 rev3 GGTCCCTTTCGGACACGCCG 
Twist2 RT F CGTCTCAGCTACGCCTTCTC 
Twist2 RT R CTGAGATGTGCAGGTGGGTC 
Rar-b RT F TTAATCTGTGGAGACCGCCAG 
Rar-b RT R TTACACGTTCGGCACCTTTCG 
Pdgfra RT F CGAGGTCGTTGACCTGCAGTGG 
Pdgfra RT R CGACGAAGCCTTTCTCGTGGACC 
Tgfb2 RT F AGAATCGTCCGCTTTGATGT 
Tgfb2 RT R GCTGGGTGGGAGATGTTACG 
Oct3/4(U) GGCGTTCTCTTTGGAAAGGTGTTC 
Oct3/4(R) CTCGAACCACATCCTTCTCT 
Gata6 RT F TCCATGGGGTGCCTCGACCA 
Gata6 RT R ACCCCTGAGGTGGTCGCTTGT 
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Abstract 
The Thymine DNA Glycosylase (TDG) initiates  Base  Excision  Repair  of  G•T  mismatches  arising   from 
deamination of 5-methylcytosine (5-mC) . Due to this substrate specificity, TDG has been suggested 
to act in a deamination-coupled 5-mC demethylation process. More recently, TDG has been 
implicated in active DNA demethylation propagated by the TET proteins as it processes 5-
formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), the final products of TET mediated 5-mC 
oxidation. However, the significance of either of these proposed pathways in the context of 
epigenetic programming during cell differentiation is yet unclear. Here, we report that TDG is 
required to establish DNA methylation at CpG islands during differentiation by controlling a 
transitory state of high epigenetic plasticity mediated by a cycle of DNA methylation and 
demethylation. We provide evidence that this cycle does not entail a deaminase but stepwise 
oxidation of 5-mC and that TDG structure and catalytic activity both contribute to controlling the 
epigenetic transitions from a pluripotent to a differentiated state. 
 
 
Introduction 
Cell type specific patterns of gene expression are shaped by chemical modifications of histone 
proteins and the DNA. As these modifications encode heritable information about cell identity that is 
not   laid  down  in  the  sequence  of  the  DNA  bases,  they  are  termed  “epigenetic”. The C5-position of 
cytosine is subject to methylation by DNA methyltransferases (DNMTs) (Goll and Bestor 2005). 5-
methylcytosine (5-mC) occurs predominantly in CpG dinucleotides, the vast majority of which is 
methylated throughout the genome, with the exception of CpG islands (CGIs) (Bird et al. 1985). These 
regions of high CpG density are maintained unmethylated and colocalize with the promoters of all 
ubiquitously expressed genes but also with about 40% of those with tissue-specific expression 
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patterns. However, a small but significant proportion of CGIs, many of which are distal to promoters, 
is differentially methylated between cell types (Illingworth and Bird 2009).  
In contrast to histone modifications that are highly dynamic in being placed, removed and replaced 
by a cohort of histone modifying enzymes (Bannister and Kouzarides 2011), cytosine methylation has 
long been regarded as a stable epigenetic mark that, once established by the de novo DNA 
methyltransferases DNMT3a and DNMT3b, is preserved through cell proliferation by the 
maintenance DNA methyltransferase DNMT1 (Goll and Bestor 2005). However, two global DNA 
demethylation events have been described to occur in the mammalian life cycle, one in the paternal 
pronucleus in the zygote and one in primordial germ cells (PGCs). Both events have recently been 
shown to be mediated by the activity of the Ten Eleven Translocator (TET) family of proteins. These 
5-mC hydroxylases convert 5-mC to 5-hydroxymethylcytosine (5-hmC) (Tahiliani et al. 2009), which in 
the case of global DNA demethylation appears to be subsequently diluted by DNA replication as 
5-hmC is not maintained by DNMT1 (Valinluck and Sowers 2007; Iqbal et al. 2011; Wossidlo et al. 
2011; Hashimoto et al. 2012; Hackett et al. 2013). Whereas the conversion of 5-mC to 5-hmC 
followed by passive removal presents a plausible and safe pathway for global demethylation, several 
lines of evidence suggest that at specific loci, DNA demethylation can occur by an active process not 
requiring DNA replication (Bruniquel and Schwartz 2003; Kangaspeska et al. 2008; Metivier et al. 
2008). Both, passive and active mechanisms are likely involved in global and targeted reprogramming 
during development. 
Interestingly, plants have been shown to utilize DNA glycosylases to excise 5-mC, followed by 
restoration of an unmethylated C by the base excision repair (BER) pathway (Zhu 2009). Efforts to 
identify analogous enzymes in mammals have implicated the thymine DNA glycosylase (TDG) as a 
prime candidate for a 5-mC demethylase. Apart from its ability to excise the deamination product of 
5-mC, thymine, from G•T  mismatches, interactions with DNMT3a and DNMT3b (Li et al. 2007; Boland 
and Christman 2008) and various transcription factors have placed TDG in the context of DNA 
methylation control and regulation of gene expression (Cortazar et al. 2007).  
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In further support of such a function, we and others have found deletion of Tdg in mice to be 
embryonic lethal, which suggests a non-redundant role of TDG in development. Furthermore, TDG-
deficient cells accumulate epigenetic aberrations with differentiation (Cortazar et al. 2011; Cortellino 
et al. 2011). While a direct 5-mC glycosylase activity of TDG has been proposed (Zhu et al. 2000), 
these findings still pend corroboration and it appears that mammalian cells apply a more complex 
mechanism than plants in erasing 5-mC. 
A plausible alternative to direct excision of 5-mC by a DNA glycosylase is the conversion of 5-mC to a 
more favorable substrate for DNA glycosylases. Three major pathways have been proposed, the most 
straightforward suggesting the deamination of 5-mC by a cytosine deaminase, e.g. the activation 
induced deaminase (AID) or the apolipoprotein B RNA-editing catalytic component (APOBEC) 
enzymes,   resulting   in   a   G•T  mismatch   that   could   be   processed   by   TDG but also the Methyl-CpG 
Binding Domain protein 4 (MBD4).  Support for such a pathway came with the finding that AID 
contributes to demethylation of the Oct4 and Nanog gene promoters during somatic cell 
reprogramming and to global DNA demethylation in primordial germ cells (PGCs) (Bhutani et al. 
2010; Popp et al. 2010). Furthermore, a deamination-coupled DNA demethylation pathway involving 
the coupled action of AID and MBD4 was described in zebrafish embryos (Rai et al. 2008). A second 
putative DNA demethylation pathway entails the coupled action of the TET proteins, converting 5-mC 
to 5-hmC, and subsequent deamination of 5-hmC to 5-hydroxymethyluracil (5-hmU), which can be 
excised by either TDG or the single-strand specific monofunctional glycosylase 1 (SMUG1) (Hardeland 
et al. 2003; Cortellino et al. 2011). However, a recent study has cast doubt on such a pathway since 
AID and the APOBEC family of deaminases appear to be mostly inactive on 5-hmC (Nabel et al. 2012). 
As neither MBD4 nor SMUG1 are essential for embryonic development (Wong et al. 2002; 
Kemmerich et al. 2012) and neither can compensate for the loss of TDG, it appears that TDG acts in a 
distinct pathway essential for embryo development that is not coupled to deamination. Such a 
pathway has taken shape with the finding that the TET proteins catalyze not only the generation of 5-
hmC but also its further oxidation to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), both of 
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which are excellent substrates for TDG-mediated BER and appear not to be processed by any other 
DNA glycosylase (He et al. 2011; Ito et al. 2011; Maiti and Drohat 2011). 
We have previously proposed a dual function of TDG in maintaining a permissive chromatin state at 
CpG island promoters during cell differentiation, first by structurally supporting the maintenance of 
active histone marks and second by counteracting errors of the DNA methylation machinery 
(Cortazar et al. 2011). However, how exactly TDG supports epigenetic stability through processes of 
cell fate determination has remained elusive. Here, we report that TDG is essential for establishing 
differentiation-induced methylation at CpG islands by structurally and enzymatically supporting an 
equilibrium of DNA methylation and oxidative demethylation during a transitory state of high 
epigenetic plasticity. 
 
 
Results 
 
Neuronal differentiation in Tdg-/- cells is accompanied by an increasing disturbance of DNA 
methylation patterns 
We reported previously that TDG is essential for embryonic development and that TDG deficient cells 
accumulate aberrant DNA methylation at CpG island (CGI) promoters, accompanied by a loss of 
active and gain of repressive histone marks in differentiated cells (Cortazar et al. 2011). To 
investigate the role of TDG in the regulation of DNA methylation, we performed MeDIP combined 
with next generation sequencing on DNA from TDG proficient and deficient embryonic stem cells 
(ESCs), early (4h) neuronal progenitors (NPs) derived by in vitro differentiation (Fig.1a) and MEFs 
isolated from Tdg+/+ and Tdg-/- embryos (Wilson 2012). Whereas Tdg-/- ESCs showed no significant 
differences in their DNA methylation patterns compared to TDG proficient cells, in vitro neuronal 
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differentiation gave rise to 942 differentially methylated regions (DMRs), and the comparison of the 
MEFs revealed 32976 DMRs (Fig.1b). This phenotype indicated a failing DNA methylation control in 
the TDG deficient cells that deteriorates with differentiation. This notion is supported by the 
observation that Tdg-/- ESCs fail to form terminal neurons in vitro and rapidly lose cell viability in 
neuronal differentiation medium (Fig.1a).  
Of the 942 DMRs found in NPs, 609 are hypermethylated and 333 hypomethylated in Tdg knockout 
cells compared to wildtype. As DNA methylation is not equally distributed throughout the genome 
and was found to negatively correlate with the density of CpG dinucleotides (Meissner et al. 2008), 
we characterized the relationship between DMRs and CpG density. In the absence of TDG, CpG poor 
DMRs were preferentially hypermethylated while DMRs with a higher CpG density were associated 
with a loss of DNA methylation (Fig.1c). We also analyzed the average distance of the DMRs to the 
nearest transcriptional start site (TSS). Hypomethylated DMRs were on average located closer to a 
TSS (24.3 kb +/- 45.0 kb) than the hypermethylated (47.7 kb +/- 77.4 kb) (Fig.1d). Accordingly, 57% of 
the hypomethylated DMRs but only 34% of the hypermethylated lie within 10 kb of a TSS. 
Intersection of the DMRs with promoter regions confirmed that only a minority of the DMRs overlap 
with promoters, but that a greater proportion of the hypomethylated DMRs are promoter-associated 
than of the hypermethylated (Fig.1e). We thus conclude that the hypomethylated DMRs are more 
likely to affect gene expression than the hypermethylated, but aberrant methylation appears to 
affect mostly regions distal to promoters. 
 
Differentiation-associated de novo methylation of CGIs is diminished in absence of TDG 
We found 123 DMRs to overlap with CGIs as defined in the UCSC genome analysis tools (Gardiner-
Garden and Frommer 1987). Unexpectedly, 122 of these 123 differentially methylated CGIs, 
henceforth called CGI DMRs, were hypomethylated in NPs derived from TDG deficient ESCs, whereas 
DMRs not classified as CGIs were predominantly hypermethylated (hyper-:hypomethylated = 3:1) 
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(Fig.2a). Although a vast majority of CGIs is maintained in a hypomethylated state in ESCs, a subset 
was shown to acquire de novo methylation during neuronal differentiation (Mohn et al. 2008). We 
therefore asked whether the hypomethylation at CGIs in Tdg knockout NPs represents a loss of DNA 
methylation present in ESCs or a failure to establish methylation during NP differentiation. We thus 
intersected the CGI DMRs with all CGIs showing increased methylation in wildtype NPs compared to 
wildtype ESCs in our setup (Wilson 2012). This revealed that 117 of the 122 CGI DMRs overlap with 
CGIs that become methylated with differentiation (Fig.2b). Thus, hypomethylation of CGIs in Tdg 
knockout NPs is associated with diminished differentiation-associated de novo methylation. 
To further explore the genomic features of the CGI DMRs, we intersected them with published 
datasets of genome-wide protein-binding sites and histone modifications in ESCs and tested for the 
enrichment or depletion of specific elements (Fig.2c). This revealed that the CGI DMRs were 
significantly depleted for gene promoters (Ensembl TSS -1kb and +0.5kb), sites of RNA-polymerase II 
(RNA-Pol II), histone acetyltransferase p300 and H3K27ac enrichment. On the other hand, we found 
the CGI DMRs to be enriched in sites of TET1 binding and H3K4me1 and H3K27me3 modification, 
suggesting that a large proportion of these CGIs represent enhancer elements and targets of the 
polycomb repressive complex 2 (PRC2) which trimethylates H3K27 (Kuzmichev et al. 2002). Enhancer 
elements were shown to be marked by H3K4 monomethylation and bound by TET1 (Heintzman et al. 
2007; Serandour et al. 2012) but the fact that the CGI DMRs are enriched for H3K4me1 and TET1 but 
depleted for H3K27ac and p300 suggests that  these enhancer elements are inactive or poised in ES 
cells (Creyghton et al. 2010). Interestingly, we found a highly significant overlap of CGI DMRs with 
low methylated regions (LMRs) that represent transcription factor binding sites at distal regulatory 
regions (Stadler et al. 2011); 52% of the CGI DMRs coincided with NP-specific LMRs and 7% with ESC-
specific LMRs (Fig.2c), whereas constitutive LMRs showed no significant overlap. The CGI DMRs thus 
appear to be enriched for polycomb targets and poised enhancer elements that acquire de novo 
methylation during differentiation. 
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Cells lacking TDG activity exhibit hypomethylation of CGIs but  no  rise  in  C→T  mutations 
The diminished differentiation-triggered methylation of CGIs and, thus, the apparent 
hypomethylation of such regions in Tdg knockout NPs can be explained in two ways: 1) by failure to 
target the DNA methylation machinery to these regions or 2) by conversion of 5-mC to another base 
that would no longer be recognized by the 5-mC antibody used in MeDIP. Conversion of 5-mC could 
occur by deamination by AID, which would generate a  G•T  mismatch that – unless repaired by TDG 
or MBD4 – will give  rise  to  C→T  mutations, or by oxidation of 5-mC to 5-hmC and further to 5-fC and 
5-caC by the TET proteins. 
To test these hypotheses and to be able to distinguish between structural and enzymatic role of TDG 
in this context, we performed in vitro differentiation in a complemented cell system, in which either 
wildtype TDG (wt), a catalytically dead mutant TDG N151A (TDG∆cat) or vector control (ko) were stably 
expressed in Tdg-/- ESCs. Genomic DNA from NPs derived from these ESCs was subjected to hairpin 
Na-bisulfite sequencing (BS-seq) to allow simultaneous analysis of strand-specific methylation status 
and mutation frequency (Arand et al. 2012). The analysis of 7 representative hypomethylated CGIs 
(Supplementary Table 1) sequenced   with   a   coverage   of   ~10’000   reads confirmed the 
hypomethylation in 5 targets (Fig.3).  Furthermore,  the  frequency  of  C→T  mutations  we  observed  did 
not rise above the error rate of the method and cannot explain the loss of 5-mC, which is in the 
higher percentage range. We thus conclude that the hypomethylation appearing in NPs is not caused 
by deamination of 5-mC or 5-hmC, as both deamination products (T and 5-hmU) are pre-mutagenic 
and would give rise to appreciable amounts of C→T  mutations  in Tdg knockout cells. Compensation 
by other DNA glycosylases like MBD4 and SMUG1 is unlikely, as neither is capable of compensating 
the 5-mC loss nor the developmental knockout phenotype of the TDG knockout. 
Notably, 2 of the 7 targets chosen for hairpin Na-bisulfite sequencing (DMR36 and 8) exhibited 
hypermethylation in TDG∆cat and (only in DMR8) knockout NPs but hypomethylation in MeDIP-seq in 
TDG deficient cells. 5-mC and 5-hmC are both protected from deamination by Na-bisulfite and can 
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thus not be distinguished by this method. MeDIP-seq, on the other hand, discriminates between the 
two C modifications as it relies on an antibody specific for 5-mC. The discrepancy between the results 
from BS-seq and MeDIP-seq thus suggests accumulation of 5-hmC at the respective targets. This 
notion is supported by the increased appearance of hemimethylated CpGs at the same targets; 5-
hmC is not maintained by the maintenance DNA methyltransferase DNMT1 (Valinluck and Sowers 
2007; Hashimoto et al. 2012) and therefore is expected to occur more often opposite an 
unmethylated CpG. 
 
Aberrant levels of higher oxidized C-modifications accumulate in the absence of TDG  
TDG was proposed to be the only DNA glycosylase capable of excising the higher oxidized 5-hmC-
derivatives 5-fC and 5-caC and, consistently, the levels of these C-modifications were shown to 
increase following a knockdown of TDG in ESCs (He et al. 2011). We wanted to investigate the 
generation of these derivatives in the context of ESC differentiation, i.e. when differential 
methylation in TDG proficient and deficient cells becomes apparent. Yet, since neither 5-hmC nor the 
higher oxidized C-modifications are maintained by DNMT1 (Valinluck and Sowers 2007; Inoue et al. 
2011), the quantitative analysis of the generation of these modifications is likely perturbed by 
dilution through DNA replication. To minimize this dilution effect, we performed a 24 h retinoic acid 
(RA) differentiation time course, allowing a maximum of two rounds of DNA replication to occur. To 
reduce epigenetic heterogeneity often observed in ESC culture, we conditioned our complemented 
ESC lines for a homogeneously undifferentiated state in 2i medium prior to RA-induced 
differentiation (Ying et al. 2008). Remarkably, we observed that culturing in 2i medium decreased the 
global 5-mC levels in comparison to cells cultured exclusively in ESC medium with LIF (Fig.S2b) by 
about 50%, irrespective of the status of TDG activity. This suggested that active inhibition of 
differentiation in the 2i medium changes the epigenetic ground state of our ESCs in a TDG 
independent manner and consistent with previous observations (Reik, W., personal communication). 
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We harvested genomic DNA and chromatin after 0, 8 and 24 hours of incubation with RA, RNA and 
protein at two additional timepoints (2i medium control and 4h) (Fig.4a). By testing the mRNA levels 
of Nanog, Oct4, Rex1 and Gata6 we verified the loss of expression of pluripotency genes and 
induction of developmental genes within these 24 h of RA differentiation (Fig.S1a), and we confirmed 
at mRNA and protein level that TET1 and TET2 expression was equal in all three cell lines (Fig.S1a and 
b and Fig.6b). The levels of AID mRNA were extremely low and protein levels were below the 
detection limit in Western blot analysis (Fig.S1c). 
We then measured levels of 5-mC, 5-hmC, 5-fC, 5-caC and 5-hmU in the genomic DNA of 
undifferentiated and differentiated cells by liquid chromatography-tandem mass spectrometry 
(LCMSMS). In agreement with previous findings in TDG knockdown experiments (He et al. 2011), we 
found a significant enrichment of 5-fC and 5-caC (~2- and 9-fold, respectively) in Tdg knockout as well 
as catalytically inactive (TDG∆cat) cells (Fig.4b). We also found the global levels of 5-mC, 5-fC and 5-caC 
to rise with differentiation, and this effect was more pronounced in cells lacking TDG activity and 
specifically induced by RA (Fig.S2a and c). Accordingly, global 5-mC levels became significantly 
different between TDG proficient and deficient (ko, TDG∆cat) cells at 24 h of differentiation (Fig.4b). 
Similarly, global 5-fC levels in knockout and TDG∆cat cells increased significantly above wildtype levels 
only after 8 and 24 h of differentiation. By contrast, 5-caC levels were ~9 fold higher in 
undifferentiated knockout and TDG∆cat cells than in wildtype ESCs and only the mutant cell lines 
showed a further significant increase in 5-caC with differentiation (Fig.S2a). Global 5-hmC and 5-hmU 
levels were not significantly different neither between any of the genotypes nor within the 
differentiation timecourse. 
From these results, we conclude that the loss of pluripotency triggers a turnover of global 5-mC, 5-
hmC, 5-fC and 5-caC, a process which is disturbed in the absence of active TDG. Overall, cytosine 
modification levels are equally affected in Tdg knockout or catalytic-dead cells, implicating a catalytic 
active role of TDG in controlling transitions in CpG methylation. 
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TDG activity is required to balance 5-mC and 5-caC at CGIs 
The absence of increased C→T   mutations at CGI DMRs in NPs derived from TDG deficient ESCs 
indicated that the hypomethylation observed is not a result of deamination-mediated loss of CpG 
sites but, instead, may originate from targeted 5-mC oxidation by the TET proteins. To address this 
hypothesis, we analyzed 5-mC (MeDIP), 5-hmC (GLIB) and 5-caC (caCDIP) levels at 4 CGI DMRs and 
compared their change in the 24 h interval of RA-induced ESC differentiation in the presence or 
absence of TDG protein and/or activity. 
While the effects we observed varied to some extent with the genomic context of the target, certain 
trends became apparent across targets. We observed a slight but consistent differentiation-induced 
increase of 5-mC in TDG wildtype and TDG∆cat ESCs set against no change or even a small decrease in 
knockout cells (Fig.5a). While the levels of 5-hmC showed a high variability between replicate 
experiments and, thus, no consistent difference between Tdg genotypes, 5-caC levels were clearly 
increased in TDG∆cat across the targets when compared to wildtype and knockout cells (Fig.5a, 
aggregated p-value < 0.0001, Anova). Comparing the proportions of 5-mC and 5-caC modifications at 
0 and 24 h (Fig.S3a) revealed a shift in the equilibrium between these modifications in a time- and 
genotype-dependent manner. While in wildtype and in Tdg ko cells, both modifications remained 
equilibrated at the CGI DMRs during the 24 h interval of differentiation, this balance tipped towards 
an increase in 5-caC in differentiated TDG∆cat cells (Fig.S3a).  
The increase of 5-mC and 5-caC at CGI DMRs in RA-stimulated wildtype and TDG∆cat ESCs indicates 
that the transition to a higher methylated state of these CGIs in the course of cell differentiation is 
accompanied by the generation of higher oxidized 5-mC-modifications, thus requiring 5-caC to be 
excised and replaced with an unmodified C for subsequent re-methylation by DNMT3a or DNMT3b. 
The fact that Tdg knockout cells did not show an increase in 5-mC but rather a reduction of 5-caC 
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suggests that TDG is structurally involved in the initiation and/or maintenance of cyclic methylation 
and oxidative demethylation.  
This cycle of methylation and demethylation appears to be disrupted in TDG∆cat, resulting in an 
increase of 5-caC over time that surpasses that observed in wildtype. To elucidate how this 
disruption occurs, we characterized TDG∆cat biochemically with respective to its activity on and 
association with 5-caC. As TDG∆cat shows residual glycosylase activity on substrates with a weak N-
glycosidic bond, e.g. 5-FU  (Kunz et al. 2009), we tested the activity of recombinant wildtype TDG and 
TDG∆cat in a standard base release assay on double-stranded oligonucleotide substrates with one 
fluorescence-labeled strand containing a single thymine or modified cytosine opposite guanine. We 
found TDG∆cat to be virtually inactive on 5-caC (Fig.5b), which is in agreement with the accumulation 
of 5-caC in TDG∆cat cells (Fig.4b). We then tested the ability of the catalytic-dead TDG to bind the 5-
caC substrate in electrophoretic mobility-shift assays with fluorescence-labeled substrate 
oligonucleotides   (G•T,   G•5-mC, G•5-hmC,   G•5-caC) in the presence of a 10 or 20 fold excess of 
unlabeled competitor DNA containing either unmodified C or a 5-caC. These competition assays 
identified 5-caC as the substrate most efficiently bound by TDG (Fig.5c); the binding specificity and 
efficiency of the catalytic-dead protein appeared to be comparable to that of the wildtype TDG 
(Fig.S3b) with the caveat that the assay with the latter most likely reflects binding of to the product 
abasic-sites  (Hardeland et al. 2000). We thus conclude that TDG∆cat binds 5-caC with higher affinity 
than 5-mC and 5-hmC. 
 
 
TDG-activity facilitates stable association of TET1 to CGIs during differentiation 
Given the differential effects of the Tdg disruption and the catalytic-dead mutant on the 
methylation-demethylation equilibrium at the CGI DMRs, we tested whether the presence or 
absence of TDG influences the association of TET1 – the most highly expressed of the TET proteins in 
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ES cells (Fig.S1a) – with these regions. Chromatin immunoprecipitation (ChIP) revealed that TET1 
enrichment increases at all selected CGI DMRs over time of RA stimulation in wildtype cells.  
Whereas the association of TET1 to the CGI DMRs appears to be independent of TDG in pluripotent 
cells, differentiation induces a gradual loss of TET1 occupancy at the CGI DMRs in both knockout and 
TDG∆cat cells (Fig.6a and S4).  These findings corroborate that initiation of ESC differentiation activates 
a cycle of DNA methylation and demethylation involving 5-mC oxidation at specific CGIs. 
Notably, while TDG∆cat is sufficient to support the stepwise oxidation of 5-mC to 5-caC structurally 
(Fig.5a), the absence of the catalytic activity in this mutant significantly destabilizes – or suppresses – 
TET1 association to the CGI DMRs (Fig.6a). The high affinity of TDG∆cat to 5-caC combined with its 
inability to turn over (Fig.5b and c) is likely to result in an accumulation of TDGΔcat at these CGIs, thus 
blocking the progression of the cycle. Indeed, by ChIP, we found TDG∆cat to be clearly enriched at the 
CGI DMRs, while association of wildtype TDG hardly rose above the background measured in Tdg 
knockout (Fig.6c, for relative enrichment, controls and statistics see Fig.S5).  
It thus appears that both TDG structure and catalytic activity are essential for stabilizing TET1-
occupancy at the CGI DMRs but that TDG structure can become an obstacle without the ability to 
turnover on 5-caC.  
 
 
 
Discussion 
 
We have found that in vitro differentiation of TDG deficient ESCs is accompanied by an increasing 
disturbance of DNA methylation patterns. The majority of differentially methylated regions arising 
with lineage restriction of Tdg knockout cells show aberrantly increased levels of CpG methylation, 
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which is in agreement with a previously proposed function of TDG in preventing de novo methylation 
errors (Cortazar et al. 2011). Remarkably though, one third of the DMRs showed reduced levels of 
methylation in the Tdg knockout cells. These hypomethylated regions display a higher CpG density, 
closer proximity to TSS and a greater overlap with gene promoters than the hypermethylated DMRs, 
suggesting that the hypomethylation phenotype is connected with the regulation of gene expression. 
Hypomethylated DMRs arising in NPs are highly enriched for CGIs, and this translates into 99% of all 
differentially methylated CGIs being hypomethylated in cells lacking TDG. The vast majority of these 
regions are CGIs that undergo de novo methylation during in vitro differentiation of ESCs to NPs, 
suggesting that TDG is essential for establishing cell-type specific methylation of CGIs in the course of 
cell differentiation. Interestingly, many of these CGI DMRs appear to be inactive or poised enhancers, 
evident from a 75% overlap of CGI DMRs with H3K4me1 enriched regions but only  a minor overlap 
with sites of H3K27ac and p300 enrichment (Creyghton et al. 2010). Furthermore, 52% of the CGI 
DMRs overlap with NP-specific LMRs (Stadler et al. 2011). At first glance, the overlap with LMRs, 
which are distal regulatory regions that display variable methylation levels due to transcription factor 
binding, and the gain of methylation at these enhancer CGIs, which correlates with a transcriptionally 
inactive state of the corresponding gene, might appear counter-intuitive. However, it is important to 
bear in mind that also the binding of transcriptional repressors can produce an LMR (Stadler et al. 
2011).  
We found that a catalytically-dead but structurally intact TDG variant (TDG∆cat) fails to rescue 
differentiation-triggered methylation at these CGI DMRs, showing that the establishment and 
maintenance of methylation patterns at these regions depends on the active excision of DNA bases. 
Furthermore, we exclude that loss of 5-mC at these CGIs arises through deamination of either 5-mC 
or 5-hmC, which was proposed to be catalyzed by AID in direct interaction with TDG (Cortellino et al. 
2011). The deamination products of 5-mC (T) and 5-hmC (5-hmU) are both pre-mutagenic and would 
result   in  C→T transition mutations if unrepaired prior to DNA replication. Yet, by hairpin bisulfite-
sequencing with high coverage of a representative set of hypomethylated CGIs, we did not detect 
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increased mutation levels, neither in Tdg knockout cells nor in cells expressing TDG∆cat. The results 
with the catalytic inactive but structurally intact TDG allow us to exclude that the lack of mutations 
may reflect a failure to recruit AID to these genomic loci. Consistently, we did not observe a 
significant increase of 5-hmU in the genomic DNA of cells lacking TDG activity, neither with regard to 
differentiation nor to genotype. Together with recent reports of AID and other APOBEC proteins 
showing little to no reactivity on 5-mC and 5-hmC (Nabel et al. 2012), our data strongly argue against 
a deamination-dependent process accounting for the loss of 5-mC at these CGIs.  
In contrast, our data support a model connecting the loss of 5-mC at CGIs in TDG deficient NPs with 
the conversion of 5-mC to 5-hmC and 5-fC/caC by TET proteins. In a 24 h timecourse of RA-induced 
ESC differentiation, we found the genomic levels of all 5-mC-derivatives to increase in Tdg wildtype, 
knockout and TDG∆cat cells, with 5-fC and 5-caC specifically accumulating in TDG deficient cells, which 
is agreement with previous reports of TDG being the only DNA glycosylase excising these bases (He 
et al. 2011; Maiti and Drohat 2011). From the similarly elevated levels of 5-fC and 5-caC in TDGΔcat 
and from a glycosylase activity assay with recombinant TDGΔcat, we conclude that the N151A 
mutation abolishes TDG’s  5-caC processing capacity (Fig.5b). However, the mutation does not disrupt 
binding of 5-caC, which we found TDG to associate more tightly with than with C, 5-mC or 5-hmC 
(Fig.5c). It is somewhat striking that relatively high levels of 5-fC and 5-caC accumulate in TDG 
deficient ESCs, considering that these undergo DNA replication every 13-16h and 5-mC oxidation 
products fail to support maintenance methylation by DNMT1 (Valinluck and Sowers 2007; Inoue et 
al. 2011; Hashimoto et al. 2012). This finding thus suggests that the higher oxidized 5-mC-
modifications are continuously generated at the same rate as replication-dependent dilution occurs. 
To what extent they arise as consequence of epigenetic modeling or simply by chemical oxidation of 
the considerable genomic 5-mC and 5-hmC pool remains to be tested. In any case, it is clear that TDG 
is required to keep control of the global 5-fC/caC levels.  
The analysis of local C-modification levels at representative CGI DMRs revealed a differentiation-
induced increase of 5-mC and 5-caC levels in wildtype, a slight rise in 5-mC coupled with pronounced 
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accumulation of 5-caC in TDG∆cat but no significant shift of C-modification levels in knockout cells 
(Fig.5a and Fig.S3a). 5-hmC levels appear to change only slightly during differentiation, which may 
reflect that this oxidation intermediate is rapidly converted to 5-fC and 5-caC. 
Although the differences that arise in the 24 h interval of in vitro differentiation are not dramatic, 
they indicate clearly that the loss of pluripotency coincides with a transition of DNA methylation 
states at certain CGIs that involves the generation of higher oxidized derivatives of 5-mC. As the 
overall trajectory at these CGIs is towards 5-mC enrichment, it is evident that these higher oxidized 5-
mC-modifications have to be erased and replaced again by 5-mC. The passive removal of 5-
hmC/fC/caC by DNA replication does not appear to be sufficient to establish methylation at these loci 
as the process clearly depends on functional TDG. We thus propose that at these CGIs, RA-induced 
differentiation triggers a cycle of DNA methylation and demethylation involving the iterative 
oxidation of 5-mC and enzymatic removal of 5-fC/caC by TDG and BER (Fig.7). This establishes a 
transient equilibrium of methylation and demethylation intermediates that, at later stages of 
differentiation (early NPs), is tipped towards methylation (Fig.7), suggesting that this cycle represents 
a transitory state that accompanies the loss of pluripotency.  
As only wildtype and even more the TDG∆cat cells exhibit an accumulation of 5-caC at these CGIs, we 
propose a dual function of TDG, one as an enzymatic component and one as a structural scaffold in 
the assembly of key factors involved in the cycle of DNA methylation and demethylation. Indeed, we 
found that TET1 associates with these loci independent of TDG in ESCs but is rapidly lost upon 
differentiation in Tdg knockout cells. TDG∆cat, on the other hand, can still function as a scaffold, as 
evident by the accumulation of 5-caC in a differentiation-dependent manner. Notably, this occurs 
despite the concomitant reduction of TET1 association with these regions in these cells, suggesting 
that the specific 5-caC binding capacity of TDG actively blocks the turnover of the 5-caC generated. 
This implies that with the accumulation of 5-caC, an increasing number of TDG∆cat molecules would 
bind at these loci but fail to catalyze the final step of demethylation, as indeed indicated by the 
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increased enrichment of TDG∆cat at these DMRs (Fig.6c and Fig.S5). Wildtype TDG on the other hand 
is capable of rapid turnover on 5-caC and accordingly associates with the CGI DMRs only transiently. 
While the failure of turnover of TDG∆cat might disrupt the methylation-demethylation complex by 
steric hindrance, excision and subsequent repair of 5-caC itself might produce signals necessary for 
associating TET1. Alternatively, the failure to excise 5-caC might result in unusual demethylation 
intermediates, i.e. hemi-5-caC sites that cannot be remethylated by DNMT1 after DNA replication. 
Also, DNMT3a and DNMT3b cannot target 5-caC for methylation and may not be able to methylate a 
CpG opposite a 5-caCpG bound by TDG∆cat. Without BER resetting the methylation state, the TET 
proteins lack a substrate and would thus lose association with the CGI DMRs. Passive erasure of 
5-fC/caC through DNA replication would eventually result in the hypomethylation observed in NPs. 
Previous reports of cyclical methylation and demethylation of the pS2 promoter in response to 
estrogen-induced transcriptional activation have implicated DNMT3a and DNMT3b as well as TDG in 
coordinating these epigenetic transitions between transcriptionally active and silent states 
(Kangaspeska et al. 2008; Metivier et al. 2008). Here, we describe a cycle driven by the activity of 
DNMTs, TET1 (possibly also TET2) and TDG that reflects a transitory state at CpG islands that undergo 
methylation during differentiation. This cycle of CpG methylation and demethylation appears to be 
induced by differentiation which is in agreement with our previous observation that RA induces DNA 
repair processes involving TDG that increase the number of XRCC1 foci and the sensitivity to PARP 
inhibitors in differentiating wildtype compared to Tdg-/- cells (Cortazar et al. 2011). In this cycle, TDG 
fulfills two functions: first, structural stabilization of a complex that drives the cycle and second, 
catalyzing the final step of 5-caC removal . However, what initiates the cycle at these specific CGIs 
and which signals determine the overall trajectory towards a methylated or an unmethylated state 
remains to be elucidated.  
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Methods 
 
Cell culture and ES cell differentiation 
For NP differentiation, ESCs were grown on Feeders at 37°C in ES cell medium (ECM: DMEM, 15% 
heat-inactivated FCS, 1x non-essential amino acids, 1 mM Na-pyruvate, 2 mM L-glutamine and 90 μM  
β-mercaptoethanol) with LIF  (1’000Uml-1) in a humidified atmosphere containing 5% CO2. 
Prior to differentiation, ESCs were grown without Feeders for 2 passages. For embryoid body 
formation, 4x106 Tdg+/-, Tdg-/- or Tdg-/- pWt,   pΔcat   and  pVec ESCs were plated onto non-adherent 
bacterial dishes (Greiner Bio-one) in differentiation medium (ECM without LIF and with 10% FCS) and 
grown at 37°C with a medium exchange after 2 days. After 4 days, 5 μM  all-trans retinoic acid (RA) 
was added and cells were further incubated for 4 days with a medium exchange after 2 days. 
Embryoid bodies were washed twice with 1x PBS and dissociated with freshly prepared trypsin 
solution (0.05% TPCK-treated trypsin in 0.05% EDTA/PBS) at 37°C for 3 min. Dissociated embryoid 
bodies were resuspended in 10 ml differentiation medium and collected by centrifugation at 700xg 
for 5 min at room temperature. The pellet was resuspended in N2 medium (DMEM-F12 nutrient 
mixture 1:1, 1xN2 supplement) and the cell suspension filtered through a 40 mm nylon cell strainer 
(BD). Filtered cells were immediately plated onto poly-L-lysine and laminin-coated dishes at a density 
of 5x106 cells per 60 mm dish or 1.5x107 cells per 100 mm dish. The N2 medium was exchanged 2 and 
24 h after plating. For MeDIP-sequencing and hairpin BS-sequencing, cells were collected after 4 h in 
N2 medium. 
Complemented ES cell lines were derived by transfection of Tdg-/- ES cells with the complementation 
vectors pTCO2 TDG wt, pTCO2 TDGΔcat  and empty pTCO2 (Cortazar et al. 2011) using jetPEI® (Polyplus 
Transfections)   according   to   the   manufacturer’s   recommendations.   Cells   were   cultivated in ECM 
supplemented with 1.5 μg ml-1 puromycin to select stable clones. 
For the 24 h RA differentiation, complemented ES cells were cultured on Feeders for 2 passages, then 
conditioned for 4 passages without Feeders in 2i medium (Neurobasal medium and DMEM/F-12 1:1, 
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1x N2 supplement, 1x B27 supplement, LIF   (1’000 Uml-1), 2 mM L-glutamine, 90 μM  
β-mercaptoethanol, 3 μM   CHIR99021   and   1 μM   PD0325901   (University   of   Dundee)   and   1x  
penicillin/streptomycin). Prior to RA differentiation, ESCs were seeded at suitable cell numbers for 
each time point onto two 140 mm dishes (for Chromatin and genomic DNA extraction) or two 30 mm 
dishes (for Protein and RNA extraction) in ECM. For differentiation, the medium was exchanged for 
ECM without LIF but supplemented with 5 μM  RA  (5 mM stock in DMSO). Chromatin, genomic DNA 
were harvested at 0, 8 and 24 h, Protein and RNA at -16 h (2i control),  0, 4, 8 and 24 h. For the DMSO 
control for LCMSMS, ES cells were treated accordingly but incubated with DMSO 1:1’000 in ECM. 
If not indicated otherwise, cell culture components were obtained from Gibco® Life Technologies, 
chemicals from Sigma and LIF from Merck Millipore. 
 
MeDIP-Sequencing 
5 μg of DNA was sonicated giving fragment sizes <500bp. Fragments were end repaired, 
phosphorylated, 3’   adenylated and ligated to Illumina adapters in accordance with the Illumina 
Multiplex Sample Preparation protocol (PE-930-1001). These samples were then subjected to MeDIP 
as described previously (Weber et al. 2005), with 3 μg  5-mC antibody (Euogentec) per 1 μg  DNA. The 
immunoprecipitated (IP) sample was purified using the DNA   Clean   &   Concentrator™-5 kit (Zymo 
Research) according   to   the   manufacturer’s   instructions. The sample isolated by MeDIP then 
underwent gel electrophoresis and library size selection (150-200 bp), prior to PCR amplification 
using Illumina paired-end primers for 18 cycles. During this step, the libraries were tagged with a 
unique identifier, or index, as per Multiplex Sample Preparation Oligonucleotide protocol (PE-400-
1001). Libraries were quantified using an Agilent Bioanalyzer 2100. 
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MeDIP-seq Data Analysis  
The generated MeDIP-seq data were analyzed using the computational pipeline MeDUSA 
(v1.0.0)(Wilson 2012) and the MEDIPS (v1.0.0) R bioconductor package (Chavez et al. 2010). MeDUSA 
comprises several analysis steps. Firstly, BWA (v0.5.8) (Li and Durbin 2009) was used to align the 
paired end sequence data to the reference mouse genome (Build mm9) using default settings. 
Filtering was performed to remove reads that were unable to be aligned as a viable pair and also 
those pairs in which neither read scored an alignment score of ≥  10. In cases of non-unique reads, 
possibly caused by PCR artifacts, all but one pair was removed. Quality control was performed using 
the tool FastQC (v0.9.4) (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/) and MEDIPS. The 
USeq (v6.8) suite of tools (Nix et al. 2008), specifically MultipleReplicaScanSeqs (MRSS) and 
EnrichedRegionMaker, were used to identify DMRs between cohorts. MRSS processes Point data for 
use in the BioConductor package DESeq (Anders and Huber 2010). Window size was set at 500. Only 
regions containing a minimum of 10 reads summed from the cohorts being compared were included 
for DMR analysis. The dataset was initially described in (Wilson 2012), and is available in the GEO 
repository (GSE27468). 
To   determine   the   overlap   between   DMRs   and   other   genomic   features,   the   “operate   on   genomic  
intervals”   tool   of   the   Galaxy   project   was   used   (http://usegalaxy.org/;   (Giardine et al. 2005; 
Blankenberg et al. 2010; Goecks et al. 2010). DMRs were intersected with promoters, defined as 
Ensembl TSS plus 1kb upstream and 0.5kb downstream, RNA-Pol II (GSM918749), p300 
(GSM918750), H3K4me1 (GSM1000121), H3K27ac (GSM1000126), H3K4me3 (GSM769008) and 
H3K27me3 (GSM1000089) peaks for ES cells, generated by ENCODE/LICR (Dunham et al. 2012), as 
well as with CGI coordinates (Gardiner-Garden and Frommer 1987) and LMRs (Stadler et al. 2011). 
TET1 binding sites (GSM706672) were converted from mm8 to mm9 using liftOver (Kent et al. 2002) 
prior to intersection with the DMRs.  
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Hairpin bisulfite deep sequencing for selected genomic regions 
The analysis was performed according to (Arand et al. 2012). Briefly, genomic DNA was digested with 
a restriction enzyme cutting in the selected DMRs, specified in Supplementary Table 1, followed by a 
ligation of a hairpin linker to link the upper to the lower strand. After bisulfite treatment the selected 
regions were amplified. Restriction enzymes and primers used in this analysis are given in 
Supplementary Table 2. The amplified products were sequenced by 454 sequencing. The sequencing 
data was then analyzed by BiQAnalyzerHT (Lutsik et al. 2011) for accurate alignment and methylation 
evaluation, followed by merging of the methylation information of the upper and lower strand using 
python scripts.  Average methylation, hemimethylation and mutation rates were calculated in 
Microsoft Excel. 
 
LCMSMS analysis of global C-modification levels 
Genomic DNA was enzymatically hydrolyzed to nucleosides essentially as described (Crain 1990), 
followed by addition of 3 volumes of methanol and centrifugation (16’000xg, 30 min, 4C). The 
supernatants were dried and dissolved in 50 µl 5% methanol in water (v/v) for LCMSMS analysis of 
the deoxynucleosides 5-hm(dC), 5-f(dC), 5-ca(dC), and 5-hm(dU). A portion of each sample was 
diluted for the quantification of 5-m(dC) and unmodified deoxynucleosides (dA, dC, dG, and dT). 
Chromatographic separation was performed on a Shimadzu Prominence HPLC system with a Zorbax 
SB-C18 2.1x150 mm i.d. (3.5 µm) column equipped with an Eclipse XDB-C8 2.1x12.5 mm i.d. (5 µm) 
guard column (Agilent Technologies). The mobile phase consisted of water and methanol (both 
supplemented with 0.1% formic acid), for 5-m(dC), 5-hm(dC), 5-f(dC), and 5-ca(dC) starting with a 
5 min gradient of 5-60% methanol, followed by 6 min re-equilibration with 5% methanol, and for 
unmodified nucleosides maintained isocratically with 85% methanol. hm(dU) was gradient 
chromatographed with a mobile phase of only water and methanol. Mass spectrometry detection 
was performed using an MDS Sciex API5000 triple quadrupole (Applied Biosystems) operating in 
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positive electrospray ionization mode for the mass transitions 258.1/ 142.1 (5-hm(dC)), 256.1/ 140.1 
(5-f(dC)), 272.1/ 156.1 (5-ca(dC)), 242.1/ 126.1 (5-m(dC)), 252.1/136.1 (dA), 228.1/112.1 (dC), 
268.1/152.1 (dG), and 243.1/127.1 (T), or negative electrospray ionization mode for the mass 
transitions 257.1/ 124.1, 257.1/ 141.1, and 257.1/ 214.1 (5-hm(dU), quantifier and qualifier ions). 
 
Purification of recombinant TDG 
See (Kunz et al. 2009), briefly, TDG wt and TDGΔcat were expressed from vectors pET28c-mTDGa.0 and 
pET28c-mTDGa.1 as described. Cell lysis was carried out in NiNTA lysis buffer (50 mM Na-phosphate 
[pH 7.5], 500 mM NaCl, 20% glycerol, 0.1% Tween-20, 20 mM imidazole, 20 mM  β-mercaptoethanol, 
0.1 mM phenylmethylsulfonyl fluoride) by sonication followed by extract clarification. The clear 
supernatant was loaded onto a 5 ml HisTrap FF crude column (GE Healthcare), bound protein was 
eluted with 400 mM imidazole and dialyzed against Heparin buffer (25 mM Na-phosphate [pH 7.0], 
250 mM NaCl, 20% glycerol, 20 mM  β-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride). The 
dialyzed fractions were loaded onto a 5 ml HiTrap Heparin HP column (GE Healthcare) and bound 
protein was eluted with a linear gradient of 250 mM – 1.5 M NaCl. For ion exchange, relevant 
fractions were pooled, dialyzed against AIEX buffer (50mM Bicine [pH 8.8], 25 mM NaCl, 20% 
glycerol,  20  mM  β-mercaptoethanol, 0.11 mM phenylmethylsulfonyl fluoride) and loaded onto a 1 ml 
Resource Q column (GE Healthcare). Bound protein was eluted with a linear salt gradient of 25 mM – 
1 M NaCl and purest fractions finally dialyzed against storage buffer (50 mM Tris-HCl [pH 8.0], 50 mM 
NaCl, 10% glycerol, 1 mM dithiothreitol), frozen on dry-ice and stored at -80°C. 
 
Base release assay 
60-mer double-stranded oligonucleotide substrates containing different modifications were prepared 
by annealing of an unlabeled upper strand oligonucleotide (5‘-TAGACATTGCCCTC 
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GAGGTACCATGGATCCGATGTCGACCTCAAACCTAGACGAATTCCG-3‘) to a (5‘-fluorescein-labeled lower 
oligonucleotide   strand   5‘-F-CGGAATTCGTCTAGGTTTGAGGTXGACATCGGATCCATGGTACCTCGAGGG 
CAATGTCTA-3‘,  where  X  =  T,  5mC,  5hmC  or  5caC. 
Base release assays were carried out in a total volume of 20 µl containing 0.5 pmol of recombinant 
protein and 0.5 pmol of the labeled DNA substrate in 1x reaction buffer (50 mM Tris-HCl [pH 8.0], 
1 mM EDTA, 1 mM DTT, 1 mg/ml BSA) for 15 min at 37°C. Generated AP-sites were cleaved by the 
addition of NaOH to a final concentration of 100 mM and heating to 99°C for 10 min. Subsequently, 
DNA was ethanol precipitated overnight at -20°C in 0.3 M Na-acetate (pH 5.2) and in the presence of 
0.4 mg/ml carrier tRNA. The DNA was collected by centrifugation (20 min,  20‘000g,  4°C) and washed 
in 80% ethanol. Air-dried pellets were resuspended in loading buffer (1x TBE, 90% formamide), 
heated at 99°C for 5 min, and then immediately chilled on ice. Reaction products were separated on 
15% denaturing polyacrylamide gels in 1x TBE. The fluorescein-labeled DNA was visualized with a 
Typhoon 9400 (GE Healthcare) and quantified using the ImageQuant TL software (GE Healthcare). 
 
Electrophoretic mobility shift assay 
EMSAs were performed to measure the DNA-binding ability of wild-type and mutant TDG protein, 
using the double-stranded oligonucleotide substrates described above. Standard EMSA were carried 
out in a total reaction volume of 10 µl containing 2 pmol of recombinant protein and 1 pmol of 
labeled DNA substrate with varying amounts of unlabeled competitor DNA in 1x reaction buffer 
(50 mM Tris-HCl [pH 8.0], 1 mM DTT, 5% glycerol, and 1 mM EDTA). After 15 min incubation at 37°C 
the reactions were loaded immediately onto 6% native polyacrylamide gels and separated in 0.5x TBE 
for 50 min at 100 V at room temperature. The fluorescein-labeled DNA was also visualized with a 
Typhoon 9400 (GE Healthcare) and quantified using the ImageQuant TL software (GE Healthcare). 
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DNA Immunoprecipitation and GLIB 
Genomic  DNA  was  prepared   from  cells  by   incubation   in   lysis  buffer   (20 mM Tris-HCl  pH  8.0,  4 mM  
EDTA,   20 mM   NaCl,   1% SDS   and   1 mg ml−1 proteinase K) at 55°C for 8-12 h and subsequent 
phenol/chloroform extraction and Na-acetate/ethanol precipitation. DNA pellets were resuspended 
in 10 mM Tris-HCl pH 8 and concentration was measured by absorbance at 260 nm. RNA was 
removed   by   incubation   with   2.5 µg   RNaseA   per   µg   DNA   for   30 min at 37°C, followed by Na-
acetate/ethanol precipitation. Quality of the DNA tested by standard agarose gel electrophoresis. 
5-mC and 5-caC were detected by MeDIP and caCDIP, performed essentially as described in (Weber 
et al. 2005). DNA was sonicated to yield fragments of 100-500bp followed by  NaCl  (400 mM)/ethanol 
precipitation in the presence of glycogen-carrier. 1 µg   fragmented DNA in TE was denatured and 
incubated  with  0,3 µg  of  monoclonal  anti-5-methylcytidine or 2 μg  polyclonal  anti-5-carboxylcytosine 
antibody (Supplementary Table 3) at 4°C for 2 h in 1x immunoprecipitation   (IP)   buffer   (10 mM  
sodium phosphate pH 7.0, 140 mM NaCl, 0.05% Triton X-100). Immuno-complexes were precipitated 
by the addition of 20 µl M-280 sheep anti-mouse IgG antibody coupled Dynabeads (Invitrogen) and 
incubation at 4°C for 2 h followed by three washes in IP buffer. Bound material was treated with 
250 µl proteinase K digestion buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 0.5% SDS and 
0.25 mg ml−1 proteinase K) at 50°C for 3 h. Immunoprecipitated methylated DNA was purified by 
phenol/chloroform extraction followed by NaCl/ethanol precipitation and re-suspended in 10 mM 
Tris-HCl pH 8.0.  
5-hmC containing DNA fragments were captured with the Hydroxymethyl Collector kit from Active 
Motif as described in the manufacturer’s  instructions.  
qPCR analysis of sonicated genomic input DNA and Me/caCDIP/GLIB DNA with target specific primers 
(Supplementary Table 4) was performed using Quantitect SYBR Green (Qiagen) with a Rotor-Gene 
3000 thermocycler (Qiagen). Statistical analysis was performed on Graphpad Prism Software. 
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 Chromatin Immunoprecipitation 
To crosslink protein-bound DNA, ES cells were incubated in 1% formaldehyde/PBS at room 
temperature.  The  reaction  was  quenched  after  10 min  by  addition  of  glycine  to a final concentration 
of  125 mM.  After  washing  three  times  with  ice  cold  PBS,  cells  were  collected  using  a  cell  scraper  and  
subsequent centrifugation at 600xg and  4 °C.  Supernatant  was  discarded  and   the  cells   snap-frozen 
until further processing. After thawing  on   ice,   nuclei  were   isolated  by   incubation   in  400 µl  of   cold  
ChIP   Lysis   Buffer   I   (10 mM  HEPES   pH   6.5,   10 mM  EDTA,   0.5 mM  EGTA,   0.25% Triton X-100, 1 mM 
PMSF)  for  5 min  on  ice  followed  by  two  incubations  of  5 min  on  ice  in  400 µl  cold  ChIP  Lysis buffer II 
(10 mM  HEPES  pH  6.5,   10 mM  EDTA,   0.5 mM  EGTA,  200 mM  NaCl,   1mM  PMSF).   All   centrifugation  
steps were conducted at 600xg and 4°C   for   5  min.   Pelleted   nuclei  were   lysed   in   400 µl   ChIP   Lysis 
buffer  III  (50 mM  Tris-HCl  pH  8.0,  1 mM  EDTA,  0.5%  Triton  X-100, 1% SDS,  1 mM  PMSF)  for  10 min  on  
ice  followed  by  sonication  for  15 min  (15 sec  on,  30 sec  off,  power  high)  using  a  Bioruptor  sonicator  
(Diagenode) to yield fragments of ~200-500 bp. The solution was cleared of remaining cell debris by 
centrifugation at 14’000xg and 4°C  for  10 min.  For  ChIP  of  TDG and TET1,  150 µg  of  chromatin  were  
diluted 1:10 in  ChIP  dilution  buffer  (50 mM  Tris-HCl  pH  8.0,  1 mM  EDTA,  150 mM  NaCl,  0.1%  Triton  X-
100, 1x protease inhibitor cocktail,   1 mM   PMSF).   After removing 1% (volume) for input analysis, 
diluted chromatin was pre-cleared at 4°C   for  1 h  with  30 µl  of   a  50% slurry of magnetic Protein G 
beads (Invitrogen) pre-blocked  with  1 mg ml−1 BSA  and  1 mg ml−1 tRNA. Pre-cleared chromatin was 
incubated with 1-2 µg   of   the   respective   antibody (Supplementary Table 3) overnight at 4°C under 
slow rotation. Immuno-complexes  were  precipitated  with  40 µl  of  a  50% slurry of blocked Protein G 
beads and further incubated at 4°C  for  2 h.  Beads  were  then  serially  washed  with  500 µl  ChIP  wash  
buffer  I  (20 mM  Tris-HCl  pH  8.0,  2 mM  EDTA,  150 mM  NaCl,  0.1% SDS, 1% Triton X-100), twice with 
500 µl  ChIP  wash  buffer  II  (20 mM  Tris-HCl pH 8.0, 2 mM  EDTA,  500 mM  NaCl,  0.1% SDS, 1% Triton X-
100).  After  two  additional  washes  with  500 µl  TE  buffer  (10 mM  Tris-HCl  pH  8.0,  1 mM  EDTA),  bound  
complexes   were   eluted   by   two   sequential   incubations   with   250 µl   elution   buffer   (1% SDS, 0.1 M 
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NaHCO3) at 65°C  for  10 min  shaking.  Crosslink  reversal  of  eluates  and  respective  input  samples  was  
done in the  presence  of  200 mM  NaCl  at  65°C  for  4 h  followed  by  proteinase  K  digestion  (50 µg ml−1) 
in   the   presence   of   10 mM  EDTA   and   40 mM Tris-HCl pH 6.5 at 45°C   for   1 h. DNA was purified by 
phenol/chloroform   extraction   and   NaCl/ethanol   precipitation,   and   resuspended   in   10 mM   Tris-HCl 
pH 8.0. qPCR analysis with target specific primers (Supplementary Table 4) was performed using 
Quantitect SYBR Green (Qiagen) with a Rotor-Gene 3000 thermocycler (Qiagen). Statistical analysis 
was performed on Graphpad Prism Software.  
 
Western Blot analyses 
Denaturing protein extracts were prepared by washing the ES cells twice in cold PBS before addition 
of lysis buffer (50 mM Tris-HCl pH 7.5, 1% SDS, 5 mM DTT). The lysate was collected using a cell 
scraper and processed by two cycles of heating to 65°C and sonication for 5 min (15 sec on, 30 sec 
off, power high), followed by 10 min centrifugation at 20’000xg and 4°C. The concentration of the 
supernatant was estimated by a standard Bradfort assay by diluting the extract 1:800 in ddH2O 
before adding Bradfort reagent (final volume 1 ml). 40 μg of protein extract was separated on a 10% 
PAA gel (for AID) or a Mini-Protean pre-cast gradient gel (BioRad) and transferred to a nitrocellulose 
membrane (Millipore). For TET1, TET2 and TDG, 10% methanol and 0.002% SDS were added to the 
transfer buffer (25 mM Tris, 192 mM Glycine), for AID no SDS but 20% methanol. Membranes were 
washed once with TBS-T (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.2% Tween-20), blocked with 
blocking buffer (TBS-T, 10% low fat dry milk) at room temperature for 1 h and incubated with the 
primary antibody at 33°C (anti-mTDG) or room temperature (anti-TET1, anti-TET2, anti-AID, anti-
DNMT3b, anti-β-actin) for 1 h in 7.5% dry milk/TBS-T. Dilutions were 1:10’000   for   the   rabbit  anti-
mTDG and the mouse anti-β-actin antibodies; 1:2’000  for  the  rabbit  anti-TET1 (Millipore) antibody; 
1:500 for the monoclonal mouse anti-AID (gift by S.K. Petersen-Mahrt) and 1:100 for the monoclonal 
rat anti-TET2 antibody (gift by H. Leonhard). Washing steps after hybridization were once at 33°C and 
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twice at room temperature for 15 min for anti-mTDG, or three times at room temperature for 10 min 
for all other antibodies. Membranes were incubated with secondary HRP-conjugated antibodies 
diluted  1:5’000 (goat anti-rabbit and goat anti-mouse) or 1:20’000  (anti-rat) in 5% dry milk/TBS-T at 
room temperature for 1 h. After three washing steps of 10 min at room temperature, detection of 
the signals was performed using the WesternBright Quantum Chemiluminescent HRP Substrate 
(Advansta). 
 
Quantitative RT-PCR  
1 μg  total  RNA  extracted  with  TRI  Reagent  (Sigma)  was  reverse   transcribed  with  the  RevertAidTM H 
Minus First Strand cDNA Synthesis Kit (Fermentas)  according  to  the  manufacturer’s  protocol.  qPCR  
with target specific primers (Supplementary Table 5) was performed using Rotor-Gene SYBR Green 
PCR mix with a Rotor-Gene 3000 thermocycler (Qiagen). Conditions for each target were validated by 
standard and melting curve analyses. Target-specific amplifications were normalized to the average 
of TBP, B2m and  β-actin. Data of three independent experiments were analyzed by Anova to test for 
differences between genotypes. 
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Figure Legends 
 
Figure 1: Differentiated Tdg-/- cells accumulate aberrant methylation patterns. a) In vitro 
differentiation of Tdg+/- and Tdg-/- ES cells to neuronal progenitors; Tdg-/- cells rapidly lose viability at 
later stages of NP differentiation (24-48h). b) MeDIP-seq reveals an increasing number of 
differentially methylated regions (DMRs) with advancing differentiation state. c) DMRs that are 
hypomethylated in knockout NPs are associated with higher CpG density, whereas CpG poor DMRs 
are almost exclusively hypermethylated; CpG density and methylation fold change refer to narrow 
peaks. d) Density plot of the log10 distance of hypo- or hypomethylated NP DMRs (center of broad 
peaks) to the nearest TSS (Ensembl), **p<0.005, Mann-Whitney T-test on average of distances 
(linear). e) Promoter-association of hypo- versus hypermethylated NP DMRs (broad peaks). 
 
Figure 2: Differentiation-dependent methylation at CpG islands fails in absence of TDG. a) Volcano-
plot of methylation fold change versus FDR-adjusted p-value (narrow peaks), CpG islands (CGIs) in 
red. 99% of the DMRs that overlap with a CGI are hypomethylated in knockout NPs, non-overlapping 
ones (other) are mostly hypermethylated. b) Overlap of CGIs hypomethylated in knockout versus 
wildtype with CGIs that become de novo methylated with differentiation; p<0.0001, Chi-square with 
Yates correction. Hypomethylation at these CGIs is caused by diminished differentiation-driven 
methylation. c) Overlap of broad peaks with published datasets. To test for enrichment or depletion 
of a feature in the hypomethylated CGIs, we compared the proportion of CGI DMRs overlapping 
(positive) or not overlapping (negative) with a feature to the analogous proportion within CGIs that 
were not differentially methylated. Percentages of CGIs overlapping (positive, grey) or not 
overlapping (negative, white). ** p<0.005; *** p<0.0001, Chi-square with Yates correction. 
 
Figure 3: Hairpin bisulfite-sequencing of representative CGI DMRs in NPs. Strand-specific 
methylation (5-mC and 5-hmC) and mutation analysis of CGI DMRs, specified with characteristics in 
Supplementary Table 1, in Tdg knockout NPs complemented with wildtype TDG (wt), a catalytically 
dead mutant (TDGΔcat) or the empty complementation vector (ko). Insulin growth factor 2 (Igf2) 
served as a control (Arand et al. 2012). The bars indicate average percentage of fully methylated, 
hemi-methylated and mutated CpGs, the according numbers are presented in the tables. The heat 
maps display neighboring CpG dinucleotides, and each line represents one sequencing read. Catalytic 
activity of TDG is essential to establish methylation. Hypomethylation at these CGIs appears to not be 
caused by deamination of 5-mC,  as  the  rate  of  C→T  mutation  is  within  the  error  rate  of  the  method. 
 
Figure 4: Global levels of 5-mC and its derivates in a 24 h differentiation timecourse. 
a) Scheme of experimental setup. ES cells preconditioned in 2i medium were seeded in ESC medium 
(ECM) with LIF 14-16 h  prior  to  differentiation,  then  transferred  to  ECM  without  LIF  and  with  5μM  
retinoic acid (RA). Samples were harvested at the indicated timepoints. b) LCMSMS analysis of global 
C-modification and 5-hmU levels in genomic DNA prepared at 0, 8 and 24 h of differentiation. We 
observe a significant rise of the global levels of 5-mC, 5-fC and 5-caC with differentiation in knockout 
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and TDG∆cat (for statistics see Fig.S2). Shown are Log2 fold changes compared to wildtype (mean with 
s.e.m.); statistical analysis was performed on absolute numbers (Fig.S2), asterisks indicate significant 
difference to the respective timepoint in wt, * p<0.05, **p<0.005, *** p<0.0001, one-way Anova. 
 
Figure 5: Targeted MeDIP, GLIB and caCDIP analysis of CGI DMRs. a) Relative enrichment (RE) of 
5-mC (n=2) and 5-caC (n=3) normalized to a randomly chosen CpG-poor region (neg.contr.). TDG and 
TDG∆cat accumulate 5-mC and 5-caC over time, 5-caC especially accumulates in TDG∆cat. Mean with 
s.e.m. Asterisk, significant difference of RE between 0 h and 24 h within a genotype, * p<0.05, one-
way Anova. Statistical comparison of genotypes with regard to the log2-transformed 24 h versus 0 h 
fold change across targets: aggregated p-value < 0.0001. b) Biochemical analysis of TDG and TDGΔcat 
glycosylase activity on 5-mC derivates. Double-stranded 60mer oligonucleotide substrates containing 
a single T, 5-mC, 5-hmC or 5-caC on a fluorescence labeled strand were incubated with recombinant 
wildtype TDG or TDG∆cat. Glycosylase activity on the indicated substrates produces an abasic site 
which is converted to a single-strand break by heating under alkaline conditions, giving rise to a 
shorter fragment of 23 nt. Shown are reaction products separated on a denaturing polyacrylamide 
gel and quantification of 3 independent experiments (mean with standard deviation). c) 
Electrophoretic mobility shift assay with labeled 60mer oligonucleotides with the indicated 
modification (Substrate*), incubated with wildtype TDG or TDG∆cat and varying amounts of unlabeled 
competitor substrate containing an unmodified C or 5-caC. See also text. 
 
Figure 6: TET1 fails to stably associate with CGI DMRs during differentiation in absence of TDG 
activity. TET1-ChIP on chromatin prepared at 0, 8 or 24h of differentiation. a) Log2 fold changes of 
relative enrichment (RE) at 8 or 24 h versus the respective RE at 0 h (median with range). TET1 loses 
affinity to the CGI DMRs with ongoing differentiation in absence of TDG activity. For RE values and 
controls, refer to Fig. S4. Asterisks, significant difference between the genotypes with regard to their 
fold change versus 0h, *p<0.05, ** p<0.005, one-way Anova with Bonferroni post-test.  b)  TET1  and  β-
actin protein levels in SDS protein extracts detected by Western blot. c) TDG-ChIP, analogous to a. 
Log2 fold changes of relative enrichment (RE) versus the respective relative enrichment in TDG ko 
cells serving as a background control (median with range). TDGΔcat  is enriched at CGI DMRs due to its 
high affinity to 5-caC present at these loci. Wildtype TDG is capable of rapid turnover on 5-caC and 
appears to be associated very transiently with the CGI DMRs. For RE values and statistical analysis, 
refer to Fig. S5.  d)  TDG  and  β-actin protein levels in SDS protein extracts detected by Western blot. 
 
Figure 7: Model for a dual function of TDG in a differentiation-driven DNA methylation and 
demethylation cycle. At the onset of differentiation, a cycle of DNA methylation and demethylation 
is triggered. CpG methylation is catalyzed by Dnmts. 5-mC is oxidized by the TET proteins in a 
stepwise manner and the final products 5-fC/caC are excised by TDG (wt, top). With ongoing 
differentiation, the equilibrium of the different C-modifications is shifted towards 5-mC, evident as 
CGI de novo methylation  in  early  NPs  (“normal  methylation”).  We  propose  that  apart  from  its  active  
function in catalyzing the final step of demethylation TDG additionally provides a structural scaffold 
to allow the recruitment of the key factors involved. In absence of TDG, initiation of the cycle fails or 
stops immediately after initiation (Tdg ko, middle), resulting in lower methylation levels in ko NPs 
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than  in  wt  NPs  (“hypomethylation”).  TDGΔcat  on the other hand provides the scaffold for assembly 
and coordination of the different steps of the cycle but upon binding to 5-caC fails to turn over 
(bottom). The lacking catalytic activity of TDG leads to the accumulation of 5-caC which is bound with 
high affinity by TDG∆cat. As the cycle fails to proceed, TET1 association is destabilized. Removal of 5-
caC by dilution through DNA replication eventually leads to the hypomethylation observed in NPs. 
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Figure 7 
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 Supplementary Figure Legends 
 
Figure S1: mRNA and protein levels in a 24h differentiation timecourse. a) mRNA levels of the 
pluripotency markers Oct4, Nanog and Rex1, and the differentiation-induced transcription factor 
Gata6, detected by qRT-PCR, confirm loss of pluripotency within 24h of differentiation. All three cell 
lines appear to differentiate with similar efficiency. TET1 mRNA levels decrease towards 24h but 
protein levels remain stable throughout this time window and are equal between cell lines (Fig.6b). 
mRNA   levels  were  normalized   to   the  average  of  TBP,  B2m  and  β-actin. b) TET2 mRNA and protein 
levels, detected by qRT-PCR and Western blot, respectively, show no differences between the cell 
lines. Note that mRNA levels of TET2 are 5-10 times lower than those of TET1. c) mRNA and protein 
levels of AID. AID mRNA levels are extremely low and protein levels are below the detection limit of 
Western blot. Activated B-cells served as a positive control for detection of AID in Western blot. 
Shown are means with s.e.m.; statistical analysis by one-way Anova revealed no significant 
differences across genotypes. 
 
Figure S2: Global C-modification levels measured by LCMSMS at 0, 8 and 24h of differentiation. a) 
Absolute numbers per 106 unmodified nucleotides. b) 5-mC levels decrease with culturing in 2i 
medium. Without 2i, n=1, with 2i n=3. c) Control for unspecific effects, 0h or 24h incubation with 
DMSO; n=2. DMSO does not induce any significant change of C-modification levels. Error bars, s.e.m.; 
statistical test between time points, * p<0.05, ** p<0.005, *** p<0.0001, Anova. 
 
Figure S3: Targeted analysis of 5-mC, 5-caC and 5-hmC at CGI DMRs. a) 5-mC and 5-caC proportions 
of the sum of both average RE. In Tdg∆cat the equilibrium of 5-mC and 5-caC is tipped towards 5-caC 
upon differentiation. 
 
Figure S4: TET1-association at CGI DMRs. Relative enrichment normalized to a randomly chosen 
CpG-poor region (neg.contr.). Bars indicate the mean, error bars the s.e.m. The promoter regions of 
Oct4, Nanog and HoxA10 served as control regions. See also Fig.7. 
 
Figure S5: TDG-association at CGI DMRs. Relative enrichment normalized to a random CpG-poor 
region (neg.contr.). Bars indicate the mean, error bars the s.e.m. The promoter regions of Oct4, 
Nanog and HoxA10 served as control regions. Statistical analysis, two-way Anova: genotypes 
significantly different, 3 p<0.05, ** p<0.005. See also Fig.8. 
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Figure S3: Targeted analysis of 5-mC, 5-hmC and 5-caC levels at CGI DMRs 
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Figure S4: TET1-ChIP, relative enrichment versus chr2neg 
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Figure S5: TDG-ChIP, relative enrichment versus chr2neg 
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 Supplementary Tables 
 
 
 
Supplementary Table 1: Targets of hairpin BS-seq with characteristics 
DMR genic/intergenic gene CGI genomic features NP vs ES 
8 5' exon Tbx3 weak TET1 hyper 
9 intron Kdm2b strong 
TET1, H3K4me1, 
H3K4me3, NP-LMR 
hyper 
10 3' exon Zfp282 strong TET1, H3K4me1, H3K4me3 hyper 
36 intron Gm5089 strong 
TET1, H3K4me1, 
H3K4me3, NP-LMR 
hyper 
39 5' exon Ldoc1l strong 
TET1, H3K4me1, 
H3K4me3, NP-LMR 
hyper 
49 intergenic  ------ strong 
TET1, H3K4me1, 
H3K4me3, NP-LMR 
hyper 
54 exon Mgat4b strong 
CTCF, H3K4me1, 
H3K4me3, NP-LMR 
hyper 
 
 
 
Supplementary Table 2: Enzymes and primers used in hairpin BS-sequencing 
DMR restriction enzyme Primer sequences 
8 MspI F GATAAGGATATTGAGTTAGAGGA 
  R AAAAACACTAAACCAAAAAAC 
9 TaqI F TTTTAGGAGATATAAAGAATAGTTT 
  R AAAAACACAAAAAACAACTC 
10 PstI F AGAAGAGTTTTAATTGTTATTTTGG 
  R AAACTTCAACTACCACTCTAACC 
36 BamHI F TTTGATATTTTTTTTTAGTTTT 
  R CCTAACACTTTCTCTTAATTT 
39 TaqI F GGATGTAGGTATTGATTAT 
  R ACCTACCAAACTTTACAA 
49 TaqI F GTGTATAGTTGGGTTTGTAGTG 
  R TAAAAAACTAAAATATCCCCTC 
54 MspI F TAGGATTGTGTTGTTTTTAGATTT 
  R CACCTATACCTTTCTCAACCA 
Igf2 according to (Arand et al. 2012).   
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 Supplementary Table 3: Antibodies used in this study 
Antibody Product Nr. Manufacturer 
Anti-5mC monoclonal antibody 33D3 Mab-081-100 Diagenode 
Anti-5-Carboxylcytosine antibody 61225 Active Motif 
Anti-Methylcytosine dioxygenase TET1 antibody 09-872 Millipore 
Anti-β-actin monoclonal ab8226 Abcam 
Anti-TET2 monoclonal  H. Leonhard 
Anti-AID monoclonal 4.26.1  S.K. Petersen-Mahrt 
Anti-Dnmt3b ab2851 Abcam 
Anti-TDG L58 polyclonal  our laboratory 
Anti-mouse Ig (horse radish peroxidase linked)  NXA931 GE Healthcare 
ECL™  Anti-rabbit IgG (HRP linked) NA934V GE Healthcare 
Anti-rat Ig (HRP linked) A9037-1ML Sigma 
 
The anti-TDG antibody used for ChIP was produced and affinity purified in our lab, for further 
information see (Neddermann et al. 1996; Hardeland et al. 2002). 
 
 
 
 
Supplementary Table 4: Primers used in ChIP, MeDIP, GLIB and caCDIP qPCR 
Primer 5’-3’  sequence 
neg. contr. F AGC ACA GCC TGA AGC CTC TA 
neg. contr. R ACA CAG CAT GGC ATC TTG AA 
DMR 54 F ACCCAGCAAAATCTCACCTG 
DMR 54 R GACACTGGACAGGGCTCCA 
DMR 39 F GAGCTGGATAGCCCTTGTAGAATG 
DMR 39 R TTGGCAGCGGAGGGAGCAG 
DMR 8 F CTGGCCACAGCTTTACCATC 
DMR 8 R AAGGACACTGAGCCAGAGGA 
DMR 49 F GCTGGGTTTGTAGTGGGAAC 
DMR 49 R GCAGGACCACACCTCACATC 
Nanog P_2 F GAGGATGCCCCCTAAGCTTTCCCTCCC 
Nanog P_2 R CCTCCTACCCTACCCACCCCCTATTCTCCC 
Oct4_PP F GTGAGGTGTCGGTGACCCAAGGCAG 
Oct4_PP R GGCGAGCGCTATCTGCCTGTGTC 
pHoxA10_T1 F CACTCCCAGTTTGGTTTCGT 
pHoxA10_T1 R GGGGGTACAGGTTCAAGAGC 
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F forward primer; R reverse primer. 
 
 
 
Supplementary Table 5: Primers used in quantitative RT-PCR  
Primer 5’-3’  sequence 
AID RT fw TTC GGC GCA TCC TTT TGC CCT 
AID RT rev GGC GGT CCT GTG CAG CTC AA 
β-actin RT fw CGT CGA CAA CGG CTC CGG CAT 
β-actin RT rev CCA CCA TCA CAC CCT GGT GCC TAG G 
B2m RT fw TCA CGC CAC CCA CCG GAG AA 
B2m RT rev TCT CGA TCC CAG TAG ACG GTC TTG G 
Gata6 RT fw TCG AAA CGC CGG TGC TCC AC 
Gata6 RT rev CCG TGA TGA AGG CAC GCG CT 
Nanog RT fw CCT TCC CTC GCC ATC ACA CTG ACA 
Nanog RT rev GAG GAA GGG CGA GGA GAG GCA GC 
Oct4 RT fw GTC CCC CAA GTT GGC GTG GAG 
Oct4 RT rev CAT GTC CTG GGA CTC CTC GGG AG 
Rex1 RT fw GGA CTA AGA GCT GGG ACA CG 
Rex1 RT rev TCC TGC TTT TTG GTC AGT GGT 
TBP RT fw CCT AAA GAC CAT TGC ACT TCG TG 
TBP RT rev ACT GAA AAT CAA CGC AGT TGT CC 
TET1 RT fw ACA CAC CTT GGG GCA GGA CCA 
TET1 RT rev TCT GAT CAC CCA CTT GGC GAC C 
TET2 RT fw GGA AGC AAG ATG GCT GCC CTG TA 
TET2 RT rev GAA TGA ATC CAG CAG CAC CGT CCC 
 
 
Arand, J., et al. (2012). "In vivo control of CpG and non-CpG DNA methylation by DNA 
methyltransferases." PLoS Genet 8(6): e1002750. 
Hardeland, U., et al. (2002). "Modification of the human thymine-DNA glycosylase by ubiquitin-like 
proteins facilitates enzymatic turnover." EMBO J 21(6): 1456-1464. 
Neddermann, P., et al. (1996). "Cloning and expression of human G/T mismatch-specific thymine-
DNA glycosylase." J Biol Chem 271(22): 12767-12774. 
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Abstract The base excision repair machinery protects
DNA in cells from the damaging effects of oxidation,
alkylation, and deamination; it is specialized to fix single-
base damage in the form of small chemical modifications.
Base modifications can be mutagenic and/or cytotoxic,
depending on how they interfere with the template function
of the DNA during replication and transcription. DNA
glycosylases play a key role in the elimination of such
DNA lesions; they recognize and excise damaged bases,
thereby initiating a repair process that restores the regular
DNA structure with high accuracy. All glycosylases share a
common mode of action for damage recognition; they flip
bases out of the DNA helix into a selective active site
pocket, the architecture of which permits a sensitive
detection of even minor base irregularities. Within the past
few years, it has become clear that nature has exploited this
ability to read the chemical structure of DNA bases for
purposes other than canonical DNA repair. DNA glyco-
sylases have been brought into context with molecular
processes relating to innate and adaptive immunity as well
as to the control of DNA methylation and epigenetic
stability. Here, we summarize the key structural and
mechanistic features of DNA glycosylases with a special
focus on the mammalian enzymes, and then review the
evidence for the newly emerging biological functions
beyond the protection of genome integrity.
Introduction
The integrity of genetic information is under constant threat
by the tendency of DNA to engage in chemical reactions in
its cellular environment. These can damage the DNA in
various ways, most frequently by oxidation, alkylation, or
deamination of the coding bases (Lindahl and Wood 1999).
Damage to DNA bases may affect their base-pairing
properties and, therefore, needs to be fixed to maintain the
template function of the DNA (Kunz et al. 2009a). Many
base lesions are pro-mutagenic, i.e., they give rise to
genetic mutations if not repaired. One such example is
7,8-dihydro-8-oxoguanine (8-oxoG), a frequent product of
DNA oxidation. 8-oxoG tends to base-pair with adenine,
thus giving rise to G•C to T•A transversion mutations.
Likewise, hydrolytic deamination of cytosine and 5-
methylcytosine (5-meC) gives rise to uracil and thymine
mispaired with guanine, respectively, causing C•G→T•A
transition mutations if not repaired. Alkylation can generate
a variety of DNA base lesions comprising O6-
methylguanine (6-meG), N7-methylguanine (7-meG), or
N3-methyladenine (3-meA). While 6-meG is pro-
mutagenic by its property to pair with thymine, 7-meG
and 3-meA block replicative DNA polymerases and are
therefore cytotoxic (Lindahl and Wood 1999).
These and many other forms of DNA base damage arise
in cells at least 10,000 times every day and only the
continuous action of specialized DNA repair systems can
prevent a rapid decay of genetic information. Single-base
lesions are eliminated by base excision repair (BER), a
pathway initiated by DNA glycosylases that recognize and
excise damaged bases. Base removal by a DNA glycosylase
generates a so-called apurinic/apyrimidinic site (AP-site) in
DNA, which is then further processed by specific AP-
endonuclease, DNA polymerase, and DNA ligase activities
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to restore the original DNA sequence (Fig. 1) (Almeida and
Sobol 2007). Accordingly, cells lacking DNA glycosylase
functions generally show increased levels of base damage in
their DNA, elevated mutation rates, and hypersensitivity to
specific DNA damaging agents. Surprisingly, however, the
phenotype of DNA glycosylase disruptions in mice is usually
rather moderate (reviewed in Robertson et al. 2009), the only
known exception being the thymine DNA glycosylase
(TDG), which was recently reported to be essential for
embryonic development in mouse (Cortazar et al. 2011;
Cortellino et al. 2011).
In this review, we will focus on the mammalian DNA
glycosylases, for which we will briefly summarize the key
structure–function concepts and discuss their role in the
repair of DNA base lesions. We will further elaborate on
their newly emerging functions beyond canonical DNA
repair, e.g., in innate and adaptive immunity and in DNA
methylation control.
DNA glycosylases—an ancient family of DNA repair
proteins
The consideration that cells must possess an ability to
remove uracil from DNA, which arises either by misincor-
poration of deoxyuridine monophosphate (dUMP) during
DNA replication or by hydrolytic deamination of cytosine,
led to the discovery of an enzyme capable of cleaving
uracil–deoxyribose bonds, the uracil N-glycosidase (Ung)
in Escherichia coli (Lindahl 1974). This finding was
followed by the isolation of many other DNA glycosylases
in species from all kingdoms of life. Eleven DNA
glycosylases have been identified in mammals and these
can be subdivided into four structurally distinct super-
families; the uracil DNA glycosylases (UDGs), the helix-
hairpin-helix (HhH) glycosylases, the 3-methyl-purine
glycosylase (MPG), and the endonuclease VIII-like (NEIL)
glycosylases (Table 1).
The uracil DNA glycosylases
E.coli Ung turned out to be the founding member of a large
superfamily of glycosylases, which now includes six
subfamilies, three of which are present in the eukarya.
Besides the UNG subfamily, these include the mismatch-
specific uracil DNA glycosylases (MUGs) (Gallinari and
Jiricny 1996) and the single-strand-specific monofunctional
uracil DNA glycosylases (SMUGs) (Haushalter et al.
1999). Despite a considerable amino-acid sequence diver-
gence, all UDGs share a common alpha–beta fold struc-
tured catalytic domain (Aravind and Koonin 2000).
Members of the UNG subfamily have been characterized
in organisms from bacteria and yeasts to humans and large
Fig. 1 The core pathway short-patch BER. The base-excision repair
pathway addresses single-base lesions (a). BER is initiated by a DNA
glycosylase, e.g., UNG, specifically recognizing and binding a base
lesion. Upon encountering a substrate base, e.g., uracil for UNG, the
glycosylase flips the base out of the base-stack into its catalytic site
pocket where specific contacts examine the substrate base and position
it for nucleophilic attack to the N-glycosidic bond (b). Release of the
substrate base results in an abasic site (c), which is further processed
by the AP-endonuclease, APE1, that cleaves the phosphate backbone
5’ to the abasic site, producing a 3’OH and a 5’deoxyribose-phosphate
moiety (5’dRP) (d). Polymerase β (Polβ) hydrolyzes the 5’dRP and
fills in the single nucleotide gap, which is subsequently sealed by the
DNA ligase III (LigIII), supported by the scaffold protein XRCC1 (e),
thus restoring the original base sequence (f). The increase of DNA
bending from UNG to Polβ might support the directionality of the
handover from one BER factor to the next
2 Chromosoma (2012) 121:1–20
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"eukaryotic" viruses. These are highly conserved both at the
amino-acid sequence and gene structure levels; the yeast
and human proteins share 40.3% amino-acid sequence
similarity and the human, mouse, and fish genes have
identical exon–intron boundaries, indicating that the exon–
intron organization has not changed for more than
450 million years (Krokan et al. 1997). Alternative splicing
as well as transcription from two distinct start sites gives
rise to the specific mitochondrial and nuclear isoforms
UNG1 and UNG2 in mouse and human cells (Nilsen et al.
1997). UNG is highly specific for processing of uracil in
DNA but also excises DNA-incorporated 5-fluorouracil (5-
FU), a uracil analog used in cancer therapy (Pettersen et al.
2011). Interactions with PCNA and RPA target the nuclear
UNG2 to sites of DNA synthesis, where its main function is
to rapidly excise uracil that gets incorporated opposite from
adenine (Otterlei et al. 1999). Accordingly, mouse cells
deficient in UNG accumulate ~100-fold increased levels of
uracil in their DNA but, notably, do not show a significant
mutator phenotype (Nilsen et al. 2000). This is unlike
human cells where inhibition of UNG appears to elevate the
mutation frequency mildly (Radany et al. 2000). However,
mice lacking Ung do develop B-cell lymphomas and show
disturbances of antibody diversification, implicating a
specific function of UNG in processing deamination-
induced U•G mismatches at immunoglobulin loci to
facilitate somatic hypermutation and class switch recombi-
nation (Rada et al. 2002; Nilsen et al. 2003). Consistently,
mutations in the human UNG gene have been associated
with a subgroup of hyper-IgM syndrome patients, showing
impaired class switch recombination (Imai et al. 2003).
The MUG subfamily of UDGs emerged with the identifi-
cation of TDG, an enzyme capable of excising thymine from
G•Tmismatches. Nonetheless, the family was named after the
E.coli Mug protein (Gallinari and Jiricny 1996), giving
credit to the fact that the G•U rather than the G•T mismatch
represents the common most efficiently processed substrate
for the members of this subfamily. MUG orthologs have
been described in Schizosaccharomyces pombe, Drosophila
melanogaster (Hardeland et al. 2003), and mammals
Table 1 Mammalian DNA glycosylases, their main substrates, modes of action, and mutant phenotypes
Type of base lesion Name Physiological
substrates
Mono
(M)/ bi(B)
functional
Mouse knockout (ko)/
knockdown (kd) phenotype
Uracil in ssDNA
dsDNA
UNG Uracil-N glycosylase U, 5-FU, ss and
dsDNA
M ko: viable, B-cell lymphomas,
disturbed antibody diversification
SMUG1 Single-strand-specific
monofunctional uracil
DNA glycosylase 1
U, 5–hmU, 5-FU,
ss and dsDNA
M kd: moderate increase in mutation
frequency (C→T)
Pyrimidine derivates
in mismatches
MBD4 Methyl-binding domain
glycosylase 4
T, U, 5-FU, εC,
opposite G, dsDNA
M ko: viable, elevated mutation
frequency (C→T)
TDG Thymine DNA
glycosylase
T, U, 5-FU, εC,
5-hmU, 5-fC, 5-caC;
opposite G, dsDNA
M ko: embryonic lethal, aberrant DNA
methylation and imbalanced
chromatin marks in CpG-rich
promoters
Oxidative base
damage
OGG1 8-OxoG DNA
glycosylase 1
8–oxoG, FaPy,
opposite C, dsDNA
B ko: viable, accumulation of 8-oxoG,
elevated mutation frequency (G→T)
MYH MutY homolog DNA
glycosylase
A opposite 8–oxoG, C
or G, 2–hA opposite
G, dsDNA
M ko: viable, see OGG1
Alkylated purines MPG Methylpurine
glycosylase
3–meA, 7-meG, 3-
meG, hypoxanthine,
εA, ss and dsDNA
M ko: viable, elevated levels of ethenoA
and hypoxanthine
Oxidized,
ring-fragmented
or –saturated
pyrimidines
NTHL1 Endonuclease III-like 1 Tg, FaPyG, 5-hC,
5-hU, dsDNA
B ko: viable
NEIL1 Endonuclease VIII-like
glycosylase 1
Tg, FaPyG, FaPyA,
8-oxoG, 5–hU, 5–
hC, ss and dsDNA
B ko: metabolic syndrome, increased
damage levels in mitochondrial DNA;
kd: hypersensitive to γ radiation
NEIL2 Endonuclease VIII-like
glycosylase 2
As NTHL1 and
NEIL1
B Unknown
NEIL3 Endonuclease VIII-like
glycosylase 3
FaPyG, FaPyA,
prefers ssDNA
B ko: normal
U, uracil; , A, adenine; , T, thymine; , C, cytosine, G, guanine; , ss single stranded; , ds, double stranded; , 5–hm, 5–hydroxymethyl; , 5-FU, 5-
fluorouracil; , ε, etheno; , 5-fC, 5-formylcytosine; , 5-caC, 5-carboxylcytosine; , 8–oxoG, 8–oxo-7,8-dihydroguanine; , Tg, thymine glycol; , FaPy,
2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine; , me, methyl; , h, hydroxyl
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(Neddermann et al. 1996). Crystal structural analyses
revealed a striking resemblance in the overall fold of the
glycosylase domains of E.coli Mug and Ung, despite the
absence of a notable sequence similarity (Barrett et al. 1998).
Unlike UNG, however, the MUG glycosylases have a
spacious and rather non-discriminating active site pocket,
accommodating a broad range of substrates including
pyrimidine derivates like 5-FU, 5-hydroxymethyluracil (5-
hmU), and 3,N4-ethenocytosine (Table 1) (reviewed in
Cortazar et al. 2007), and they process these substrates with
an extremely low turnover rate (Waters and Swann 1998;
Hardeland et al. 2000). Compared to E.coli Mug, which
consists of the catalytic core only, TDG contains additional
N- and C-terminal domains, providing non-specific DNA
interaction and regulatory functions (Hardeland et al. 2002;
Steinacher and Schär 2005; Baba et al. 2005). Knockout of
Tdg in mouse is embryonic lethal, suggesting that, unlike
other UDGs, it has a non-redundant essential function in
embryonic development (Cortazar et al. 2011; Cortellino et al.
2011). TDG-deficient cells do not show increased sensitivity
towards agents that would cause TDG-relevant DNA base
lesions, nor do they show increased levels of spontaneous
mutations (Cortazar et al. 2011), implicating functions
beyond canonical DNA repair, which will be discussed
below. An involvement of TDG in DNA repair becomes
obvious, however, in the processing of the anti-cancer drug
5-FU when incorporated into the DNA. In this special case,
the repair activity of TDG does not provide drug resistance
as might be expected; excision of the base analog by TDG
results in an accumulation of toxic AP-site intermediates and
DNA strand breaks and, thus, mediates the DNA-directed
cytotoxic effect of 5-FU (Kunz et al. 2009b).
SMUG-family glycosylases were initially identified as
a uracil-excising activity in Xenopus, insect, and human
cells (Haushalter et al. 1999). As such, it appears to serve
as back-up for UNG in limiting uracil accumulation (U•A)
in genomic DNA and in preventing C→T mutation
following cytosine deamination (U•G) (Haushalter et al.
1999; An et al. 2005). While Xenopus SMUG has a
preference for uracil in single-stranded DNA, hence the
name “single-strand-specific monofunctional uracil DNA
glycosylase”, the human homolog processes uracil also in
double-stranded DNA (Table 1) (Haushalter et al. 1999;
Kavli et al. 2002). SMUGs show only limited amino-acid
sequence similarity with members of other UDG sub-
families and the conservation seems restricted to catalytic
site residues, showing mosaic features of the UNG and
MUG enzymes. Crystallographic analysis of SMUG1
identified a pyrimidine binding pocket topologically
similar to other UDGs and implicated a water displace-
ment/replacement mechanism to account for the enzyme's
preference for uracil over thymine (Wibley et al. 2003).
Like TDG, SMUG1 is active on 5-FU but, unlike TDG,
appears to protect cells from the cytotoxic effects of the
drug as shown in siRNA knockdown experiments (An et
al. 2007). Notably, a 5-hmU DNA glycosylase activity
originally discovered in calf thymus was later identified as
SMUG1 (Cannon-Carlson et al. 1989; Boorstein et al.
2001). So, like TDG, SMUG1 is capable of processing the
deamination product of 5-hydroxymethylcytosine (5-
hmC), a substrate that has recently gained attention in
the context of active DNA demethylation.
Additional subfamilies of UDGs appear to have
evolved in archaeal and bacterial organisms thriving
under extreme environmental conditions such as high
temperature, favoring hydrolytic deamination of cytosine
and 5-meC. As these will not be further discussed here,
the reader is referred to the excellent classification of the
UDG superfamily originally published by Aravind and
Koonin (2000).
The helix-hairpin-helix glycosylases
The second superfamily of DNA glycosylases, charac-
terized by a shared helix-hairpin-helix (HhH) domain,
comprises a diverse group of enzymes present in
organisms throughout all kingdoms of life. Phylogenetic
analysis in 94 genomes from bacteria, archaea, and
eukaryotes identified six distinct families of HhH DNA
glycosylases: Nth (homologs of the E. coli EndoIII
protein), OggI (8-oxoG DNA glycosylase I), MutY/Mig
(A/G-mismatch-specific adenine glycosylase), AlkA
(alkyladenine-DNA glycosylase), MpgII (N-methylpur-
ine-DNA glycosylase II), and OggII (8-oxoG DNA
glycosylase II) (Denver et al. 2003). The Nth and MutY/
Mig family glycosylases as well as some of the MpgII
type proteins contain iron–sulfur [4Fe4S] clusters that are
thought to play a structural role in DNA binding and
substrate recognition (Cunningham et al. 1989; Kuo et al.
1992; Guan et al. 1998; Porello et al. 1998; Begley et al.
1999).
The founding member of the Nth family was originally
discovered as an endonuclease activity (EndoIII) in E.coli
(Radman 1976) but then turned out to be a DNA glycosylase
with an associated AP-lyase activity. Nth proteins appear to
be the most highly conserved subfamily within the HhH
glycosylases (Denver et al. 2003). The mammalian homolog,
NTHL1 (endonuclease III-like 1), acts on ring fragmented
purines or oxidized pyrimidine residues like thymine glycol
(Tg), formamidopyrimidine (FaPy), 5-hydroxycytosine (5-
hC), and 5-hydroxyuracil (5-hU), preferentially when placed
opposite guanine (Table 1) (Dizdaroglu et al. 1999; Eide et al.
2001). Nth1 knockout mice show no overt abnormalities
presumably because the loss of its repair function can be
compensated for by NEIL glycosylases (see below) (Ocampo
et al. 2002; Takao et al. 2002).
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MutY was first identified in E.coli as an enzyme
excising adenine from A•G mispairs (Au et al. 1988),
while Mig.Mth was discovered in hyperthermophilic
archaea by its ability to excise U or T mispaired with G
(Horst and Fritz 1996). MutY/Mig homologs are wide-
spread in bacterial genomes, but only about half of the
eukaryotes and less than a third of the archaeal species
analyzed have glycosylases of this family (Denver et al.
2003). The mammalian homolog of MutY, termed MYH,
excises adenine opposite 8-oxoG, guanine, or cytosine
(Table 1) (McGoldrick et al. 1995), contributing to a
multimodal defense against the mutability of guanine
oxidation (van Loon et al. 2010). Facilitating the replace-
ment of A opposite 8-oxoG with a C, MYH produces the
preferred substrate for the 8-oxoG directed DNA glyco-
sylase OGG1. Hence, disruption of Myh in mice does not
produce a mutator phenotype per se because it is masked
by OGG1, which corrects the bulk of oxidized guanines
before replicative DNA polymerases get a chance to
misinsert adenine opposite the damaged base. Knocking
out both Myh and Ogg1, however, results in a synergistic
increase in G→T mutations (Russo et al. 2004). In humans,
germline mutations in the MYH gene have been associated
with a predisposition to colorectal cancer (Al-Tassan et al.
2002; Jones et al. 2002).
The Ogg1 protein family is less well represented across
the phylogeny. While present in most eukaryotic genomes,
Ogg1 encoding genes seem to be missing in bacteria and
archaea (Denver et al. 2003). Ogg1 was originally
discovered in yeast and later also identified in mammals
(Nash et al. 1996; Lu et al. 1997; van der Kemp et al. 1996;
Radicella et al. 1997), where it provides the major activity for
the removal of 8-oxoG opposite cytosine (Friedberg et al.
2006). It does, however, also excise other oxidized pyrimi-
dines or ring-fragmented purines like formamidopyrimidine
(FaPy) (Table 1) (Dherin et al. 1999; Karahalil et al. 1998).
In Saccharomyces cerevisiae, inactivation of OGG1 results
in an accumulation of G→T transversion mutations
(Thomas et al. 1997). Ogg1 null mice are viable but
exhibit a 2-fold increase in chromosomal 8-oxoG and
moderately elevated spontaneous mutation frequencies
(Klungland et al. 1999). Polymorphisms in the human
OGG1 gene impairing the 8-oxoG incision activity were
found to be associated with non-small cell lung cancer (Janik
et al. 2011) and an increased risk of childhood acute
lymphoblastic leukemia (Stanczyk et al. 2011).
Although closely related to the Nth and MutY proteins,
MBD4, also known as MED1, is special in two ways; it has a
methyl-CpG binding domain (MBD) and is therefore also a
member of the MBD protein family, and it functionally
interacts with MLH1, a protein of the postreplicative
mismatch repair system (Hendrich and Bird 1998; Bellacosa
et al. 1999). Like the structurally unrelated TDG, MBD4 is a
mismatch-directed DNA glycosylase processing a wide
range of G-mispaired base lesions, including thymine, uracil,
5-FU, and 3,N4-ethenocytosine (Table 1) (Petronzelli et al.
2000; Cortellino et al. 2003). Its methyl-CpG binding
domain in addition to its activity on the deamination product
of 5-meC has made MBD4 a prime candidate for an active
DNA demethylase, an epigenetic function likely to be
important in embryogenesis. However, Mbd4 knockout mice
show no developmental defects, but a mild increase in C→T
mutation frequency and a predisposition to gastrointestinal
cancer in APC-deficient tumor models (Millar et al. 2002;
Wong et al. 2002), consistent with a role of MBD4 in repair
of cytosine or 5-meC deamination damage.
E.coli AlkA, the founding member of the AlkA family
of HhH glycosylases, acts on alkylated bases, e.g., 3-meA.
While homologs are present in many bacterial and
eukaryotic genomes (Denver et al. 2003), mammals appear
to be devoid of this particular class of enzyme. Instead, they
use a structurally unrelated enzyme, MPG, to eliminate
specific forms of base alkylation damage.
The 3-methyl-purine glycosylase (MPG)
MPG, also known as AAG or MDG, originally identified in
rat (O'Connor and Laval 1990) and later in human, is a
DNA glycosylase excising a range of alkylated bases from
DNA, including 3-meA, 7-meG, 3-methylguanine (3-meG)
as well as ethylated bases in single- and double-stranded
DNA (Table 1) (O'Connor 1993; Lee et al. 2009). MPGs
form a structurally distinct class of glycosylases; they lack
helix-hairpin-helix motifs nor do they have an alpha–beta
fold structure characteristic of UDGs. Mice lacking MPG are
viable and show a mild increase in the frequency of
spontaneous mutation (Engelward et al. 1997; Hang et al.
1997), and they are more prone to develop azoxymethane-
induced colon cancer than their wild-type counterparts (Wirtz
et al. 2010). Reminiscent of TDG’s role in the DNA-directed
cytotoxic effect of 5-FU, MPG drives alkylation-induced
retinal degeneration in mice by generating cytotoxic BER
intermediates (Meira et al. 2009).
The endonuclease VIII-like glycosylases
Although their substrate spectrum overlaps with that of
endonuclease III (Nth), the homologs of E. coli endonuclease
VIII, encoded by the nei gene, are structurally related to the
formamidopyrimidine-DNA glycosylase Fpg and form a
separate family of DNA glycosylases. Nei was discovered in
E. coli as a second activity next to Nth acting on thymine
glycol (Tg) and urea (Melamede et al. 1994).
The mammalian counterparts are termed Nei-like
(NEIL)1, 2, and 3, and share a conserved helix-two-turn-
helix motif with the E. coli Fpg and EndoVIII proteins. The
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preferred substrates of NEIL1 and NEIL2 are oxidized
pyrimidines such as Tg, 5-hC, FaPyA, and FaPyG (Hazra
et al. 2002; Morland et al. 2002; Rosenquist et al. 2003),
but also 5-hydroxyuracil (5-hU) and 8-oxoG in DNA
bubble structures (Table 1) (Dou et al. 2003). NEIL3, on
the other hand, excises FaPy but is inactive on 8-oxoG
(Liu et al. 2010). Mice with a targeted inactivation of the
Neil1 gene exhibit a phenotype reminiscent of the
metabolic syndrome, as well as increased levels of DNA
damage in mitochondrial DNA (Vartanian et al. 2006).
Neil3 knockout mice are viable and fertile, and the protein
appears to be preferentially expressed in hematopoietic
tissues (Torisu et al. 2005), implicating a possible function
in hematopoiesis or the immune system.
Structure function aspects
DNA glycosylases evolved to counter the many different
forms of chemical damage occurring to DNA bases. They
are highly specialized enzymes with distinct structures and
substrate specificities, but they all share a common
principle of action. DNA glycosylases recognize their
cognate substrates by rotating bases out of the DNA helix
into a specifically fitting pocket that harbors the active site.
Substrate selectivity is mostly achieved by steric exclusion
from the binding pocket of bases that are not to be
processed, and to some extent also by the catalytic
efficiency of the active site configuration. If base fitting is
successful, cleavage of the N-glycosidic bond will occur,
resulting in the release of a free base and the generation of a
base-less sugar, an AP-site in the DNA.
Detection and verification of base damage
Detecting a single damaged base in a vast excess of regular
bases in the genome amounts to the proverbial task of
searching a needle in a haystack, and this is not helped by
the fact that the lesions addressed by BER do not usually
cause notable distortions to the DNA helix. A human cell
suffers about 104 base lesions per day, translating into
roughly one lesion every 10 s within a genome of about
14 billion nucleotides that must be spotted and repaired.
How DNA glycosylases manage to efficiently search for
and recognize these lesions is not clear but biochemical and
structural work has provided some insight into possible
mechanisms.
Scanning the genome for damaged bases
Little is known about how DNA glycosylases find damaged
bases in the genome. One idea, proposed on the basis of
biochemical evidence and theoretical considerations, postu-
lates the association of the glycosylase with undamaged
DNA by non-specific interactions, facilitating sliding along
the DNA duplex for a certain distance and scanning the
sequence for irregular bases (Berg et al. 1981). Considering
the structural and functional diversity of DNA glycosylases,
however, there are likely to be different translocation
mechanisms, variably involving features of tracking, diffu-
sion, and hopping on the DNA (Blainey et al. 2009;
Steinacher and Schär 2005; Friedman and Stivers 2010).
Recently, an appealing DNA scanning concept was pro-
posed for DNA glycosylases harboring an [4Fe4S] cluster.
The underlying observation was that E. coli MutY and Nth
change the oxidation state of their iron–sulfur cluster from
[4Fe4S]2+ to [4Fe4S]3+ upon contact with DNA, which
stabilizes the interaction. Thus, if such DNA glycosylases
bind in the vicinity of each other, they might act as electron
donors and acceptors for each other, making use of the
DNA for charge transfer. This may facilitate the dissocia-
tion of one glycosylase upon binding of another by
reduction of its [4Fe4S] cluster. If the electron transfer
involved is perturbed by a base lesion between the two
glycosylases, however, both will stay bound to the DNA,
increasing the likelihood of damage detection (Boal et al.
2009). This way, [4Fe4S] clusters may support the search
for base damage without a need of scanning the entire DNA
sequence.
Detection of DNA base damage by DNA glycosylases
ultimately requires a full examination of the chemical
surface of single bases. To minimize the effort, DNA
glycosylases employ strategies of damage pre-selection.
OGG1 and UNG, for instance, were proposed to pre-select
substrates by establishing superficial base contacts through
conserved residues in close proximity to the mouth of their
catalytic pocket. This allows potential substrates to be
identified without fully inserting every base into the active
site pocket (Fig. 2) (Banerjee et al. 2005; Parker et al.
2007). Consistently, NMR studies on human UNG showed
the glycosylase to undergo a conformational change upon
DNA binding, allowing for oscillation between an open
form, loosely interacting with the DNA in an unspecific
manner, and a closed form engaged in base examination
without fully rotating the base out of the helix (Fig. 2)
(Friedman et al. 2009). Base pre-scanning is likely to be
facilitated by DNA breathing, considering that many base
lesions affect base pairing dynamics to some extent and are
therefore likely to enhance local DNA melting.
Formation of a mature enzyme substrate complex
For final damage verification, the base needs to be flipped
out of the DNA helix and accommodated in the active site
cavity of the glycosylase. This increases the surface for
molecular interactions, providing for a sensitive discrimi-
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nation of even minor base alterations and, ultimately,
catalysis of the base release. One of the best-studied
glycosylases with regard to damage recognition is UNG.
On its surface, UNG forms a positively charged groove that
accommodates the minor groove of the DNA and contains
the active site cavity. Upon encountering a uracil in DNA,
UNG uses a hydrophobic side chain of a conserved leucine
to push the uracil out of the base stack and insert it into the
catalytic pocket (Fig. 3). The same residue stabilizes the
double helix by occupying the vacated space (Mol et al.
Fig. 2 Mechanism of base removal by monofunctional and bifunc-
tional glycosylases. While all DNA glycosylases share a common
principle of action, they differ in details of damage search,
recognition, and excision. Among the monofunctional DNA glyco-
sylases, UNG searches for uracil in DNA by oscillating between an
open conformation, making unspecific contacts with the DNA, and a
closed conformation for base-interrogation (a), involving conserved
structures at the mouth of the catalytic site pocket (b). Pre-selected
bases are flipped out of the DNA duplex and inserted into the catalytic
pocket, where specific hydrogen bonds align the base for nucleophilic
attack by an activated water molecule strategically positioned by a
conserved aspartic acid residue (red asterisk, c). TDG differs from
UNG by its non-specific interaction with DNA through a clamp
formed by the N-terminal domain (a), its larger catalytic pocket that
accommodates a broader range of substrates, and its ability to involve
the opposing base in lesion recognition (b). The catalytic residue in
TDG is an asparagine (black asterisk) that positions, but does not
activate, a water molecule which can then act as a weak nucleophile
(c). TDG stays firmly bound to the abasic site upon base release (d)
until SUMOylation induces dissociation by neutralizing the N-
terminal DNA binding activity (e). Similar to UNG, the bifunctional
OGG1 pre-selects bases for flipping by interactions with conserved
amino-acid residues at the mouth of the catalytic cavity (a, b), and
similar to TDG, it also takes the opposing base into account for
substrate selection (c). Bifunctional glycosylases use a conserved
amino-acid residue (blue asterisk) for nucleophilic attack, which
results in a covalent intermediate between the glycosylase and the
DNA substrate (d). Resolution of this intermediate produces a DNA
nick that is further processed by APE1 (e)
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1995; Savva et al. 1995). At the same time, UNG pinches and
compresses the double-stranded DNA backbone, thereby
inducing DNA bending by about 45° at the site of the damage
(Fig. 1) (Parikh et al. 1998). Selectivity for uracil is mediated
by several structural features: purine bases are sterically
excluded from the active site by the overall narrow geometry
of the binding pocket, while the entry of thymine and other 5-
methylated pyrimidines is blocked by a side chain of a
conserved tyrosine residue. Accordingly, UNG can be
converted into a thymine-processing enzyme by an amino
acid substitution that eliminates this sterical block (Kavli et al.
1996). Cytosine can enter the active site but, due to
unfavorable hydrogen bonding at the bottom of the cavity,
cannot be positioned correctly for catalysis (Kavli et al. 1996;
Slupphaug et al. 1996).
While UNG is highly specialized to the excision of DNA
uracil, TDG is a good example of a broad spectrum UDG
showing mismatch dependency. Unlike UNG, the bacterial
and human TDG orthologs have rather spacious pyrimidine-
binding pockets, accommodating a large variety of base
derivatives (Barrett et al. 1998, 1999; Baba et al. 2005; Maiti
et al. 2008), although the preferred substrates are G-
mismatched deaminated pyrimidines (Waters and Swann
1998; Hardeland et al. 2003). Because TDG acts on thymine,
it needs to be able to discriminate between a regular thymine
in DNA (A•T) and one that resulted from deamination of 5-
meC (G•T). Substrate selection thus has to take into account
not only the base structure itself but also the opposite base.
Structural and biochemical studies of E.coliMug and human
TDG (Barrett et al. 1998; Maiti et al. 2008, 2009) have shed
light on how this might be achieved. In contact with DNA,
TDG undergoes a conformational change in its N-terminal
domain, forming a clamp-like structure that permits TDG to
track along the DNA (Fig. 2) (Steinacher and Schär 2005).
Upon encountering a G-mismatched substrate (G•T), the
substrate base is pushed out of the DNA helix by an insertion
loop wedging into the DNA helix. This same wedge
stabilizes the base stack and forms specific hydrogen bonds
with the widowed guanine, mimicking Watson–Crick base
pairing (Barrett et al. 1998, 1999; Maiti et al. 2008). These
interactions then cooperate with the non-specific DNA
binding activity of the N terminus to stabilize the TDG–
substrate complex for efficient base excision (Hardeland et al.
2000; Steinacher and Schär 2005).
Another DNA glycosylase well studied with regard to
damage recognition is OGG1. Following successful pre-
selection of a potential 8-oxoG substrate (Fig. 2) (Banerjee
et al. 2005), the oxidized base is flipped into the active site
cavity of OGG1, inducingDNAbending of about ~70° due to a
tyrosine residue that wedges between the opposing C and its 5′
neighbor. Unstacking of the widowed C facilitates enzyme–
DNA contacts that maintain opposite base selectivity. The void
generated by 8-oxoG rotation is occupied by a conserved
asparagine residue, which contributes to hydrogen bonding
with the opposing cytosine. While A, C, and T are excluded
from the active site pocket by several strategically positioned
amino-acids, a conserved glycine is the only residue discrim-
inating between G and 8-oxoG (Bruner et al. 2000).
Catalysis of base removal
The catalytic mechanism subdivides DNA glycosylases into
monofunctional and bifunctional enzymes (Table 1). Mono-
functional glycosylases perform base excision only, using
an activated water molecule for nucleophilic attack on the
N-glycosidic bond, while bifunctional glycosylases use an
amino group of a lysine side chain for the same purpose,
forming a Schiff-base intermediate, and subsequently
cleave the DNA backbone 3′ to the lesion.
Monofunctional DNA glycosylases
To illustrate the monofunctional mode of action, we will
focus on UNG and TDG as two well-studied UDGs
Fig. 3 The base-flipping
intermediate captured in a crystal
structure of substrate bound
human UNG. The UNG double
mutant L272R/D145N, stabilizing
the glycosylase–substrate
complex, was co-crystallized with
an oligonucleotide bearing a U•G
mismatch. Uracil (red) is flipped
into an extrahelical position (a)
and inserted deeply into the tight
fitting active site pocket of UNG
(b), where it is positioned by
specific molecular interactions for
the nucleophilic attack on the
N-glycosidic bond (Slupphaug
et al. 1996)
8 Chromosoma (2012) 121:1–20
Appendix IV
showing contrasting catalytic features. Upon recognition,
uracil is tightly fitted into the active site pocket of UNG
(Fig. 3). Interactions between the uracil and amino-acid
residues at the bottom of the pocket position the N-glycosidic
bond for hydrolysis (Mol et al. 1995; Savva et al. 1995;
Slupphaug et al. 1996). Structure and mutational analyses
have established a catalytic mechanism involving the
polarization of the N-glycosidic bond by a conserved
histidine to make it susceptible for nucleophilic attack, and
the positioning and deprotonation of a water molecule by a
conserved catalytic aspartate, which then attacks the C1 of
the deoxyribose (Fig. 2) (Mol et al. 1995; Slupphaug et al.
1996). N-glycosidic bond cleavage is completed by addition
of the water nucleophile to uracil, resulting in a free base and
an AP-site.
The mismatch-specific uracil glycosylases, e.g., Mug
and TDG, interact less specifically with the substrate
base within the catalytic pocket and use a less potent
mechanism of catalysis, as first revealed in the crystal
structure of E.coli Mug (Barrett et al. 1998, 1999). In
place of the catalytic aspartate in UNG, Mug/TDG
enzymes have an asparagine. This asparagine positions a
water molecule but, unlike the aspartate in UNG, is
unable to protonate it for an efficient nucleophilic attack
on the N-glycosidic bond (Fig. 2). Also, an appropriate
residue for polarization of the N-glycosidic bond appears
to be missing in Mug/TDG, altogether explaining the
comparably low catalytic efficiency of the MUG enzymes
(Hardeland et al. 2000; Maiti et al. 2009). These differ-
ences illustrate that the mode of catalysis can vary
considerably even within one DNA glycosylase super-
family, most likely reflecting the requirement to fine tune
substrate spectrum and catalytic efficiency in the evolu-
tion of subfamilies with distinct biological functions.
Bifunctional DNA glycosylases
DNA glycosylases that use an amino group of a lysine
side chain as a nucleophile for base cleavage form a
covalent Schiff-base intermediate with the substrate. The
resolution of this reaction intermediate incises the DNA
3′ to the product AP-site, generating a strand break with
3′phosphate and 5′OH ends. Thus, these enzymes couple
base excision with an AP-lyase step, as best illustrated
by the bifunctional mechanism proposed for OGG1 (Sun
et al. 1995; Nash et al. 1997). Once an 8-oxoG is stably
fitted in the active site cavity of OGG1, the side chain amino
group of a suitably positioned catalytic lysine is activated as a
nucleophile to attack the C1 of the deoxyribose. The resulting
rearrangement to a covalent Schiff-base intermediate releases
the damaged base from the DNA, which is then held in
position to further participate in the catalysis of the β-lyase
reaction, cleaving the DNA strand at the 3′phosphate. Notably,
all steps of the OGG1 catalyzed base release involve the
transfer of protons and this is promoted by the excised base
itself (Bruner et al. 2000; Fromme et al. 2003). An interesting
variation on the bifunctional mode of action is displayed by
the mammalian NEIL proteins and their E.coli counterpart
Nei. These enzymes couple base excision to beta and delta
elimination, incising the DNA strand both 3′ and 5′ to the
AP-site (Takao et al. 2002). Moreover, unlike OGG1, E. coli
Nei ejects the excised base from the catalytic site immedi-
ately, i.e., is capable to perform the AP-lyase reaction without
contribution of the damaged base (Zharkov et al. 2002).
AP-site dissociation and turnover of glycosylases
Upon base release, DNA glycosylases tend to stay bound to
the product of their action, the AP-site. In fact, many
glycosylases display a higher affinity to AP-sites than to
their actual substrate base (Parikh et al. 1998; Waters et al.
1999; Hardeland et al. 2000; Hill et al. 2001; Pope et al.
2002). The release of the glycosylase from the AP-site is
thus rate limiting in the BER process (Fig. 1). Since AP-
sites are chemically unstable and lack base coding potential,
the binding of the glycosylase might serve to protect cells
against their cytotoxic and mutagenic effects. This consid-
ered, it appears reasonable that the release of the AP-site is
coordinated with the recruitment and assembly of the
downstream acting BER factors. Consistently, the AP-
endonuclease APE1 was reported to stimulate the turnover
of several DNA glycosylases including UNG2, TDG, and
OGG1 (Parikh et al. 1998; Waters et al. 1999; Hill et al.
2001), and a similar effect was observed for the XPC
protein on TDG and SMUG1 (Shimizu et al. 2003, 2010).
It remains to be clarified, though, to what extent these
stimulatory effects reflect active processes or simply a
passive competition for a common DNA substrate.
Another, perhaps more sophisticated, way to regulate
AP-site interaction of the glycosylase is by posttransla-
tional modification. In this direction, UNG2 was reported
to be cell cycle specifically phosphorylated at serine 23,
which markedly increases its association with replicating
chromatin but also its turnover rate, apparently to
facilitate efficient correction of misincorporated uracil
during ongoing DNA replication (Hagen et al. 2008). In
the case of TDG, which binds AP-sites very rigidly,
dissociation is regulated by modification of a C-terminal
lysine residue with small ubiquitin-like modifiers
(SUMOs). This induces a conformational change that
neutralizes the non-specific DNA-binding capacity of its
N-terminal domain, thereby facilitating AP-site dissocia-
tion (Fig. 2) (Hardeland et al. 2002; Steinacher and Schär
2005). SUMO modification might be triggered by the
presence of downstream acting BER factors, providing for
a controlled handover of the AP-site intermediate in the
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repair process (R. Steinacher and P. Schär, unpublished
data).
It appears to be a general feature of DNA glycosylases to
bend DNA upon establishing a mature enzyme–substrate
complex; UNG for example induces a bend of ~45° (Parikh
et al. 1998), OGG1 of even ~70° (Bruner et al. 2000). On the
basis of these and similar observations with other BER
factors, it was proposed that the DNA bending might serve as
a structural determinant to orchestrate the handover from one
step in the repair process to the next (Fig. 1) (Parikh et al.
1999; Wilson and Kunkel 2000).
Functions of DNA glycosylases beyond DNA repair
Although DNA glycosylases are optimally suited for the repair
of damaged DNA bases, their structural and biochemical
properties would support a much wider spectrum of genetic
functions. The ability to recognize and excise chemically
modified bases can be used to edit the DNA at specifically
marked sites. The UDG superfamily in particular appears to
comprise enzymes with specialized functions, e.g., in innate
immunity and antibody diversification, as well as in the
regulation of gene expression and epigenetic maintenance.
DNA glycosylases in immunity
UDGs haven been functionally associated with mechanisms
providing innate immunity against viral infection as well as
antibody diversity in the adaptive immune system. All these
processes are triggered by enzymatic deamination of
cytosine by members of the apolipoprotein B mRNA
editing catalytic polypeptide (APOBEC) family of proteins,
including the activation-induced cytidine deaminase (AID)
(Conticello et al. 2005).
DNA glycosylases providing innate immunity
Proteins of the human APOBEC3 subfamily were shown to
inhibit replication of a variety of retroviruses, including
human immunodeficiency viruses (HIV) (reviewed in
Holmes et al. 2007). APOBEC3G was discovered by its
ability to restrict replication of a mutant HIV-1 lacking the
viral infectivity factor (Vif) (Sheehy et al. 2003). Cells
infected with such a virus package APOBEC3G into HIV-1
virions. When these infect new cells, APOBEC3G will
deaminate multiple cytosines in the viral cDNA during
reverse transcription, which inactivates the provirus
(reviewed in Holmes et al. 2007). While APOBEC3G
appears to intervene with the viral life cycle at several steps,
the antiviral activity mediated by uracilation of the viral
genome is coupled to the action of UNG2 and APE1.
UNG2 is thought to introduce AP-sites into the deaminated
viral cDNA, triggering the cleavage and thus degradation by
APE1 (Harris et al. 2003; Yang et al. 2007). Consistently,
inhibition and/or downregulation of either UNG2 or APE1
was shown to decrease the antiviral potency of APOBEC3G
(Yang et al. 2007). Given that HIV-1 evolved Vpr, a small
protein specifically targeting UNG2 and SMUG1 for
degradation by the ubiquitin–proteasome system, supports a
critical role of uracil base excision in antiviral defense
(Schrofelbauer et al. 2005, 2007).
DNA glycosylases providing adaptive immunity
The cooperation of cytidine deaminase and UDG activities is
also central to the genetic transactions associated with
antibody diversification in the adaptive immune system, i.e.,
somatic hypermutation (SHM) and class switch recombina-
tion (CSR) (Fig. 4) (Muramatsu et al. 2000; Rada et al.
2002).
SHM introduces point mutations in the light chain
variable (V) region of immunoglobulin loci. Mutagenesis
is initiated by AID, which is targeted to these loci to
deaminate multiple cytosines in single-stranded DNA
occurring during transcription (reviewed in Pavri and
Nussenzweig 2011). Mutations can arise from these U•G
mismatches in several ways (Fig. 4): (1) in the absence of
uracil excision, replication across the U•G mismatch would
generate a C→T mutation in one of the daughter strands;
(2) uracil excision by a UDG and subsequent replication
across the resulting AP-site can potentially give rise to any
type of base substitution at the site of deamination,
although replicative DNA polymerases preferentially insert
A opposite an AP-site; (3) long-patch BER, initiated by a
UDG, or MMR coupled to error-prone DNA synthesis
would cause mutations in proximity to the deaminated
cytosine, allowing for mutations to occur also at A•T base
pairs.
An involvement of UNG2 in antibody diversification
was first implicated by a general perturbance of both SHM
and CSR in an UNG2 inhibited chicken B-cell line as well
as in UNG-deficient mice (Di Noia and Neuberger 2002;
Rada et al. 2002). While the loss of UNG mainly affected
SHM at G•C base pairs, inactivation of the mismatch repair
system (MMR) was found to diminish hypermutation
at A•T pairs (Rada et al. 1998; Wiesendanger et al. 2000).
This suggested that error prone MMR contributes to muta-
genesis at sites away from the deaminated cytosine (Wilson et
al. 2005). Later work then implicated that MMR can indeed
operate at an AID induced G•U mismatch if assisted by
UNG2, providing a nick at a nearby G•U for initiation of
strand excision (Frieder et al. 2009; Schanz et al. 2009).
AID, UNG2, and APE1 were also shown to play a
crucial role in the initiation of CSR, a specialized
recombination process switching the Ig isotype of an
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Fig. 4 Uracil DNA glycosylase in antibody diversification. UNG
plays a central role in somatic hypermutation (SHM) and class switch
recombination (CSR). UNG2 is targeted to immunoglobulin loci in
activated B-cells by AID converting cytosine to uracil in single-
stranded DNA during transcription. While replication across unpro-
cessed uracil itself will generate C→T mutations, uracil excision by
UNG provides for a wider range of mutations both at the C•G and
nearby A•T base pairs; (1) by generating non-instructive AP-sites
which, upon DNA replication give rise to transition or transversion
mutations, (2) by initiating long-patch BER or, (3) following cleavage
by APE1, by providing a DNA strand nick for activation of MMR.
Error-prone synthesis associated with long-patch BER and MMR
would then produce mutations at A•T base pairs. Similarly, DNA
strand breaks occurring through BER of deaminated cytosines in
switch regions of immunoglobulin heavy chain loci may induce CSR
(blue panel)
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antibody without affecting its antigen specificity. CSR
rearranges the antibody constant region of heavy chain
genes (CH) by strand breakage in and joining of two
selected switch (S) regions located upstream of every CH-
coding segment. The DNA strand breaks required for
initiation of CSR were shown to arise through cytosine
deamination, subsequent uracil excision, and AP-site
cleavage by AID, UNG2, and an AP-endonuclease,
respectively (Fig. 4) (Imai et al. 2003). Consistently, murine
B-cells lacking UNG2 show a severe reduction of CSR and
in humans, recessive mutations in the UNG gene have been
associated with the hyper-IgM syndrome caused by a
deficiency in CSR (Rada et al. 2002; Imai et al. 2003). It is
also reported, however, that the catalytic activity of UNG2 is
dispensable for efficient CSR, while an N-terminal sequence
motif appears to be important, suggesting that UNG2 is not
responsible for the DNA cleavage step of CSR (Begum et al.
2007, 2009). It is possible that UNG2 simply marks AID-
induced G•U mismatches for further processing by other
factors, whereby the N terminus is required to mediate
specific protein–protein interactions.
Residual CSR and SHM in UNG2-deficient mice hint at
a possible contribution of other UDGs. Indeed, over-
expression of SMUG1 in MSH2 UNG2 double-deficient
cells could partially restore SHM and CSR. A biological
role of SMUG1 in antibody diversification, however, is
questionable as it is downregulated upon B-cell activation
(Di Noia et al. 2006). Likewise, the U•G mismatch-directed
glycosylase MBD4 is unlikely to play a major role in either
SHM or CSR as a knockout of the gene in mouse showed
no effect on either processes (Bardwell et al. 2003). The
situation is less clear for TDG. While the impact of a TDG-
deficiency on antibody diversification remains to be
investigated, its upregulation in activated mouse B-cells
hints at a specific function in B-cell maturation (Christophe
Kunz and Primo Schär, unpublished data). In this context,
TDG might be simply required to prevent mutations at non-
Ig genes arising from mistargeted AID. It might, however,
also directly contribute to SHM and CSR. Considering its
tight interaction with AP-sites, TDG would be optimally
suited to delay processing of these repair intermediates,
thereby favoring error-prone translesion synthesis and
recombination repair.
DNA glycosylases in DNA methylation control
Distinct patterns of DNA methylation and histone mod-
ifications are established during cell lineage restriction to
determine and maintain cell-type-specific gene expression
programs. In mammals, DNA methylation occurs mainly in
the form of 5-meC in CpG dinucleotide sequences and is
controlled by a methylation machinery consisting of both
methylating and demethylating components. While the de
novo establishment and the maintenance of CpG methylation
can be rationalized by the biochemical features of the DNA
methyltransferase (DNMT) activities involved (Hermann et al.
2004), the reverse process of demethylation has remained
elusive. In principle, however, DNA demethylation can be
achieved through active and/or passive mechanisms. Whereas
passive demethylation occurs upon DNA replication with
downregulation or inhibition of the maintenance DNA
methyltransferase, active demethylation describes the enzy-
matic removal of 5-meC and replacement with C. Active
mechanisms have been implicated in several important
biological processes, including the demethylation of the
paternal pronucleus in the murine zygote (Mayer et al.
2000; Oswald et al. 2000), the genome-wide methylation
erasure and reset of parental imprinting during gametogenesis
(Monk et al. 1987; Kafri et al. 1992), and the reprogramming
of methylation patterns observed after transfer of somatic cell
nuclei to enucleated oocytes (Dean et al. 2001; Simonsson
and Gurdon 2004). Active demethylation has also been
reported to be targeted to select gene regulatory regions
during neurogenesis, memory formation, and immune re-
sponse (Bruniquel and Schwartz 2003; Miller and Sweatt
2007; Ma et al. 2009).
Mechanistically, the conversion of 5-meC to C in DNA
can occur in different ways: (1) by a direct removal of the
methyl group, (2) the replacement of 5-meC with C by
excision repair, or (3) the deamination or oxidation of 5-
meC followed by replacement of the nucleotide by BER.
Consistent with an excision repair scenario, an increasing
number of observations point at an engagement of DNA
glycosylases in active demethylation. In plants, the removal
of 5-meC by at least four bifunctional DNA glycosylases is
well established; ROS1, DEMETER (DME), and the DME-
like (DML) 2 and 3 all process 5-meC in CpG and non-
CpG sequence contexts (reviewed in Zhu 2009). Mutations
in these glycosylases affect cytosine methylation at specific
loci but not in the overall genome, suggesting that they act
in a targeted rather than a global manner (Penterman et al.
2007; Lister et al. 2008). In vertebrates, the situation is less
clear; MBD4 and TDG have been implicated in DNA
demethylation but they do not seem to be potent enough to
excise 5-meC directly.
Concepts of DNA glycosylase-mediated demethylation
in vertebrates
First evidence for an involvement of DNA glycosylases in
active demethylation in vertebrates came with the discovery
of a 5-meC DNA glycosylase activity in extracts of chicken
embryos (Jost et al. 1995). The responsible enzyme later
revealed itself as a homolog of the human TDG (Zhu et al.
2000b). 5-meC DNA glycosylase activity was then also
reported for the human TDG and MBD4 proteins by the
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same group (Zhu et al. 2000a, 2001). Yet, as several
attempts to reproduce these finding were unsuccessful, the
idea of TDG and MBD4 acting as demethylating glyco-
sylases did not achieve broad acceptance. Recent observa-
tions, however, indicate that the difficulty in reproduction
might lie in the necessity of unknown co-factors that either
boost the catalytic efficiency of these glycosylases or
convert 5-meC into a more favorable substrate.
MBD4 was recently reported to control CpG methylation
in the context of parathyroid (PTH) hormone-induced gene
activation. This was shown for the CYP27B1 promoter,
which undergoes active demethylation upon hormone
stimulation (Kim et al. 2009). Both promoter activation
and cytosine demethylation coincided with and depended on
the physical association of MBD4 and downstream BER
factors, but not of the functionally related TDG. Remarkably,
this study further showed that phosphorylation of MBD4 by
PKC may potentiate its activity to process 5-meC, suggesting
that posttranslational modification might be required to
unleash a potentially harmful but dormant 5-meC glycosylase
activity in certain DNA glycosylases for targeted demethyla-
tion under specific conditions (Fig. 5a). This might apply as
well to TDG, given its propensity to posttranslational
modification by SUMOylation (Hardeland et al. 2002),
ubiquitylation (Hardeland et al. 2007), phosphorylation
(Um et al. 1998), and acetylation (Tini et al. 2002). It will
thus be necessary to revisit TDG's activity as a 5-meC
glycosylase under conditions that support the formation of
these posttranslational modifications.
Other lines of investigation support demethylation
scenarios that involve the conversion of 5-meC to more
favorable substrates for DNA glycosylases. Deamination of
5-meC by a cytidine deaminase is one possibility. This
would generate a G•T mismatch that can be acted on by
Fig. 5 Possible pathways of active DNA demethylation involving
BER. Enzymatic removal of 5-meC has been suggested to be
accomplished by different DNA glycosylase mediated mechanisms.
Direct excision of 5-meC by mammalian DNA glycosylases has been
tested with contradicting results, suggesting the possibility that
posttranslational modification might induce a shift in the substrate
spectrum, allowing for the removal of 5-meC. (a) Another possibility
is the enzymatic conversion of 5-meC to substrates more favorable to
DNA glycosylases, such as deamination to thymine (b), hydroxylation
to 5-hydroxymethylcytosine (c) and/or further oxidation or deamina-
tion of 5-hmC to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-
caC) (d) or 5-hydroxymethyluracil (e), respectively. All these
processes could be accomplished by a cooperation of 5-meC
deaminases like AID, hydroxylases like the TET proteins, and DNA
glycosylases like TDG (G•T, G•5hmU, G•fC, G•caC), MBD4 (G•T, ?)
and possibly SMUG1 (G•T, G•5hmU, ?)
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MBD4 or TDG (Fig. 5b). Along these lines, it was shown
that the estrogen responsive pS2/TFF1 promoter undergoes
cyclic DNA methylation and demethylation during tran-
scriptional activation, involving 5-meC deamination by the
methyltransferase Dnmt3a/b itself and subsequent TDG-
dependent BER (Metivier et al. 2008; Kangaspeska et al.
2008). The demethylation complex also includes the RNA
helicase p68, implicating an RNA component in either
targeting and/or stabilization of the complex, consistent
with previously reported observations on the chicken 5-
methylcytosine DNA glycosylase (Jost et al. 1997; Schwarz
et al. 2000). Additional support for a deamination-coupled
demethylation pathway came from a study in zebrafish
embryos, implicating AID in the deamination of 5-meC and
MBD4 in the excision of the resulting G•T mismatch, as
well as Gadd45 as an auxiliary factor (Rai et al. 2008). The
same concept was adopted more recently to explain TDG-
mediated 5-meC demethylation as it may occur during
somatic differentiation of the developing mouse embryo
(Cortellino et al. 2011). This, however, was mainly inferred
from the co-immunoprecipitation of overexpressed AID and
Gadd45 with TDG and therefore needs to be corroborated by
more direct functional evidence. Finally, an AID-dependent
and, thus, deamination-mediated mechanism has been associ-
ated with global DNA demethylation occurring in primordial
germ cells as well as during the reprogramming of somatic cell
nuclei towards pluripotency (Bhutani et al. 2010; Popp et al.
2010). Obviously, genome-wide 5-meC deamination would
generate massive amounts of G•T mismatches, and all of
these would have to be repaired by the G•T-directed DNA
glycosylases MBD4 or TDG. A strong prediction of a
deamination-based demethylation model is therefore that a
failure of G•T repair would result in genome-wide C→T
mutagenesis. This has not been observed so far in MBD4
and/or TDG-deficient cells (Cortazar et al. 2011) and will
have to be tested more carefully.
The recent discovery of DNA dioxygenases acting on 5-
meC in DNA introduced another conceptual framework for
active demethylation. The principle of oxidative demethy-
lation of DNA bases was first described for the bacterial
DNA repair protein AlkB. AlkB belongs to a large
superfamily of Fe(II)/2-oxoglutarate (2-OG)-dependent
hydroxylases and catalyzes the hydroxylation of N-
methylated bases like 1-methyladenine (1-meA) and 3-
methylcytosine (3-meC), ultimately resulting in demethylation
upon release of the hydroxymethyl moiety as formaldehyde
(Falnes et al. 2002; Trewick et al. 2002). The superfamily of
Fe(II)/2-OG hydroxylases also contains the kinetoplastid
base J binding proteins (JBP). Base J stands for β-D-
glucosyl(hydroxymethyl)uracil, an abundant base in the
genome of kinetoplastida, synthesized through a 5-hmU
intermediate generated by enzymatic hydroxylation of thy-
mine by JBP1/2 (reviewed in Borst and Sabatini 2008).
Computational analyses identified the mammalian oncogenic
TET proteins as close relatives of the JBPs (Iyer et al. 2009).
The ultimate finding that TETs comprise a catalytic domain
capable of catalyzing the oxidation of 5-meC to 5-hmC
uncovered a functional link between these proteins and DNA
methylation, possibly demethylation (Tahiliani et al. 2009; Ito
et al. 2010). Indeed, 5-hmC was suggested to trigger passive
demethylation through inhibition of the maintenance methyl-
transferase DNMT1 (Valinluck and Sowers 2007). Besides
that, 5-hmC might represent an intermediate of active DNA
demethylation through stepwise oxidation of 5-meC coupled
to either excision repair or decarboxylation (Fig. 5d).
Direct excision of 5-hmC by a DNA glycosylase would
seem a plausible scenario (Fig. 5c). A 5-hmC DNA
glycosylase was reported to be active in calf thymus
extracts (Cannon et al. 1988). The responsible protein,
however, has never been purified, nor has 5-hmC glyco-
sylases activity been associated with any known mamma-
lian DNA glycosylase. Given their activity on 5-hmU, TDG
and SMUG1 would seem good candidates for 5-hmC
processing, but recent evidence shows that at least TDG
fails to do so at an appreciable rate (He et al. 2011; Maiti
and Drohat 2011). Thus, while direct 5-hmC excision by
DNA glycosylases may occur and contribute to DNA
demethylation, the underlying enzymatic pathway remains
to be clarified.
Another possible route of demethylation would be the
further conversion of 5-hmC to an intermediate for DNA
glycosylase mediated excision. The deamination of 5-hmC
by a specific deaminase (e.g., AID), for example, would
give rise to 5-hmU mismatched with G (Rusmintratip and
Sowers 2000), which is a substrate for SMUG1 and TDG
(Fig. 5e) (Boorstein et al. 2001; Hardeland et al. 2003;
Cortellino et al. 2011). As discussed above for 5-meC
deamination, however, the concept of demethylation
through a pro-mutagenic 5-hmU intermediate is debatable
as this would require an immensely efficient and accurate
coupling of the deamination and repair processes, particu-
larly in densely methylated DNA sequences, if genome
integrity is to be maintained.
Less problematic in this regard seems a more recently
implicated mode of TET-mediated demethylation. The key
discovery was that TET proteins do not only generate 5-
hmC but can oxidize this intermediate further to 5-
formylcytosine (5-fC), and 5-carboxylcytosine (5-caC) (Ito
et al. 2011), which are good substrates for excision by TDG
(He et al. 2011; Maiti and Drohat 2011) (Fig. 5d). Given
this, a DNA glycosylase-mediated conversion of 5-meC to
C may thus occur without a need to deaminate, i.e., to
generate a mutagenic intermediate. However, such a
pathway would still trigger massive DNA incision activity
in the context of genome-wide active demethylation, which
seems a genetically risky and energetically wasteful way to
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erase an epigenetic mark. A more straightforward way to
eliminate 5-caC under these conditions would be to couple
the 5-meC oxidation cascade with a decarboxylation step to
generate C and CO2 as final products. A 5-caC decarbox-
ylase is thus an activity to watch out for.
G•T-directed DNA glycosylases and epigenetic stability
Active demethylation of 5-meC in mammalian cells occurs
under different circumstances for different purposes, such
as genome-wide epigenetic reprogramming, activation of
tissue-specific genes during embryogenesis, and the main-
tenance of active and bivalent chromatin states during and
after cell-lineage commitment. These circumstances gener-
ate specific demands for a demethylation mechanism (e.g.,
targeting, catalysis, processivity, efficiency) which are most
likely addressed by distinct pathways.
Any of the above considered routes of DNA repair-
mediated active demethylation of 5-meC requires an
enzyme capable of recognizing and excising a cytosine
derivative (5-meC, 5-hmC, 5-caC, T, 5-hmU) in a base
(mis)pairing configuration with guanine. On the basis of
their substrate spectra, the two DNA glycosylases MBD4
and TDG appear to be most suitable for this purpose, and
both have been implicated in one way or another in DNA
demethylation as discussed. The biological functions
associated with these activities, however, still need to be
clarified. Considering, for instance, the reported involve-
ment of MBD4 in hormone-induced promoter demethyla-
tion, and the requirement of such demethylation for
derepression of select genes during embryogenesis, it is
surprising that Mbd4 knockout mice develop normally and
display no apparent epigenetic abnormality (Millar et al.
2002; Wong et al. 2002). So, either promoter demethylation
during embryogenesis is not developmentally important, or
MBD4 is not or only redundantly involved in these
processes. The phenotype of Tdg knockout mice, however,
has provided more direct evidence for an epigenetic
function.
Disruption of TDG in mouse causes embryonic lethality
(Cortazar et al. 2011; Cortellino et al. 2011), most likely
because TDG-deficient cells fail to properly establish and/
or maintain cell-type-specific gene expression programs
during cell lineage commitment (Cortazar et al. 2011). This
phenotype coincides with the occurrence of aberrant
chromatin modifications at promoters of misregulated
genes: a loss of active histone marks (H3K4me2), a gain
of repressive histone marks (H3K9me3, H3K27me3) and,
nota bene, a gradual accumulation of CpG methylation
(Cortazar et al. 2011). Together with evidence for a TDG-
dependent engagement of BER at affected gene promoters
(Cortazar et al. 2011; Cortellino et al. 2011), this suggests
that TDG protects CpG-rich promoters from aberrant
hypermethylation by active demethylation of erroneously
methylated cytosines.
TDG may also contribute to active demethylation of
originally methylated sequences. Tissues of TDG defi-
cient embryos showed hypermethylation at the Alb1
enhancer and the Tat glucocorticoid-responsive unit, both
undergoing demethylation in the process of tissue specific
gene activation (Cortellino et al. 2011). These results can,
however, be interpreted in two ways; while the hyper-
methylation measured in the absence of TDG can indeed
be explained by inefficient active CpG demethylation
during tissue differentiation, it can equally well be
accounted for by a lack of TDG-dependent maintenance
of the unmethylated state following successful active
demethylation through a different pathway. Hence, while
the concept of TDG-mediated active demethylation in the
maintenance of hypomethylated states at CpG-rich gene
promoters is well supported, its potential contribution to
demethylation of methylated sequences requires further
validation.
The functions of MBD4 and TDG in mediating DNA
demethylation are clearly distinct but there might be a
partial overlap; TDG might compensate for the loss of
MBD4 in knockout mice but obviously not vice versa. A
plausible scenario would be that MBD4 is primarily
involved in the demethylation of methylated sequences in
the context of developmental gene activation, whereas
TDG’s function is to protect unmethylated promoter
sequences across the genome from aberrant de novo
methylation. This would be supported by the ability of
MBD4 to bind to methylated CpGs, and the preferential
association of TDG with unmethylated gene promoters.
Conclusion
Given their ability to interrogate the surface of DNA
bases by flipping them out of the helix into a selective
active site pocket, DNA glycosylases represent efficient
tools to specifically recognize unduly modified bases and
eliminate them from the DNA, thereby enforcing genetic
integrity. Yet, while being perfectly equipped to function
in DNA repair, their structure and mode of action could
provide for more. This is supported by accumulating
evidence for non-canonical functions of these DNA-
probing enzymes, the most recent and most intensely
discussed being an involvement in DNA demethylation
and epigenetic control. Further studies will shed light on
the mechanism surrounding the action of DNA glyco-
sylases in such a context, from the signals required for
the temporal and spatial regulation of their action to the
co-factors necessary for efficient base-flipping and
excision.
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